id,weighted_error_percent,schema_version,error_percent,weighted_quality_rating,title,quality_score,weighted_quality_score,completeness_percent,publisher,pid,quality_rating,weighted_completeness_percent
0056a5c8-4f98-4e9e-b74a-bd498be71c0d,46.03,1.1.7,46.51,Not Rated,KPIC,29.12,29.36,4.76,,11dee486-22d2-4cf4-a955-512249e61645,Not Rated,4.76
00a784aa-ea3a-4a57-9612-81b0745e0763,50.79,1.1.7,51.16,Not Rated,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Wales,33.95,41.27,19.05,,602cbc9b-0113-4712-8c4a-0efe8d86b77c,Not Rated,33.33
00e1b694-3072-4d25-ab2d-a1de59629ae3,50.79,1.1.7,51.16,Not Rated,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),33.95,41.27,19.05,,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,Not Rated,33.33
00ffee70-43d6-4a81-8568-32b0b6d9e39c,26.98,1.1.7,27.91,Not Rated,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,61.05,59.52,50.0,ALLIANCE > HQIP,b0979e07-3331-408f-853b-5eeba80ce8f9,Not Rated,46.03
0121c132-5be6-414e-853b-885ff301854f,17.46,1.1.7,18.6,Bronze,PTCL Biobank,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,19fa25a7-c15d-441c-b635-ad49043e7a96,Bronze,60.32
01470238-7a17-47a5-a131-17178ba26a0a,15.87,1.1.7,16.28,Bronze,Human Developmental Biology Resource (HDBR),76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,Silver,60.32
01a5c44c-c2fd-4c1e-856e-9875ee1beafa,60.32,1.1.7,55.81,Not Rated,BathTAP Switching Cohort 2,31.62,36.5,19.05,,ea1aca1f-6ddb-44a0-b530-0645a26b2bee,Not Rated,33.33
0315886c-f34a-4f1d-8f76-2dfa80a6e949,15.87,1.1.7,16.28,Bronze,Cam-UroOnc Biorepository,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,21044030-1cd5-46b1-b072-c9959fd330b4,Silver,60.32
039c0b29-63f6-4ce9-8d89-87012a52e44f,33.33,1.1.7,32.56,Not Rated,The Leicester City and County Chronic Kidney Disease Cohort,48.0,45.24,28.57,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,4dfec37d-dd24-465f-85ea-30209aff3a26,Not Rated,23.81
03abf37c-41b2-4ff3-9c09-2cfea438526a,20.63,1.1.7,20.93,Bronze,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",70.48,66.67,61.9,HUB > BREATHE,2f1244b8-7cbf-4fa3-8534-433efd769d48,Bronze,53.97
03b7acd5-ecfe-4cd6-a6dc-bf9e3f98c772,55.56,1.1.7,53.49,Not Rated,National Asthma and COPD Audit (NACAP): Adult Asthma secondary care clinical,32.78,38.88,19.05,,becd2624-9a01-4f01-bcf8-56e94545a49a,Not Rated,33.33
03cdf92e-b6ea-4e1d-a861-e9da4372ed36,55.56,1.1.7,53.49,Not Rated,NIHR BioResource: Consent records,32.78,38.88,19.05,,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,Not Rated,33.33
03fb3b18-4419-44f7-a035-9ddfecfcadfc,36.51,1.1.7,30.23,Not Rated,COVIDsortium,64.64,65.87,59.52,OTHER > UNIVERSITY COLLEGE LONDON,529f126b-660c-4c31-aeb2-765dac1d9df0,Not Rated,68.25
0477b06f-cbed-4949-982e-ce248a47ed1a,36.51,1.1.7,37.21,Not Rated,SOLUS,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,e653b264-3e44-4ed1-a376-86df45db7f72,Not Rated,14.29
04f22c93-53df-440a-a71a-50d6827450bc,22.22,1.1.7,18.6,Gold,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),87.13,87.31,92.86,HUB > DISCOVER NOW,ed08c844-343e-44fa-a02d-3ad5ecf25184,Gold,96.83
04f28919-aa6c-4beb-b186-0ad0043c1c6c,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Sample holding,32.78,38.88,19.05,,f2af20f9-af84-40ce-8a07-7d095948653e,Not Rated,33.33
04fb4aac-415b-4493-986b-65bbef5214d3,36.51,1.1.7,37.21,Not Rated,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,44.49,42.86,26.19,ALLIANCE > HQIP,1982d9ef-890a-41ff-a86a-de61d65aaa09,Not Rated,22.22
05716e41-9842-4c07-8ddd-af9f9231e056,15.87,1.1.7,13.95,Gold,Bowel Screening Wales,90.64,92.06,95.24,ALLIANCE > SAIL,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,Gold,100.0
05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,20.63,1.1.7,16.28,Gold,COVID-19 Shielded People list,89.48,89.69,95.24,ALLIANCE > SAIL,dc22db56-8791-4e96-9ce6-6b6a58b1241f,Gold,100.0
0664f988-276e-4268-af43-1986a3101f38,15.87,1.1.7,16.28,Bronze,INCA Trial,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,edd55990-a616-4a9c-a4a2-38af136a349b,Silver,60.32
069c213c-eb04-463e-a300-7614c03cf623,15.87,1.1.7,16.28,Bronze,HCV Research UK,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,01492322-9b33-41cc-9f51-484024e45878,Silver,60.32
06dee089-8c10-4a8b-aa94-7cb699dc3c80,19.05,1.1.7,18.6,Gold,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",87.13,89.68,92.86,HUB > PIONEER,0eb789bb-0047-46ac-83ff-631f31e98da0,Gold,98.41
0711cc7e-80d5-4781-a1ab-2637ea176ceb,36.51,1.1.7,37.21,Not Rated,Millennium Clinical Events,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,Not Rated,14.29
0715a950-3999-46d8-a646-6496866638a1,12.7,1.1.7,11.63,Silver,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,84.66,79.37,80.95,HUB > BREATHE,bb8de9d2-cc38-4c40-b104-ffd167f64f76,Silver,71.43
077a21b9-5c5a-4c68-a9f0-b4fa3384aead,50.79,1.1.7,51.16,Not Rated,COVID-19 Sequence Data,33.95,41.27,19.05,,602cbc9b-0113-4712-8c4a-0efe8d86b77c,Not Rated,33.33
0786f8b9-77b1-4bc4-8464-28c664298adb,55.56,1.1.7,53.49,Not Rated,Cancer Network Information System (CNIS / CANISC),32.78,38.88,19.05,,da91f0eb-1761-485b-8b7f-9121b6a1d004,Not Rated,33.33
07b82dd5-adc3-42c5-8a60-914042b5bc40,26.98,1.1.7,27.91,Not Rated,Exome sequencing,52.71,52.38,33.33,UK Biobank,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,Not Rated,31.75
07e3ac82-a38d-45f3-9933-07439f6a761d,25.4,1.1.7,25.58,Silver,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,75.31,79.36,76.19,HUB > PIONEER,323dc330-aad9-472a-b579-ab66f5f75906,Bronze,84.13
084ab1d8-78f6-4c04-b829-6891c6463ca9,50.79,1.1.7,51.16,Not Rated,Breast Test Wales (SBTW),33.95,41.27,19.05,,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,Not Rated,33.33
08846261-45f0-4bcf-9801-fe785dcef1c9,22.22,1.1.7,20.93,Silver,Careers Wales dataset,80.01,83.34,80.95,ALLIANCE > SAIL,e4004e0e-6adb-4b11-82c2-af0caf61d751,Silver,88.89
089a0dd5-b2bd-4152-8033-d53552fe2c80,46.03,1.1.7,46.51,Not Rated,Klang Asthma Cohort,29.12,29.36,4.76,,a2eddb27-c8bd-42ae-94f8-2a3026220da3,Not Rated,4.76
08bffe91-46aa-4718-ab3a-9e9b60353ea2,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Primary Shoulder Replacement dataset,32.78,38.88,19.05,,0e903b9e-a329-478a-937c-480eecee4996,Not Rated,33.33
08d1a4f5-92b0-4142-a38d-8bac734086e8,55.56,1.1.7,53.49,Not Rated,Tayside Pathology,32.78,38.88,19.05,,419e5a82-2d82-48a7-a8f3-a83e64a54e92,Not Rated,33.33
0910383a-44d6-4652-98da-550df7204416,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),32.78,38.88,19.05,,750063ea-6bfd-4492-9748-2a18080cf6ea,Not Rated,33.33
0942304f-8b91-4258-af9c-3a1801c7e79f,25.4,1.1.7,25.58,Silver,The acute presentation of pregnant women to non-maternity Emergency departments,74.12,78.57,73.81,HUB > PIONEER,86632207-1e57-4272-b178-ea069a13cae1,Bronze,82.54
0969dc51-1ab9-469a-8b35-3ec63f30fa89,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme - National Heart Failure Audit,29.12,29.36,4.76,,834618f3-0c6d-4ed2-abae-39208c6b3080,Not Rated,4.76
097cc6bd-ce98-47ec-a73d-5d2c250f2697,15.87,1.1.7,16.28,Bronze,ICON9 Trial,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,1fdf266c-d5d8-418d-a423-81265da540a2,Silver,60.32
09d1cc0f-4b4d-4525-853a-012ece4a1ab2,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Revision Hip Replacement dataset,32.78,38.88,19.05,,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,Not Rated,33.33
09f04291-670d-4db0-a3e4-7e0d84555231,46.03,1.1.7,46.51,Not Rated,Development of ELISA and Rapid Testing Kits for COVID-19,29.12,29.36,4.76,,6b2aca2c-b03a-44ba-80a1-883b744421b6,Not Rated,4.76
0a137eec-4288-400b-8c47-0275319c9f09,46.03,1.1.7,46.51,Not Rated,Lothian Birth Cohort 1921 (LBC1921),29.12,29.36,4.76,,df288318-6663-417d-9870-666e75920bed,Not Rated,4.76
0abfceb7-5a56-4559-b0d4-88326e0331a3,20.63,1.1.7,16.28,Gold,Pathology Data from WRRS,89.48,89.69,95.24,ALLIANCE > SAIL,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,Gold,100.0
0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,55.56,1.1.7,53.49,Not Rated,Pathology Data from WRRS (PATH) - Legacy,32.78,38.88,19.05,,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,Not Rated,33.33
0ac9438e-da8d-4488-bdc6-8285d1401b1d,28.57,1.1.7,25.58,Silver,Census 2011 E&W - Household structure for COVID-19 models,76.5,78.57,78.57,NCS > OFFICE FOR NATIONAL STATISTICS,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,Silver,85.71
0b06a5c0-f015-4ce6-bf53-cab304334ae0,46.03,1.1.7,46.51,Not Rated,Determinants of Adolescent Social Wellbeing & Health (DASH),29.12,29.36,4.76,,9d242d12-2d2e-4941-93e4-9ec40d239dd1,Not Rated,4.76
0b7ea326-fc05-4aca-a962-3f93128b91d1,19.05,1.1.7,18.6,Bronze,HPB Biobank,75.22,70.64,69.05,ALLIANCE > TISSUE DIRECTORY,ebe6c9dd-fb95-4301-a929-c21b8077753a,Bronze,60.32
0b835c3e-9968-4f12-8aad-c4f10a7d460f,50.79,1.1.7,51.16,Not Rated,Welsh Demographic Service Dataset (WDSD),33.95,41.27,19.05,,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,Not Rated,33.33
0c219a61-a1d6-4c5b-bec2-3537454e4137,19.05,1.1.7,18.6,Bronze,Teleconsultation in remote rural India: management of COPD and Asthma,74.03,69.05,66.67,HUB > BREATHE,de496590-26b3-4e74-bc5e-1ff5c83f5b43,Bronze,57.14
0c50801d-1079-4879-b608-5e8f112b313f,19.05,1.1.7,18.6,Bronze,Tissue Access for Patient Benefit (TAPb),75.22,70.64,69.05,ALLIANCE > TISSUE DIRECTORY,35985f8e-f01a-41cc-a9e2-30299d3d6eed,Bronze,60.32
0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,19.05,1.1.7,16.28,Bronze,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),77.58,69.84,71.43,HUB > BREATHE,25bc9862-5b6c-4dda-80b2-46642d9e518a,Silver,58.73
0c8fcf41-177b-4ca8-a01f-d86ca8bd5a03,55.56,1.1.7,53.49,Not Rated,Substance Misuse Dataset (SMDS),32.78,38.88,19.05,,291c0dd4-0988-42d2-8e0b-878a892add57,Not Rated,33.33
0c98200b-48b5-418a-b8d0-a7708abc1f39,30.16,1.1.7,32.56,Not Rated,Mental Health Services Data Set - Community,57.53,57.94,47.62,ALLIANCE > NHS DIGITAL,f3bb6a68-2c32-40a7-9a79-61a718068893,Not Rated,46.03
0cd32bab-357b-4ea2-bba0-eca90b7b36e9,60.32,1.1.7,55.81,Not Rated,"Problem, Diagnosis and Procedures",31.62,36.5,19.05,,51b41359-1558-48df-9950-88f75ca6ac4c,Not Rated,33.33
0d65fabc-6cb0-4a77-a01d-cb341b0b053c,46.03,1.1.7,46.51,Not Rated,NIHR IBD BioResource: NHS Trust data,29.12,29.36,4.76,,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,Not Rated,4.76
0d6ab9af-c43b-490d-b39c-2d72de46a661,15.87,1.1.7,16.28,Bronze,The Cleft Collective,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,12288034-00a4-47a8-a779-1cf7a55270e4,Silver,63.49
0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,15.87,1.1.7,16.28,Bronze,MRC Brain Banks Network,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,Silver,60.32
0d79e0d8-9b3d-4450-9c34-0539673dc9a5,15.87,1.1.7,16.28,Bronze,Leeds NIHR Biomarker Research Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,8648d251-6186-4383-82fc-c036a87c3842,Silver,60.32
0ddb1d67-e0b9-4b08-898c-9957a09d7e69,55.56,1.1.7,53.49,Not Rated,Renal Register – PHS National Dataset,32.78,38.88,19.05,,32edd77d-533c-423f-b045-937507f8505d,Not Rated,33.33
0ddcb454-2372-4180-9ba0-a7e1896d4fe2,33.33,1.1.7,32.56,Bronze,Real Time Data Network (RTDN),70.62,73.02,73.81,HUB > DATA-CAN,616c4488-65a5-4608-a187-0c6bc78b359a,Bronze,79.37
0e07413c-892c-4f06-bd22-2a917eb5c905,30.16,1.1.7,27.91,Bronze,Cancer Registration Data,71.76,74.61,71.43,ALLIANCE > NHS DIGITAL,2ed7bbbc-80db-46c2-a45b-632dda40794b,Bronze,79.37
0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Episodes,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,29c61f09-c4a1-425f-9bbc-888c23d99516,Not Rated,77.78
0e9e034a-913a-4764-8615-961c3647b268,50.79,1.1.7,51.16,Not Rated,"Cancer and cerebrovascular events: frequency, cancer types and outcomes",33.95,41.27,19.05,,ae3fd121-141d-466b-b002-06c3959116d0,Not Rated,33.33
0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,15.87,1.1.7,16.28,Bronze,Cardamon Clinical Trial Samples,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,Silver,60.32
0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,50.79,1.1.7,51.16,Not Rated,Better Rx BRIT2 Patient GP Dataset,33.95,41.27,19.05,,656b2c22-9e57-4f15-9b3c-1969da6495ca,Not Rated,33.33
0f1a2789-e8b3-4e36-9622-65d76cebff26,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme -  Congenital Heart Disease Audit (NCHDA),29.12,29.36,4.76,,2b640175-725a-465f-9aec-6794e6d27791,Not Rated,4.76
0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,15.87,1.1.7,16.28,Bronze,UKALL14 Trial,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,b5533cb5-0c59-495b-9b11-3c401daeb958,Silver,60.32
0fc61ace-397d-4489-9e62-77f88082e775,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,Not Rated,77.78
1045ca85-0c8f-453b-9da3-778144cf3744,46.03,1.1.7,46.51,Not Rated,"National Audit of Dementia - spotlight audit on  psychotropic medication, 2019",29.12,29.36,4.76,,949d9d7a-a3f1-480a-8563-3fb024300561,Not Rated,4.76
1046cc4d-bd35-43de-a156-80bddb3eb415,55.56,1.1.7,53.49,Not Rated,COVID-19 Test Trace and Protect (CTTP),32.78,38.88,19.05,,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,Not Rated,33.33
108d652d-3afb-4001-8ae6-b5a42e8b2daa,50.79,1.1.7,51.16,Not Rated,NHS 111 Dataset (NHSO),33.95,41.27,19.05,,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,Not Rated,33.33
112db000-f69f-47a4-8dd7-db7b6d839e68,46.03,1.1.7,46.51,Not Rated,Bangladesh Asthma Hajj Study,29.12,29.36,4.76,,27e1ffc7-5804-40e2-83e2-93f570906127,Not Rated,4.76
115109e7-9a35-420f-831e-0707bc96375c,55.56,1.1.7,53.49,Not Rated,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,32.78,38.88,19.05,,3d2d9c5e-6111-4583-a6db-07affd628f1e,Not Rated,33.33
1199f5b5-99f0-4aae-9769-ab754f05dcdb,33.33,1.1.7,32.56,Not Rated,National Maternity and Perinatal Audit Organisational Survey 2019,48.0,45.24,28.57,ALLIANCE > HQIP,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,Not Rated,23.81
125202ff-1d00-4f8e-96e1-1d5a310ab326,50.79,1.1.7,51.16,Not Rated,2019 UK Parkinson's Audit - Occupational therapy,33.95,41.27,19.05,,9890eee9-44d4-49f7-8674-16c05a5f82e0,Not Rated,33.33
12d62b02-2167-407d-acdb-6ddb9d251d36,46.03,1.1.7,46.51,Not Rated,NIHR IBD BioResource: SNP imputation data,29.12,29.36,4.76,,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,Not Rated,4.76
12dba445-dfa9-46af-abc0-5bd3701061a7,17.46,1.1.7,18.6,Bronze,UK primary Sjogren's syndrome Registry,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,Bronze,60.32
135f2650-ea0c-4cad-80ac-c86449a176a8,55.56,1.1.7,53.49,Not Rated,Tayside Radiology,32.78,38.88,19.05,,af10ec29-1866-4726-b33f-3948afe182f2,Not Rated,33.33
1406c52a-e5d6-4c57-883d-62e405eb604a,17.46,1.1.7,18.6,Bronze,Manchester Eye Tissue Repository,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,47fc8f03-eba1-4efa-ae3e-148a76b56517,Bronze,60.32
140ce7b6-8a58-4d0f-a24b-81b0f4289a68,55.56,1.1.7,53.49,Not Rated,Referral to Treatment Times (RTTD),32.78,38.88,19.05,,0bf54842-c1db-4bdb-9f55-c5be490bf758,Not Rated,33.33
1450ff1a-4526-4a6e-b9e9-25969878449d,22.22,1.1.7,20.93,Not Rated,COPDMAP Consortium,70.48,64.28,61.9,HUB > BREATHE,bcbc41cb-99f7-482e-ba3d-561164abbd4e,Bronze,50.79
145916c8-d3ca-4465-a719-93dd0770a6e4,17.46,1.1.7,16.28,Not Rated,Optimum Patient Care Research Database,69.24,64.28,54.76,HUB > BREATHE,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,Bronze,46.03
147576e2-b445-4d36-aecc-d604302bd34e,55.56,1.1.7,53.49,Not Rated,National Asthma and COPD Audit  (NACAP): secondary care  – CYP asthma (org),32.78,38.88,19.05,,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,Not Rated,33.33
148ebbaa-28f4-42e0-a27f-8587e516c3bf,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Sweat Tests,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,34f0c2bd-d42e-4441-a89b-e0e384f12afa,Gold,100.0
15805559-2115-4822-b91f-635de36fb289,20.63,1.1.7,16.28,Gold,Active Adult Survey,89.48,89.69,95.24,ALLIANCE > SAIL,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,Gold,100.0
1584af1e-9683-4727-8c9b-9bea8beaa68d,28.57,1.1.7,25.58,Silver,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,77.69,80.16,80.95,HUB > PIONEER,5bf9bf39-3cd7-4a54-994b-9914405f945e,Silver,88.89
15aebc30-1e52-4a36-8b17-f9801f35f649,46.03,1.1.7,46.51,Not Rated,Health and Employment After Fifty (HEAF),29.12,29.36,4.76,,ea2d54a2-a6d4-4e82-b2e4-95184f00bbdc,Not Rated,4.76
15efea36-d022-495c-a5b6-90f51631a643,19.05,1.1.7,18.6,Gold,GENOMICS ENGLAND 100K QUICK VIEW,88.32,90.47,95.24,GENOMICS ENGLAND,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,Gold,100.0
1638cce2-12f5-410b-9624-86d2f407c502,26.98,1.1.7,20.93,Silver,COVID-19 Clinical Information Network (CO-CIN),81.2,80.95,83.33,ALLIANCE > ISARIC 4C,84336be3-23bd-466e-b29b-df48db897665,Silver,88.89
16445ebd-bd45-4ded-a7ae-05f33f676598,15.87,1.1.7,16.28,Bronze,MFT Biobank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,d17efe5d-325f-4fcf-b25e-87d1f6269bea,Silver,63.49
167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,15.87,1.1.7,16.28,Bronze,Cambridge Blood and Stem Cell Biobank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,c51ab59a-33ce-4145-a642-7f3f96bca545,Silver,60.32
16d40748-66f1-4fc3-bdb3-7c8103cadeb7,50.79,1.1.7,51.16,Not Rated,2019 UK Parkinson's Audit - Physiotherapy,33.95,41.27,19.05,,27690c58-a5da-4359-909a-8e19ff6ca463,Not Rated,33.33
16f11980-e2e7-4f79-8e33-39ba4dc3547f,60.32,1.1.7,55.81,Not Rated,Suspected Cancer Pathway Daily (SPCD),31.62,36.5,19.05,,9ea2f685-d6c2-49fe-a0e2-735910584d67,Not Rated,33.33
172242ce-a1c5-4915-9c71-686f6e7d5789,36.51,1.1.7,37.21,Not Rated,ARIA Medonc,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,88eb839c-bc51-45f0-b15e-ea89bba9ffca,Not Rated,14.29
1785cc1a-ace0-4980-8352-5977b2b72969,28.57,1.1.7,25.58,Silver,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,77.69,80.16,80.95,HUB > PIONEER,5acfadf9-21a7-4517-a1b2-620d20469611,Silver,88.89
17cd75a2-e2b5-440c-89b1-22c9f3b03a03,17.46,1.1.7,18.6,Bronze,IoN Trial,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,e10a660d-b84c-475f-abd4-024dd1af7a5d,Bronze,60.32
1900af1a-bd21-4157-ac48-203eec682073,20.63,1.1.7,16.28,Gold,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,89.48,89.69,95.24,ALLIANCE > GENOMICS ENGLAND,98999c67-0133-4f11-be95-b84ee5727c84,Gold,100.0
19231ac4-4256-46e5-958b-b98d12e036f8,46.03,1.1.7,46.51,Not Rated,UK Biobank - Online Questionnaires,29.12,29.36,4.76,,70dc8c5d-2dfa-429d-bfd3-695f5904c244,Not Rated,4.76
19525c5f-92ee-41b6-bb79-673624b27bdd,55.56,1.1.7,53.49,Not Rated,Improving Access to Psychological Therapies Data Set,32.78,38.88,19.05,,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,Not Rated,33.33
196dc924-9289-4f31-900d-d9310dc34361,50.79,1.1.7,51.16,Not Rated,Patient Episode Dataset for Wales (PEDW),33.95,41.27,19.05,,4c33a5d2-164c-41d7-9797-dc2b008cc852,Not Rated,33.33
199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,55.56,1.1.7,53.49,Not Rated,COVID-19 Consolidated Deaths (CDDS),32.78,38.88,19.05,,70e37f44-5c3e-4c83-a42a-89b3476d1d45,Not Rated,33.33
1a412ff0-6275-4cab-a485-bb76befc7afe,15.87,1.1.7,16.28,Bronze,UK real-world lymphoid tissue bank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,c9f82f86-79e1-4067-932f-5e6dc939006d,Silver,63.49
1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient CFQ-R,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,Gold,100.0
1bafa55c-5616-47db-8ac8-798038146254,50.79,1.1.7,51.16,Not Rated,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",33.95,41.27,19.05,,36886b21-12ff-45e7-82bc-fb5308c12450,Not Rated,33.33
1bbcb128-dd3e-4f56-81d5-17df2dab3c52,34.92,1.1.7,34.88,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,46.84,44.45,28.57,ALLIANCE > HQIP,4559a14f-563d-4fd2-93ae-27c6c0fd891e,Not Rated,23.81
1bc9ccd6-44d0-43db-843a-f9fa293c4090,31.75,1.1.7,30.23,Silver,Mother-Baby Link for CPRD GOLD,75.36,79.37,80.95,ALLIANCE > CPRD,b734a1b5-37d3-4859-85d4-bf011df2a951,Bronze,90.48
1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,23.81,1.1.7,23.26,Silver,NIHR BioResource: Health and Lifestyle Questionnaire,77.66,80.95,78.57,ALLIANCE > NIHR BIORESOURCE,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,Silver,85.71
1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,55.56,1.1.7,53.49,Not Rated,Deaths General Registrar Office – National Records Scotland,32.78,38.88,19.05,,5362cfea-d554-43ba-916a-4460da39cc0c,Not Rated,33.33
1c942123-845d-4c31-9f04-8e044be00e58,31.75,1.1.7,30.23,Silver,HES Admitted Patient Care data for CPRD Aurum,77.74,80.16,85.71,ALLIANCE > CPRD,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,Silver,92.06
1ca52b96-27d9-491a-b5f0-5787852d39d2,46.03,1.1.7,46.51,Not Rated,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,29.12,29.36,4.76,,185e9c5c-e686-4174-bcba-5e2f584b5cbb,Not Rated,4.76
1cb397d5-a86d-4354-b1f7-565b7ef5054b,23.81,1.1.7,23.26,Not Rated,Asthma self-management behaviour in Bangladesh and Pakistan,65.75,61.11,54.76,HUB > BREATHE,3b378225-48e1-45fa-b62d-fc4ed4b39bec,Not Rated,46.03
1cc3dc2c-adf3-4c66-ab7b-cfc00388a6a8,60.32,1.1.7,55.81,Not Rated,Labour Force Survey (Person),31.62,36.5,19.05,,8c60a308-1e47-4a0c-8b69-9259f05338cb,Not Rated,33.33
1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,55.56,1.1.7,53.49,Not Rated,Tayside Microbiology: Tests,32.78,38.88,19.05,,826be5be-9977-49f9-b6d1-83ed9de08ebe,Not Rated,33.33
1d46f920-e253-4e7d-a72a-843d068d3c69,20.63,1.1.7,16.28,Gold,Critical Care Dataset,89.48,89.69,95.24,ALLIANCE > SAIL,1789286a-deaf-49df-88cd-660e92934af6,Gold,100.0
1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,30.16,1.1.7,32.56,Not Rated,Mental Health Services Data Set - Service Users,57.53,57.94,47.62,ALLIANCE > NHS DIGITAL,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,Not Rated,46.03
1e465797-5e54-4667-9120-d373e75be64f,38.1,1.1.7,39.53,Not Rated,Somerset Cancer Registry,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,Not Rated,15.87
1e875c15-4a99-4c3e-9621-e4ebf594469f,55.56,1.1.7,53.49,Not Rated,UK Renal Registry - CKD and AKI on Dialysis Dataset,32.78,38.88,19.05,,b7152f21-0f2c-4ed9-a013-51e725242f94,Not Rated,33.33
1f6118ce-4051-4ba6-b13e-63dca0032d8d,55.56,1.1.7,53.49,Not Rated,Emergency Care Data Set (ECDS),32.78,38.88,19.05,,7749d90e-dd7a-4697-8a9c-666491c64a0c,Not Rated,33.33
1fd6e7d5-266a-4c79-b492-7045910cd291,55.56,1.1.7,53.49,Not Rated,COVID-19 Shielded People List (CVSP),32.78,38.88,19.05,,dc22db56-8791-4e96-9ce6-6b6a58b1241f,Not Rated,33.33
203cc8b4-7711-4d1f-9213-af982d6cff28,33.33,1.1.7,32.56,Not Rated,Sentinel Stroke National Audit Programme Clinical Dataset,48.0,45.24,28.57,ALLIANCE > HQIP,059a6495-a7d5-435b-8e2b-806c6ccccf2e,Not Rated,23.81
208f79dc-2294-4370-8f16-0d0f7bec9d10,23.81,1.1.7,20.93,Gold,Moorfields Eye Image Dataset Release 001,85.97,86.51,92.86,HUB > INSIGHT,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,Silver,96.83
211e90db-3cfe-4bd4-b349-784de809d429,50.79,1.1.7,51.16,Not Rated,Welsh Ambulance Services NHS Trust (WASD),33.95,41.27,19.05,,4dd97609-2753-46ed-8066-3482d6dbdb34,Not Rated,33.33
21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,31.75,1.1.7,32.56,Bronze,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,74.19,69.84,80.95,ALLIANCE > SLaM,a25a9892-9141-4e78-8415-945ba73da11e,Bronze,71.43
21d1277b-baf8-4fb8-826e-3f4910d18098,46.03,1.1.7,46.51,Not Rated,NIHR BioResource: Returned datasets,29.12,29.36,4.76,,261bcf76-8621-4f0d-b2e6-310993d73daa,Not Rated,4.76
22173802-db99-475e-b95e-d69798734077,30.16,1.1.7,25.58,Silver,NHS 111 Dataset,76.5,77.78,78.57,ALLIANCE > SAIL,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,Silver,85.71
226b52f4-1be8-46c2-86a4-261eb48ec542,50.79,1.1.7,51.16,Not Rated,SAIL Dementia e-Cohort (SDEC),33.95,41.27,19.05,,f48b7c05-6a44-480c-84c6-4f7a684f29f8,Not Rated,33.33
22739526-317f-4b0e-a23b-ece0c859958f,15.87,1.1.7,16.28,Bronze,QTL Programme at MRC HGU,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,351cc017-caff-4303-8a48-1aa1b90fce2b,Silver,63.49
227fe0ea-d76e-4c14-a33e-ca255380937d,15.87,1.1.7,16.28,Bronze,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,Silver,60.32
22974866-44c7-4176-9c51-6b57a1dda39d,15.87,1.1.7,16.28,Bronze,University of Liverpool - GCP Laboratory Facility,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,029b7f0f-911e-46ce-837f-031959f067da,Silver,60.32
22aecb42-9ea3-4d60-b392-d3cdd0a806f8,38.1,1.1.7,39.53,Not Rated,CDE Encounters,40.95,40.48,21.43,ALLIANCE > BARTS HEALTH,3598723f-62fb-4377-9a8b-b264ced1aabd,Not Rated,19.05
239e8253-a997-4676-8940-16b74a004365,28.57,1.1.7,23.26,Silver,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,85.99,85.72,95.24,GENOMICS ENGLAND,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,Silver,100.0
23d790f2-de80-4c7a-b57a-03c8467c54e9,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Accident & Emergency Dataset (PHS/National),32.78,38.88,19.05,,750063ea-6bfd-4492-9748-2a18080cf6ea,Not Rated,33.33
24f2374a-e804-434e-a805-e29b332b0693,17.46,1.1.7,18.6,Bronze,SWIFT-RTB,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,d387ed7c-14fa-49e2-8ced-df0f9372eb88,Bronze,60.32
2550f814-0849-4d19-b83e-edef46b157fb,26.98,1.1.7,23.26,Silver,Intensive Care National Audit and Research Centre - Covid19,80.03,81.75,83.33,ALLIANCE > SAIL,add6226b-0f21-439a-84a6-51dc26cdc425,Silver,90.48
260f4fb2-b40a-4e20-888d-1e3c9c2ddd8e,55.56,1.1.7,53.49,Not Rated,DOLORISK,32.78,38.88,19.05,,0a467180-a898-44d8-a586-ca4762de362e,Not Rated,33.33
262c28eb-151e-4ab2-a813-81841f5292eb,26.98,1.1.7,27.91,Silver,Patient postcode linked deprivation measures for CPRD Aurum,75.33,80.16,78.57,ALLIANCE > CPRD,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,Bronze,87.3
263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,2964d1b0-2630-468a-82c1-00f5ac901b3d,Not Rated,77.78
263f28a4-9835-4856-b1c3-0a0d4085f207,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v2.6 (Sensitive),60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,dc37fcd6-1e68-46e5-b73d-4896e069746a,Not Rated,77.78
263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,15.87,1.1.7,16.28,Bronze,Arden Tissue Bank,78.77,74.6,73.81,ALLIANCE > TISSUE DIRECTORY,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,Silver,65.08
268d54cf-189e-46ea-8f0e-71ad8907bea3,50.79,1.1.7,51.16,Not Rated,Welsh Dispensing Dataset (WDDS),33.95,41.27,19.05,,50ef6443-ed4b-40f9-97fb-1cfd53be6579,Not Rated,33.33
26ac9d75-df76-49e5-ba41-d4c0e83a8765,50.79,1.1.7,51.16,Not Rated,Child Health Systems Programme - 27-30Months Review,33.95,41.27,19.05,,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,Not Rated,33.33
270b55a8-a9ee-44ee-8db6-eb214e721eea,17.46,1.1.7,18.6,Bronze,Scottish Human Papillomavirus Archive,78.8,74.6,76.19,ALLIANCE > TISSUE DIRECTORY,4883530f-1c8d-49aa-886e-ea3b958772ea,Silver,66.67
273e091c-d0b3-4529-9cd2-4bc1a1b6195a,25.4,1.1.7,25.58,Silver,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",76.5,80.16,78.57,HUB > PIONEER,38ff49e2-dffa-4103-87a8-386f9f424d22,Silver,85.71
274238a8-ec06-4ee4-83ae-a419a925d43b,28.57,1.1.7,27.91,Not Rated,Unified Cohorts Research Network,53.9,50.8,35.71,HUB > BREATHE,cffcf30d-cedb-421b-a5dc-6726633cb99a,Not Rated,30.16
27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,60.32,1.1.7,55.81,Not Rated,NIHR IBD BioResource: SNP chip data,31.62,36.5,19.05,,3c749cfc-4008-4916-b64f-969d6a754c0f,Not Rated,33.33
2887c7b4-66d4-404c-a352-83fcff441568,50.79,1.1.7,51.16,Not Rated,Cholecystectomy and post-operative complications from over 9000 surgical cases,33.95,41.27,19.05,,4abba8ec-9a67-4334-91fc-e624173f3055,Not Rated,33.33
2918676c-74b0-4a4e-8814-697e9aa6a81c,28.57,1.1.7,30.23,Silver,National Radiotherapy Dataset (RTDS) for CPRD GOLD,75.36,80.16,80.95,ALLIANCE > CPRD,56a66de8-3470-4a36-ac71-4d5471e72654,Bronze,88.89
29de7178-dcf3-4859-bd96-ca6d944db5f8,39.68,1.1.7,41.86,Not Rated,DENDRITE Dataset,38.59,38.09,19.05,ALLIANCE > BARTS HEALTH,31920b14-d114-410f-8255-522e6451c44e,Not Rated,15.87
2a17a802-a2da-4bfc-8571-b2015350eed4,46.03,1.1.7,46.51,Not Rated,Treatment of Bangladeshi children with severe pneumonia,29.12,29.36,4.76,,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,Not Rated,4.76
2a4ef602-0485-47d2-a6f7-9e2ccf849a5d,55.56,1.1.7,53.49,Not Rated,National Audit of Care at the End of Life - Quality Survey,32.78,38.88,19.05,,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,Not Rated,33.33
2a725f9d-c4a9-4c89-aa37-b3c25cc83389,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,7c2b435c-5442-4a05-9b8d-08024ec57c30,Not Rated,77.78
2a826781-0f58-44d6-89f3-7d899eb3cd45,55.56,1.1.7,53.49,Not Rated,National Asthma and COPD Audit (NACAP): COPD secondary care clinical dataset,32.78,38.88,19.05,,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,Not Rated,33.33
2b09ea87-5b22-4049-b7dd-de0889699115,22.22,1.1.7,18.6,Gold,Millennium Cohort Study,87.13,88.09,92.86,ALLIANCE > SAIL,a380bd6b-009f-4b78-b638-ba9ee62be2eb,Gold,98.41
2b40a784-79ea-4403-a4bd-0950a7a36a6c,26.98,1.1.7,27.91,Silver,Leeds-IQVIA Collaboration,75.33,79.36,78.57,HUB > DATA-CAN,00b897c7-d50d-486a-af1b-bd94821b58f7,Bronze,85.71
2b77663f-c71d-4138-8fad-f45a1f8b1222,50.79,1.1.7,51.16,Not Rated,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),33.95,41.27,19.05,,d47c809f-3da8-4f8a-b1ee-258d21aad530,Not Rated,33.33
2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,20.63,1.1.7,20.93,Bronze,UCL Infection DNA Bank,75.25,71.43,71.43,ALLIANCE > TISSUE DIRECTORY,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,Bronze,63.49
2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,15.87,1.1.7,16.28,Bronze,MDSBio,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,13c71637-144e-4742-8aea-aefb778a360e,Silver,60.32
2ca2a23d-64c3-4691-9289-197436dddfa3,55.56,1.1.7,53.49,Not Rated,Millennium Cohort Study Dataset (MCSD),32.78,38.88,19.05,,a380bd6b-009f-4b78-b638-ba9ee62be2eb,Not Rated,33.33
2cb07157-1c99-48dc-9926-0ad968a09166,55.56,1.1.7,53.49,Not Rated,Higher Education Statistics Agency (HESA) Student Data,32.78,38.88,19.05,,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,Not Rated,33.33
2d25b733-d95a-485b-9499-907a48b51919,36.51,1.1.7,32.56,Silver,Mental Health Dataset (MHDS) for CPRD GOLD,74.19,76.19,80.95,ALLIANCE > CPRD,d5c0cc93-3347-46f0-b8dd-f44e82718e38,Bronze,88.89
2d4b933d-1c8b-4fde-860e-c324454d28f9,23.81,1.1.7,20.93,Gold,GENOMICS ENGLAND 100K NHSD LINKED DATA,87.16,88.09,95.24,GENOMICS ENGLAND,14c31b39-f189-4417-bd38-635268495593,Gold,100.0
2d4d0d89-edfb-448a-b95b-a3c0401ebe75,60.32,1.1.7,55.81,Not Rated,COVID-19 Vaccination Adverse Reaction,31.62,36.5,19.05,,080a90e4-4bc6-4153-a4c6-c120eef5ba94,Not Rated,33.33
2d6e8e68-2fc9-4b9c-a517-c5c5677af225,22.22,1.1.7,20.93,Not Rated,IBD NIHR BioResource: NHS Trust data,68.1,62.7,57.14,HUB > GUT REACTION,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,Bronze,47.62
2d7a047c-a90f-48e4-82ee-9a8a082a696e,50.79,1.1.7,51.16,Not Rated,Welsh Cancer Intelligence and Surveillance Unit (WCISU),33.95,41.27,19.05,,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,Not Rated,33.33
2d9240b4-6f54-4d00-9c2e-d19220c33211,55.56,1.1.7,53.49,Not Rated,NHS Tayside - A&E drugs given during an A&E visit,32.78,38.88,19.05,,acfbef89-344c-49a5-8079-7344f4316e0f,Not Rated,33.33
2e98ae87-b10d-4aa0-acec-773a2b028af1,55.56,1.1.7,53.49,Not Rated,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - NI,32.78,38.88,19.05,,3d2d9c5e-6111-4583-a6db-07affd628f1e,Not Rated,33.33
2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,17.46,1.1.7,16.28,Gold,Patient Episode Dataset for Wales,89.48,91.27,95.24,ALLIANCE > SAIL,4c33a5d2-164c-41d7-9797-dc2b008cc852,Gold,100.0
2f9c0340-2116-41f5-bdbd-921561476061,46.03,1.1.7,46.51,Not Rated,Community perception on public health measures for COVID-19 prevention/control,29.12,29.36,4.76,,6464fb4f-2838-495b-9963-4001204ed166,Not Rated,4.76
2fcd3d4f-773b-4adc-a8cf-c80841c92d51,55.56,1.1.7,53.49,Not Rated,Deaths – National Records Scotland,32.78,38.88,19.05,,5362cfea-d554-43ba-916a-4460da39cc0c,Not Rated,33.33
2fee4aae-94c4-40b2-9e35-4f9558a5b223,20.63,1.1.7,20.93,Bronze,Cancer Patient Experience Survey (CPES) for CPRD Aurum,72.87,69.84,66.67,ALLIANCE > CPRD,fded6e24-8fef-47a4-a65e-9455bed043d3,Bronze,60.32
3008933e-6fc1-415c-b2c6-ebb12e8f3b99,55.56,1.1.7,53.49,Not Rated,CDE Patient Demographics,32.78,38.88,19.05,,209d7fae-0521-4d07-8a4d-e0843a46a107,Not Rated,33.33
30524e8c-c92c-4f01-84bd-c5593ada3e43,55.56,1.1.7,53.49,Not Rated,Covid-19 UK Non-hospital Antigen Testing Results,32.78,38.88,19.05,,f06ec631-77d0-4b12-a21f-f11e7af49ba5,Not Rated,33.33
30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,15.87,1.1.7,16.28,Bronze,Watch and Wait Trial,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,e46dccbf-484d-45d2-a42a-4d308b87c113,Silver,60.32
30e1343e-0628-47aa-b4f6-756cdb6e54c6,50.79,1.1.7,51.16,Not Rated,COVID-19 Sequence Data (CVSD),33.95,41.27,19.05,,602cbc9b-0113-4712-8c4a-0efe8d86b77c,Not Rated,33.33
31503f67-c546-4223-aec6-9255263e8b66,50.79,1.1.7,51.16,Not Rated,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),33.95,41.27,19.05,,98cda353-0011-45b2-80ca-4ed24cd084bf,Not Rated,33.33
320d4c1e-df08-4eaa-ab9f-bd342d1799a0,46.03,1.1.7,46.51,Not Rated,Webex Cohort,29.12,29.36,4.76,,9254f941-db57-4a97-922e-880b84855a21,Not Rated,4.76
32bff357-1c24-43d5-8741-261f5a764802,28.57,1.1.7,30.23,Silver,Practice postcode linked deprivation measures for CPRD Aurum,72.98,78.57,76.19,ALLIANCE > CPRD,9f689ef4-26c6-4f85-80ff-5116974f315a,Bronze,85.71
32f2d582-3b99-44a8-ac30-0a0819fc2523,55.56,1.1.7,53.49,Not Rated,Falls and Fragility Fracture Audit  National Hip Fracture clinical dataset,32.78,38.88,19.05,,e06b951b-e9d8-4a2c-a51f-1d819f669205,Not Rated,33.33
333d92ca-3a32-41bd-8b16-96aee2dc85b1,22.22,1.1.7,18.6,Gold,Wales Asthma Observatory,88.32,88.89,95.24,HUB > BREATHE,8604bcdc-235a-4c70-b29b-1617396815e6,Gold,100.0
3373aa9c-219e-4036-91a5-78bb98e8a7f5,46.03,1.1.7,46.51,Not Rated,National Bowel Cancer Audit -  Organisational Survey dataset,29.12,29.36,4.76,,4e232aa8-ad56-4d82-adcc-cd06715a5c45,Not Rated,4.76
33e4b8c6-23cc-4c5f-a7a5-8380035b6601,17.46,1.1.7,18.6,Bronze,TRICON8B,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,ff875c08-58e6-4e33-8ffe-6f51c8364333,Bronze,60.32
34396fa9-0691-42a6-9477-e49e3ae854e6,55.56,1.1.7,53.49,Not Rated,National Neonatal Research Database,32.78,38.88,19.05,,67020745-9def-4c6e-b5ac-bb273bd0a20e,Not Rated,33.33
349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,55.56,1.1.7,53.49,Not Rated,Emergency Department (eEMS),32.78,38.88,19.05,,2ba72371-1527-4d8d-94e2-f795e45b9f77,Not Rated,33.33
34c47ecf-09ff-4f12-afaa-50c785d482c5,50.79,1.1.7,51.16,Not Rated,Rural Payments Wales (RPWD),33.95,41.27,19.05,,9dc76035-dd6c-4246-8686-403087ed8890,Not Rated,33.33
34d2310f-c5f2-42c4-be1a-31c1ad579013,28.57,1.1.7,27.91,Silver,Hospital Episode Statistics Critical Care,75.33,78.57,78.57,ALLIANCE > NHS DIGITAL,80564a6b-1458-41de-a131-772eb93c0509,Bronze,85.71
34f9be53-2445-439b-8ca4-f151359d7e46,26.98,1.1.7,27.91,Silver,National Cancer TRE,75.33,79.36,78.57,HUB > DATA-CAN,b5439bc5-8141-4a13-a024-a6db2003b40e,Bronze,85.71
359006d7-1c6c-43c2-8905-09b016398ae1,15.87,1.1.7,16.28,Bronze,BRAIN UK,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,Silver,63.49
3591992f-cfae-4e26-96e7-da80997e81e7,46.03,1.1.7,46.51,Not Rated,National Audit of Dementia Round 4 - organisational checklist,29.12,29.36,4.76,,0a305b29-cf23-4261-9299-5251e41ee9f0,Not Rated,4.76
35919e8c-5cea-4d79-bf3f-e28efec1b686,50.79,1.1.7,51.16,Not Rated,NIHR BioResource: Full Blood Counts,33.95,41.27,19.05,,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,Not Rated,33.33
35cc06b0-3de1-45b0-8d40-9a8da9b77866,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Virology,32.78,38.88,19.05,,855a84b2-9d58-4b2b-a450-b6c6d534e403,Not Rated,33.33
35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,46.03,1.1.7,46.51,Not Rated,The Malaysian Asthma Hajj Study,29.12,29.36,4.76,,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,Not Rated,4.76
36047c5f-7d57-4d25-a114-2bcc6c11708f,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v3_3.5 (Sensitive),60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,c123f74c-0731-428e-b31b-eee2723df54d,Not Rated,77.78
36d3480e-38ae-470c-ab6f-b704ee2645ec,28.57,1.1.7,30.23,Silver,Practice postcode linked deprivation measures for CPRD GOLD,72.98,78.57,76.19,ALLIANCE > CPRD,3326d554-ca11-4dc6-aff0-c5b314442d27,Bronze,85.71
36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,20.63,1.1.7,20.93,Not Rated,Exploring the provision of supportive care for patients with COPD in Malaysia,66.91,63.5,54.76,HUB > BREATHE,af8cdc87-789e-4bea-9d8b-927aa689d211,Bronze,47.62
372083bc-3243-4fce-989d-914e677a12cd,28.57,1.1.7,30.23,Silver,National Radiotherapy Dataset (RTDS) for CPRD Aurum,75.36,80.16,80.95,ALLIANCE > CPRD,9c535c8d-ebac-4212-b602-fc2489df2c92,Bronze,88.89
375dae92-2015-478b-b1bc-5de90b6d53a9,50.79,1.1.7,51.16,Not Rated,Glaucoma dataset at University Hospitals Birmingham,33.95,41.27,19.05,,48c44534-0184-471e-93b8-1385f92c6631,Not Rated,33.33
37687806-bab2-4de8-87a7-844a0061e7f8,15.87,1.1.7,16.28,Bronze,Bristol Dental School Saliva Bank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,Silver,63.49
381413fe-8808-47f8-b8df-e65baa543ae4,15.87,1.1.7,16.28,Bronze,UK MND Collections,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,89e2d798-c488-4eaf-a50f-a93616093304,Silver,63.49
38194ca7-57f5-40ff-b463-900e306cd40f,26.98,1.1.7,20.93,Silver,North West London Pathology (NWL PATH),85.97,84.92,92.86,HUB > DISCOVER NOW,2c5f3ef6-53f8-42e6-a077-8718261df026,Silver,96.83
38254214-35f1-4564-b7bb-aab331732dab,19.05,1.1.7,18.6,Bronze,NIHR Nottingham Digestive Diseases Collection,75.22,70.64,69.05,ALLIANCE > TISSUE DIRECTORY,f20bf814-ee80-4e67-ab00-afff884ddbb4,Bronze,60.32
382d8665-a580-4ac1-a279-4fa53cb5bcc1,60.32,1.1.7,55.81,Not Rated,Admitted Patient Care Dataset,31.62,36.5,19.05,,b67f0edd-fed2-4d68-a25f-d225759aa3b0,Not Rated,33.33
38468759-3351-4722-9eeb-4c6dc9fa44ce,15.87,1.1.7,13.95,Gold,Congenital Anomaly Register and Information Service,90.64,92.06,95.24,ALLIANCE > SAIL,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,Gold,100.0
38b0da08-c889-4538-95f2-f2f2c1a86919,50.79,1.1.7,51.16,Not Rated,National Exercise Referral Scheme (NERS),33.95,41.27,19.05,,131784c0-769d-4f7b-b7d0-b5f4b89886d4,Not Rated,33.33
391ab58c-3412-4fa0-96f6-fdd5ae380b86,25.4,1.1.7,25.58,Silver,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,76.5,80.16,78.57,HUB > PIONEER,a9018475-452b-4864-bbc3-80eda2067820,Silver,85.71
3935e2fd-0c30-4f56-8388-45a02e0499b4,42.86,1.1.7,39.53,Bronze,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,62.38,67.46,64.29,ALLIANCE > NHS DIGITAL,2f73575d-23c8-4bb8-87db-115cde076127,Not Rated,77.78
39445f3f-c05c-4967-81a9-77a34529ad8e,46.03,1.1.7,46.51,Not Rated,Optimising the treatment of Bangladeshi adults with severe pneumonia or ARDS,29.12,29.36,4.76,,224b1065-340b-4c01-842f-d422911d9334,Not Rated,4.76
396e55fb-9a71-4b8c-9e33-2e7179a87d1f,46.03,1.1.7,46.51,Not Rated,Neuropathic Pain Profiling in Retroviral Infection Study (NIPPR),29.12,29.36,4.76,,41f5c96c-a27a-4015-be50-af967b6c4bac,Not Rated,4.76
3a0a0acd-c549-41f4-8188-14235decf473,46.03,1.1.7,46.51,Not Rated,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",29.12,29.36,4.76,,37c82bb7-eaae-4f16-97b6-045373b7ba18,Not Rated,4.76
3a0d2dea-32c4-40bc-8ad8-be8cd20440b8,50.79,1.1.7,51.16,Not Rated,Congenital Anomaly Register and Information Service (CARS),33.95,41.27,19.05,,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,Not Rated,33.33
3a56c317-bf1b-448d-89ab-3421eae3aa18,23.81,1.1.7,25.58,Not Rated,Death register,58.64,57.14,42.86,UK Biobank,722056a5-5fc6-4ad2-8efe-62a80dd6389b,Not Rated,38.1
3a880d1a-bd02-4d23-bca0-4b6ac45b09f1,60.32,1.1.7,55.81,Not Rated,SICSAG Daily (Scottish Intensive Care Audit Group),31.62,36.5,19.05,,811a54fb-8b79-442f-8e28-a725a0561a15,Not Rated,33.33
3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,20.63,1.1.7,16.28,Gold,Annual District Birth Extract,89.48,89.69,95.24,ALLIANCE > SAIL,12a77014-4a77-4eb1-8b26-f49689352d1b,Gold,100.0
3abe6b38-e479-4eb3-87d6-ef4803ff88f9,20.63,1.1.7,16.28,Gold,Emergency Department Data Set,89.48,89.69,95.24,ALLIANCE > SAIL,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,Gold,100.0
3adb43c7-cc13-423a-9625-8fd571bbcb26,55.56,1.1.7,53.49,Not Rated,National Paediatric Diabetes Audit - Parent and Patient Experience measures,32.78,38.88,19.05,,b0979e07-3331-408f-853b-5eeba80ce8f9,Not Rated,33.33
3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,22.22,1.1.7,18.6,Silver,IBD NIHR BioResource: Consent records,84.75,84.92,88.1,HUB > GUT REACTION,44ca2cf8-679e-447c-a9eb-55b32159679a,Silver,92.06
3b6d2dbe-0241-4c38-9038-2d6ce1e280de,34.92,1.1.7,34.88,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,46.84,44.45,28.57,ALLIANCE > HQIP,24b88d1a-4363-4619-870e-9ba9fc5d09e1,Not Rated,23.81
3b752633-8274-4418-b15b-4502bab03935,38.1,1.1.7,39.53,Not Rated,CDE Surginet Documentation,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,4c4bc482-16f5-462f-8daf-51ec6492074d,Not Rated,15.87
3b8357ac-bf06-44c4-9a43-8e772bec709c,55.56,1.1.7,53.49,Not Rated,IBD NIHR BioResource: Demographic,32.78,38.88,19.05,,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,Not Rated,33.33
3b84d205-2175-4c9a-bbe3-d0e24434e625,50.79,1.1.7,51.16,Not Rated,"Investigations, interventions, and outcomes for acute coronary syndrome",33.95,41.27,19.05,,b8f2c611-21d0-424e-a1ed-6976b1c207ec,Not Rated,33.33
3bb25cba-b4dc-47f1-ab5e-b63f89500612,19.05,1.1.7,18.6,Bronze,IBD NIHR BioResource: SNP imputation data,72.84,69.05,64.29,HUB > GUT REACTION,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,Bronze,57.14
3c14d319-4ff5-42ff-b440-400f099f9b13,55.56,1.1.7,53.49,Not Rated,Active Adult Survey Dataset (AASD),32.78,38.88,19.05,,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,Not Rated,33.33
3c23941a-42a7-4940-b32f-aea743c0dc2a,17.46,1.1.7,18.6,Bronze,Tissue Solutions Ltd,76.42,72.22,71.43,ALLIANCE > TISSUE DIRECTORY,bbcdc352-e0f7-4672-93a7-134bcf5001b1,Silver,61.9
3c870bf2-acfb-44d1-8437-06ebb3c0993c,55.56,1.1.7,53.49,Not Rated,Postponed Admitted Procedures (CAPD),32.78,38.88,19.05,,bff94600-a254-4111-82f7-6167084d81ca,Not Rated,33.33
3cefb3f4-a463-4762-909b-3e4f3cef8e93,55.56,1.1.7,53.49,Not Rated,COG-UK Viral Genome Sequences,32.78,38.88,19.05,,1fe02b65-7b77-43bf-93c8-4f0743fee672,Not Rated,33.33
3d51dc99-c44f-44ff-bdab-da205c5e394e,22.22,1.1.7,18.6,Gold,North West London Outpatient Care Data (NWL OP),87.13,87.31,92.86,HUB > DISCOVER NOW,9f1df859-f1d0-4f1e-959e-affd05138a25,Gold,96.83
3db58c78-fc8b-49b2-a847-b43fd0184500,15.87,1.1.7,16.28,Bronze,Ethical Tissue - University of Bradford,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,Silver,60.32
3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,60.32,1.1.7,55.81,Not Rated,Diagnostic Imaging Dataset,31.62,36.5,19.05,,86f46be3-bc29-4820-8363-de6530a94c6f,Not Rated,33.33
3ed8d3fe-92a3-43bc-9fba-274fb34847af,46.03,1.1.7,46.51,Not Rated,Higher Education Statistics Agency (HESA),29.12,29.36,4.76,,36f54a48-6f0a-4827-a86b-fd677a22a88f,Not Rated,4.76
3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,46.03,1.1.7,46.51,Not Rated,mHealth for pneumonia prevention,29.12,29.36,4.76,,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,Not Rated,4.76
3f00330d-1f45-4cab-86c2-e91b7c1a59e9,15.87,1.1.7,16.28,Bronze,Multiple Sclerosis and Parkinson's Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,Silver,60.32
3f6962d8-1f4c-49b0-80a8-e491d5205827,60.32,1.1.7,55.81,Not Rated,Outpatient Appointment Dataset,31.62,36.5,19.05,,1c27bfbf-c659-42ff-8afe-d58250b49c07,Not Rated,33.33
3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,26.98,1.1.7,27.91,Silver,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,75.33,79.36,78.57,ALLIANCE > BARTS HEALTH,d6e8163f-2ab8-4880-bbb6-a174b4a95632,Bronze,85.71
3fc555e1-3e36-46dc-bef1-2d94d560bcb2,30.16,1.1.7,27.91,Silver,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,75.33,77.78,78.57,HUB > PIONEER,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,Bronze,85.71
3fcdcced-e16a-4f04-a521-ffe1047f37cb,55.56,1.1.7,53.49,Not Rated,National Paediatric Diabetes Audit - survey of workforce in PDUs,32.78,38.88,19.05,,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,Not Rated,33.33
3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,15.87,1.1.7,13.95,Gold,Cafcass Wales,90.64,92.06,95.24,ALLIANCE > SAIL,29a714e1-5289-4362-be24-2848c954344e,Gold,100.0
3fd2760d-ab12-48ee-8b32-b229aead60a4,46.03,1.1.7,46.51,Not Rated,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,29.12,29.36,4.76,,56130df6-1880-4600-a7a4-afa9a4bcc895,Not Rated,4.76
40573895-497b-4d47-90e1-6aafe70b93f6,36.51,1.1.7,37.21,Not Rated,Endobase,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,e830b2a5-14d6-4643-a206-619bf5372dc8,Not Rated,14.29
41a667eb-1c84-4665-b0d4-d26405d277c5,26.98,1.1.7,25.58,Bronze,Domiciliary Social Care Worker [DSCW],72.93,75.4,71.43,ALLIANCE > SAIL,0e38bbf4-c788-4a1a-9af8-a24821250154,Bronze,77.78
41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,17.46,1.1.7,16.28,Bronze,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,74.0,69.05,64.29,HUB > BREATHE,4346676d-6108-47de-b579-6cef74c6acef,Bronze,55.56
41ce265a-c252-45c4-9b80-d764b0737f38,30.16,1.1.7,27.91,Silver,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,76.52,79.37,80.95,ALLIANCE > CPRD,bfb90d2b-746d-44a6-a896-4979d73d9276,Silver,88.89
41f6dfe9-d5e2-4641-9953-1589c7d35e07,55.56,1.1.7,53.49,Not Rated,Death Registration Data - Finalised Extracts,32.78,38.88,19.05,,fdfa5116-4f44-457d-99ef-e8c1852aa858,Not Rated,33.33
425e39b4-cc2b-4a15-851a-a0093ef1e1f8,55.56,1.1.7,53.49,Not Rated,National Asthma and COPD Audit (NACAP): secondary care  – CYP asthma (clinical),32.78,38.88,19.05,,33b36393-3760-40d8-bb98-61806fea5398,Not Rated,33.33
4262e057-6978-4e4c-a05d-c4f328422090,39.68,1.1.7,39.53,Bronze,Mental Health and Learning Disabilities Data Set,61.19,67.46,61.9,ALLIANCE > NHS DIGITAL,e9b43936-e700-40c9-8b32-57ed44583f3d,Not Rated,74.6
42ac7c27-a37b-4081-8a33-51ac077e6a4e,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Microbiology Cultures,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,9c1727f6-2032-413f-bf60-470769b2616e,Gold,100.0
42e4299f-1e06-4e24-ab40-b71949f5cba3,55.56,1.1.7,53.49,Not Rated,Pathology - PATH,32.78,38.88,19.05,,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,Not Rated,33.33
4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,55.56,1.1.7,53.49,Not Rated,Covid-19 Infection Survey linked with VOA and EPC data,32.78,38.88,19.05,,2193ad56-6671-4ecc-9ecf-6da84e23e9fd,Not Rated,33.33
4353b5fa-b3aa-4786-9e7f-4fb2273f5d3e,33.33,1.1.7,32.56,Silver,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,75.38,78.58,83.33,ALLIANCE > CPRD,f8af632e-442d-4931-a370-b7fa2fa4b896,Bronze,90.48
45499ef9-daca-4a88-8493-c3c1a92960d0,15.87,1.1.7,13.95,Gold,Welsh Ambulance Services NHS Trust,89.45,91.27,92.86,ALLIANCE > SAIL,d415a5c5-8432-4a81-937f-12135ade6de7,Gold,98.41
458d7f2d-9ba8-4593-862c-14160692d494,17.46,1.1.7,16.28,Bronze,Asthma and COPD: practices and perceptions of GPs in rural India,76.38,70.63,69.05,HUB > BREATHE,c15bc3ad-c053-496b-863f-1d54075d5bd4,Silver,58.73
459387f3-c484-441d-9abb-b6ee22df86d2,55.56,1.1.7,53.49,Not Rated,Public Health Research Database (PHRD),32.78,38.88,19.05,,a325f33e-bac8-49af-896f-1e025941dae8,Not Rated,33.33
46493a09-b3bb-4c0e-b944-82665ee21508,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,Not Rated,77.78
46762bdc-42f9-4c92-92fe-9c757083ad33,34.92,1.1.7,34.88,Not Rated,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,46.84,44.45,28.57,ALLIANCE > HQIP,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,Not Rated,23.81
46e30817-b19e-40f2-9b06-9611b2985148,15.87,1.1.7,13.95,Gold,Maternity Indicators Dataset,90.64,92.06,95.24,ALLIANCE > SAIL,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,Gold,100.0
46f6e0d3-412e-4799-8683-1ca649b99eec,46.03,1.1.7,46.51,Not Rated,Developing and Evaluating Interventions to Improve Asthma Care,29.12,29.36,4.76,,d57d7956-d13e-49c4-bb31-889b8e560596,Not Rated,4.76
4710222c-9830-4ae4-8be6-b25c723812e1,33.33,1.1.7,32.56,Not Rated,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,48.0,45.24,28.57,ALLIANCE > HQIP,fe6a4c83-f46f-4f61-8460-e120fdf8d864,Not Rated,23.81
47d22aea-cbe9-47d4-8f65-45861d9c5f6f,15.87,1.1.7,16.28,Bronze,Tayside Biorepository,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,6ac9b356-00f1-49da-825a-6eb04d18e49d,Silver,60.32
47e26b2b-8be1-4595-a327-a9f00e0d4712,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Consent records,32.78,38.88,19.05,,44ca2cf8-679e-447c-a9eb-55b32159679a,Not Rated,33.33
47f57de8-aa71-4df1-af4a-a81e37d4ae8c,19.05,1.1.7,20.93,Bronze,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",75.25,72.22,71.43,ALLIANCE > TISSUE DIRECTORY,425f4534-51c4-4f75-8ca0-d7c731dbd903,Bronze,63.49
480ccd8a-309e-417a-ac23-5b2d9cd281b1,25.4,1.1.7,25.58,Not Rated,Genotype,56.26,54.76,38.1,UK Biobank,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,Not Rated,34.92
48182af6-2ccd-44b2-92d5-69cc140e7d67,22.22,1.1.7,18.6,Gold,North West London Primary Care Prescriptions Data (NWL PCP),87.13,87.31,92.86,HUB > DISCOVER NOW,0fb33df6-ab36-4170-9fad-1eaf35a3a812,Gold,96.83
483be944-b3ea-4037-b22b-4e9ffca3e613,50.79,1.1.7,51.16,Not Rated,A granular assessment of the day-to-day variation in emergency presentations,33.95,41.27,19.05,,ef850406-2993-43ec-80b9-ef504734f2ac,Not Rated,33.33
483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,55.56,1.1.7,53.49,Not Rated,National Vascular Registry - Organisational Audit dataset,32.78,38.88,19.05,,3c661240-e4d2-456c-a809-133c23f9c469,Not Rated,33.33
484bff65-c47e-47ce-9eb5-5d381f961160,33.33,1.1.7,32.56,Silver,Cancer registration data for CPRD Aurum,75.38,78.58,83.33,ALLIANCE > CPRD,3f3df3be-05a8-42b2-89d9-f731deb7ea66,Bronze,90.48
489cb34a-f20d-4fe0-849a-db85f00141f5,34.92,1.1.7,34.88,Not Rated,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,46.84,44.45,28.57,ALLIANCE > HQIP,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,Not Rated,23.81
48deb24e-7a15-48d7-ba2c-c477ae61b55d,55.56,1.1.7,53.49,Not Rated,NIHR BioResource: Sample holding,32.78,38.88,19.05,,56993820-96e4-4a1f-9de1-bad53108c201,Not Rated,33.33
491cc634-05e8-48fe-9018-ffb9e7eed84e,34.92,1.1.7,34.88,Not Rated,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",46.84,44.45,28.57,ALLIANCE > HQIP,949d9d7a-a3f1-480a-8563-3fb024300561,Not Rated,23.81
4a860548-406b-4a05-991e-0bc840e67974,50.79,1.1.7,51.16,Not Rated,Health & Attainment of Pupils in a Primary Education Network (HAPN),33.95,41.27,19.05,,464d8653-4e69-406b-93fd-d68c29d5dfdc,Not Rated,33.33
4abe1436-3a14-4779-aa03-28929e817411,55.56,1.1.7,53.49,Not Rated,Tayside & Fife Radiology,32.78,38.88,19.05,,af10ec29-1866-4726-b33f-3948afe182f2,Not Rated,33.33
4b2fbd88-71c7-4572-99ea-5987a72a0c1a,34.92,1.1.7,34.88,Not Rated,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,46.84,44.45,28.57,ALLIANCE > HQIP,2c737d63-69f4-4a02-8df9-54c1e65e845f,Not Rated,23.81
4b3d70f4-ce62-478b-9ada-0419850d17af,46.03,1.1.7,46.51,Not Rated,South East London Community Health Study (SELCoH),29.12,29.36,4.76,,cda770e3-0d4d-466f-8102-c56beff04848,Not Rated,4.76
4b59ff6f-2830-4f2b-b35a-623ef4520eb8,50.79,1.1.7,51.16,Not Rated,Systemic Anti-Cancer Therapy Dataset (SACT),33.95,41.27,19.05,,6c4ed998-0f05-415c-a3e4-42430bb62d24,Not Rated,33.33
4b6d3344-e73a-4f46-8e9d-fabb85827772,15.87,1.1.7,13.95,Gold,Daily Situation Report Data,89.45,91.27,92.86,ALLIANCE > SAIL,c74a9b9e-1fea-4aac-99fd-54e30668e085,Gold,98.41
4b79bce2-6d1c-448b-969e-56b424f3d57a,55.56,1.1.7,53.49,Not Rated,National Early Inflammatory Arthritis Audit - organisational survey dataset,32.78,38.88,19.05,,a9ac99fe-32be-40ef-9509-03e6b2713ddf,Not Rated,33.33
4c171540-5caa-42f7-868d-1d4d7b969f11,46.03,1.1.7,46.51,Not Rated,Assessment of ASHA’s workload and its determinants,29.12,29.36,4.76,,1a02bc11-a378-4f9e-82f9-c52674b388bd,Not Rated,4.76
4cb9082f-619d-4be2-8d09-641f2c573d38,19.05,1.1.7,18.6,Bronze,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",72.84,68.25,64.29,HUB > BREATHE,2581994d-5be2-4465-bb62-60c4c97e8e2b,Bronze,55.56
4cde083a-bf5a-4f57-97c6-38632e10050d,15.87,1.1.7,16.28,Bronze,Obesity Research Biobank Syndicate (ORBiS),76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,264a1987-a8cb-4a83-81e0-70b4c3893b7d,Silver,60.32
4d0c3779-9251-4a4a-9eff-41a47869157f,33.33,1.1.7,32.56,Not Rated,National Oesophago-Gastric Cancer Audit - clinical dataset,48.0,45.24,28.57,ALLIANCE > HQIP,306274ee-a098-43cc-b113-2df8116a8703,Not Rated,23.81
4d1271dd-b256-454b-9b13-be38bef73f15,33.33,1.1.7,32.56,Not Rated,Paediatric Intensive Care Audit Network - core dataset (admission),48.0,45.24,28.57,ALLIANCE > HQIP,4ca76471-6970-4ad4-87c7-fae77a98cbf5,Not Rated,23.81
4d560a49-6ab2-460c-980f-94d76d1527f2,60.32,1.1.7,55.81,Not Rated,NIHR BioResource: SNP chip data,31.62,36.5,19.05,,c388676c-a5e5-419c-967c-239c1f0c3c5c,Not Rated,33.33
4dd3f23c-44be-4126-aac5-ba655d07855c,15.87,1.1.7,16.28,Bronze,POUT-T,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,Silver,60.32
4ee43bb7-54a1-40a9-9a2a-4f07cd5b1920,60.32,1.1.7,55.81,Not Rated,Hospital Episode Statistics Outpatients,31.62,36.5,19.05,,d4362d41-0838-4f41-bba3-c3268312c444,Not Rated,33.33
4f3fff58-7c32-4879-8ac2-f3c7641fbb85,46.03,1.1.7,46.51,Not Rated,National Audit of Dementia Round 4 - carer experience survey,29.12,29.36,4.76,,3b5907da-256d-49a3-b24b-00893afe8bdd,Not Rated,4.76
501b0226-1cbf-4717-8dee-adf189dd0088,34.92,1.1.7,34.88,Not Rated,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",46.84,44.45,28.57,ALLIANCE > HQIP,11deee42-5876-4ebe-acca-e996702e1343,Not Rated,23.81
50609a73-30a0-46ca-847d-4a9c1bfec5fc,34.92,1.1.7,34.88,Not Rated,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),46.84,44.45,28.57,ALLIANCE > HQIP,3558f8a1-6d52-4b59-b513-51c068095bc2,Not Rated,23.81
50925199-a35d-4327-87cd-7761d713a72b,31.75,1.1.7,30.23,Silver,HES Outpatient data for CPRD Aurum,76.55,78.57,83.33,ALLIANCE > CPRD,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,Silver,88.89
51221591-a4d4-4b9f-a220-b72d860d99fd,46.03,1.1.7,46.51,Not Rated,National Audit of Dementia Round 4 - staff questionnaire,29.12,29.36,4.76,,ef6e68d6-dcba-410c-943c-26ca21376a3a,Not Rated,4.76
51ad73b3-dd3e-44ad-b941-0d5d12bcb0cd,50.79,1.1.7,51.16,Not Rated,Looked After Children Wales (LACW),33.95,41.27,19.05,,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,Not Rated,33.33
5271131b-ba5b-452d-b230-077094a031c2,38.1,1.1.7,39.53,Not Rated,ARIA Dataset,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,621dd611-adcf-4434-b538-eecdbe5f72cf,Not Rated,15.87
52c784f6-99c6-4407-b660-abaa1682c955,36.51,1.1.7,32.56,Silver,Mental Health Dataset (MHDS) for CPRD Aurum,74.19,76.19,80.95,ALLIANCE > CPRD,48627b2d-f247-4921-9ee1-6c37adfff10d,Bronze,88.89
535a0983-6618-4211-a939-ae2edfe26f9a,26.98,1.1.7,20.93,Silver,North West London Adult Social Care Data (NWL ASC),85.97,84.92,92.86,HUB > DISCOVER NOW,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,Silver,96.83
53846ac7-61b7-4403-8556-c319d04b546d,65.08,1.1.7,58.14,Not Rated,National Records of Scotland (NRS) - Deaths Data,30.45,34.12,19.05,,e600dae2-a83c-4b7a-8d23-af4ac31ca374,Not Rated,33.33
53b7c446-667b-409e-920e-67cb516de3ae,25.4,1.1.7,25.58,Silver,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,74.12,78.57,73.81,HUB > PIONEER,cacba424-6c2c-4b57-8f5b-64e92a78370a,Bronze,82.54
53dbbca0-b57d-4f93-8f05-37f626f9a7bc,55.56,1.1.7,53.49,Not Rated,Scottish Medical Imaging (SMI) Research Dataset,32.78,38.88,19.05,,1c49a822-6432-468b-8ba5-6aab534654b9,Not Rated,33.33
542bf16f-baea-4fca-be51-fcef9732494a,50.79,1.1.7,51.16,Not Rated,Cervical Screening Wales (SCSW),33.95,41.27,19.05,,b32325d7-7f00-4d20-9935-dd02e1bc6932,Not Rated,33.33
54a7dd45-d6c7-4b4d-801d-2becd2b694f1,15.87,1.1.7,16.28,Bronze,Epilepsy Society Brain and Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,f13258c3-f85a-4772-b42e-da8a84c5064a,Silver,60.32
55b311a8-7162-410c-8cf7-eef1ac9ff544,46.03,1.1.7,46.51,Not Rated,IBD Registry COVID-19,29.12,29.36,4.76,,ffdf167b-f3a3-4d78-a228-2865aea90509,Not Rated,4.76
567b23fe-abf2-4e2e-88f7-505dfeaa3cde,15.87,1.1.7,16.28,Bronze,LBIH Biobank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,Silver,60.32
567b5d24-07df-4430-8466-4444ecbe86c8,46.03,1.1.7,46.51,Not Rated,Assessing the feasibility and effectiveness of introducing pulse oximetry,29.12,29.36,4.76,,2f36b7b3-e50f-459f-a691-f62dde65e2bd,Not Rated,4.76
56f3e791-a204-4f67-a4d0-52803148d71a,17.46,1.1.7,18.6,Bronze,TNT: Triple Negative breast cancer Trial,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,Bronze,60.32
5727d014-0c5c-4dcb-89c9-ff33e1b680bb,46.03,1.1.7,46.51,Not Rated,Wellcome Sanger Institute: Whole Exome Sequencing,29.12,29.36,4.76,,cd20517c-2f75-40e9-9ee8-563d32624b55,Not Rated,4.76
57458394-945e-4e6a-abc7-91df0f44cb60,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Health and Lifestyle Questionnaire,32.78,38.88,19.05,,18bfe765-5733-41f3-8114-0a1ec2524b5b,Not Rated,33.33
575514e3-6e8f-4218-bd75-ff32742abc52,31.75,1.1.7,25.58,Silver,Coronavirus and the social impacts on Great Britain,76.5,76.19,78.57,NCS > OFFICE FOR NATIONAL STATISTICS,e253257c-48c2-491b-b3b9-205161a16a7e,Silver,84.13
57726e95-afe2-4d62-ab1e-81d90eb0ec1d,17.46,1.1.7,16.28,Gold,COVID-19 Test results,89.48,91.27,95.24,ALLIANCE > SAIL,f5f6d882-163d-4ef1-a53e-000fba409480,Gold,100.0
590e7bb7-a6e3-4f87-af2f-e46943f98ce9,46.03,1.1.7,46.51,Not Rated,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,29.12,29.36,4.76,,e0d00cb7-62e1-4a38-8df6-cf537b59228d,Not Rated,4.76
598ab9d9-04a3-4628-be64-d8f026d266ac,46.03,1.1.7,46.51,Not Rated,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,29.12,29.36,4.76,,cf9bc775-1db7-44e4-9a16-317d5bb063a2,Not Rated,4.76
59f5b724-234f-401d-a8f5-df35ea9ecdc9,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme - Percutaneous Coronary Interventions (PCI),29.12,29.36,4.76,,ac7016ce-f7a9-4c71-bebb-6af6efa27844,Not Rated,4.76
5a6009f8-c74a-4e72-b2a1-83be100f7841,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),29.12,29.36,4.76,,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,Not Rated,4.76
5ad2e0c9-f0ba-4947-90f7-b19431080f83,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Primary Ankle Replacement dataset,32.78,38.88,19.05,,b8d009d0-0163-4aaf-8bd6-ad363c859862,Not Rated,33.33
5b456d15-cb68-4944-839c-c25a2986e572,50.79,1.1.7,51.16,Not Rated,Longitudinal C-reactive protein concentrations in COVID-19: an OMOP dataset,33.95,41.27,19.05,,597524d4-038e-4fc2-aff9-1c9b87d3e16c,Not Rated,33.33
5b9b7964-615b-438a-b151-d2f884a24aee,26.98,1.1.7,20.93,Silver,North West London Accident and Emergency Data (NWL A&E),85.97,84.92,92.86,HUB > DISCOVER NOW,721db252-8069-433d-bb6d-4b44b243d364,Silver,96.83
5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,15.87,1.1.7,16.28,Bronze,VinCaP,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,e57dd7a2-3c5c-4285-8001-8e2589c395e9,Silver,60.32
5c7ae78d-53e6-427d-a3a9-52538f8342dc,31.75,1.1.7,30.23,Not Rated,International Severe Asthma Registry,61.08,55.55,52.38,HUB > BREATHE,9711e6cc-426c-4cef-afb3-64382f8d7ed4,Not Rated,42.86
5cd5a6a1-f7a2-4d83-a3e3-423495c3a281,55.56,1.1.7,53.49,Not Rated,Education Daily Attendance Dataset (EDAD),32.78,38.88,19.05,,17056e83-ee5a-4fe7-86e1-f09563256be1,Not Rated,33.33
5ce6905a-8b54-4d6c-9da6-e2d57ce45419,55.56,1.1.7,53.49,Not Rated,National Waiting List Diagnostics,32.78,38.88,19.05,,e508951d-e118-4217-84a4-722e50fdd400,Not Rated,33.33
5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,55.56,1.1.7,53.49,Not Rated,Renal Register – ISD National dataset,32.78,38.88,19.05,,32edd77d-533c-423f-b045-937507f8505d,Not Rated,33.33
5d577e70-2b9b-4286-81f3-824978dc3069,50.79,1.1.7,51.16,Not Rated,Moorfields Ophthalmic Prescription 004,33.95,41.27,19.05,,2ec8d8e3-35bc-4304-83e8-3afed4438cd5,Not Rated,33.33
5de9d313-fb9f-4dbf-a959-1329062eb1ef,60.32,1.1.7,55.81,Not Rated,NIHR BioResource: Case report form,31.62,36.5,19.05,,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,Not Rated,33.33
5e022f8f-4d07-44bb-a87c-43e31200fe1e,36.51,1.1.7,37.21,Not Rated,ARIA Radonc,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,59d72237-6969-4f59-9e87-48138978abe8,Not Rated,14.29
5e044863-b792-4256-aa45-3235a6546e39,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Primary Hip Replacement dataset,32.78,38.88,19.05,,03280e87-6975-4a2a-967d-b332cb788e44,Not Rated,33.33
5e19a471-64e3-4aa4-ac56-6901d5e39e28,25.4,1.1.7,18.6,Silver,North West London Mental Health Data (NWL MH),87.13,85.72,92.86,HUB > DISCOVER NOW,2d3ec99a-a087-4355-8539-5a22cef58910,Gold,96.83
5e2a7277-dc64-499a-b16d-51850d9ad00b,20.63,1.1.7,16.28,Gold,Emergency Department Dataset Daily,89.48,89.69,95.24,ALLIANCE > SAIL,fa257aa8-51fc-4eb7-a448-e473fa54686d,Gold,100.0
5e442584-9acd-4e8d-9448-5f8f2b937d56,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Biochemistry (Lab Data Restructured),32.78,38.88,19.05,,10ffac16-d0c2-4d53-ab6a-69a38e283223,Not Rated,33.33
5e9d4a4b-544c-4739-b079-62f353086fde,50.79,1.1.7,51.16,Not Rated,Moorfields AMD Dataset Release 002,33.95,41.27,19.05,,bf392537-82b4-4d71-ace0-e7bea3b167fb,Not Rated,33.33
5e9d9633-c4f4-47cc-96d9-350191e18539,30.16,1.1.7,27.91,Silver,HES Diagnostic Imaging Dataset for CPRD Aurum,76.52,78.57,80.95,ALLIANCE > CPRD,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,Silver,87.3
5e9fba37-017b-4481-bc69-75ef1e005c2f,50.79,1.1.7,51.16,Not Rated,National Community Child Health Database (NCCHD),33.95,41.27,19.05,,20fe153c-a5e5-4991-900e-8fa9988e771a,Not Rated,33.33
5ef3573a-274a-41e1-8f64-9330109d59d1,55.56,1.1.7,53.49,Not Rated,National Cancer Registration and Analysis Service,32.78,38.88,19.05,,0a852454-ee67-443b-a091-d13499a71b41,Not Rated,33.33
5fdfa652-eda8-4709-89e0-02d8412851d4,60.32,1.1.7,55.81,Not Rated,Covid-19 Infection Survey,31.62,36.5,19.05,,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,Not Rated,33.33
601f1504-2706-405b-94cb-8cd14231f434,26.98,1.1.7,20.93,Gold,North West London population data (NWL POP),87.16,86.51,95.24,HUB > DISCOVER NOW,1032850f-7631-4d9e-a760-b0532bffd21a,Gold,100.0
602dc3ef-8c76-4ad4-941b-0a39e50481e7,50.79,1.1.7,51.16,Not Rated,"Investigating the impact of frailty, age and illness severity during COVID-19",33.95,41.27,19.05,,108ba1b0-994d-449c-b192-2331698e477d,Not Rated,33.33
60b148f7-b48c-49c4-9286-b83691cfc7b2,15.87,1.1.7,16.28,Bronze,STAMPEDE,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,71eb0192-1124-4b27-86e4-1139e0047a02,Silver,60.32
61b34cfb-041b-46a3-801d-1932b92795b9,55.56,1.1.7,53.49,Not Rated,Weekly SUS Inpatient Dataset,32.78,38.88,19.05,,3858647c-5161-45dc-ba49-66a4fc4499c2,Not Rated,33.33
61df41f6-6d91-4144-b29d-489dd73c48a1,55.56,1.1.7,53.49,Not Rated,COVID-19 Wastewater data,32.78,38.88,19.05,,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40,Not Rated,33.33
62c01293-83a5-4d4d-9d36-9d7aa2bf120f,23.81,1.1.7,20.93,Gold,GENOMICS ENGLAND 100K PHE LINKED DATA,87.16,88.09,95.24,GENOMICS ENGLAND,ea748742-568a-46e2-b603-2fada49024e1,Gold,100.0
62fef8d2-c397-43c3-b14a-69cf89423887,28.57,1.1.7,27.91,Not Rated,Vitamin D supplementation meta-analyses,53.9,50.8,35.71,HUB > BREATHE,2454a964-be58-4d1f-8f9a-ffae9db9129c,Not Rated,30.16
63f5c784-e0ee-46db-bbe5-279164033ed4,55.56,1.1.7,53.49,Not Rated,Intensive Care National Audit and Research Centre - Covid19 (ICNC),32.78,38.88,19.05,,add6226b-0f21-439a-84a6-51dc26cdc425,Not Rated,33.33
6421830a-148d-4f86-8cd3-cefb5177610c,55.56,1.1.7,53.49,Not Rated,Tayside Microbiology Lab,32.78,38.88,19.05,,826be5be-9977-49f9-b6d1-83ed9de08ebe,Not Rated,33.33
645168a0-21b1-4e13-85d8-266ad9040af8,60.32,1.1.7,55.81,Not Rated,Suspected Cancer Pathway Monthly (SPCM),31.62,36.5,19.05,,fcf5a844-f48d-428e-aa06-abe64e66185e,Not Rated,33.33
6456c509-aa71-45de-b4f4-251448e45cbc,55.56,1.1.7,53.49,Not Rated,Intensive Care National Audit and Research Centre (ICCD),32.78,38.88,19.05,,fa8bf269-4769-491b-b398-fa63137d14ab,Not Rated,33.33
645cb77f-30e7-42be-a07d-2384cee4966e,50.79,1.1.7,51.16,Not Rated,"A synthetic dataset of 15,000 ""patients"" with Community Acquired Pneumonia (CAP)",33.95,41.27,19.05,,a6575d98-0b2b-4c06-b9c6-88c1729257b9,Not Rated,33.33
646d65df-fc4c-4680-b949-79ec8f40b406,46.03,1.1.7,46.51,Not Rated,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",29.12,29.36,4.76,,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,Not Rated,4.76
649261ce-833f-459e-908c-2ef93c5fed41,65.08,1.1.7,58.14,Not Rated,Civil Registration - Deaths,30.45,34.12,19.05,,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,Not Rated,33.33
65481fcf-cc98-44f0-bcfe-c21bcb8db0f5,31.75,1.1.7,30.23,Silver,HES Accident and Emergency data for CPRD Aurum,76.55,79.37,83.33,ALLIANCE > CPRD,c43501ec-08b4-4d33-a7dd-d19fca821925,Silver,90.48
658c4030-3a6d-4e67-abea-25601a478861,50.79,1.1.7,51.16,Not Rated,Welsh Cancer Intelligence and Surveillance Unit (WCSU),33.95,41.27,19.05,,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,Not Rated,33.33
65c8a30c-de2c-47bf-87e4-18c86e75e54a,20.63,1.1.7,16.28,Gold,Diagnostic and Therapy Services Waiting Times,88.29,88.89,92.86,ALLIANCE > SAIL,97896866-ab5e-408a-ac5a-072802db9faf,Gold,98.41
65ce36d2-f5fa-4a10-b210-b917fbb7c8a5,50.79,1.1.7,51.16,Not Rated,Careers Wales Dataset (CARW),33.95,41.27,19.05,,e4004e0e-6adb-4b11-82c2-af0caf61d751,Not Rated,33.33
65eaa19c-e4b6-4611-922a-4be585a6d348,55.56,1.1.7,53.49,Not Rated,Falls and Fragility Fracture Audit  Programme - Inpatient Falls clinical dataset,32.78,38.88,19.05,,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,Not Rated,33.33
6615ba0a-9bcf-4a3b-8204-283c5e741b2b,55.56,1.1.7,53.49,Not Rated,Fife Microbiology Lab,32.78,38.88,19.05,,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,Not Rated,33.33
661b27db-38d4-4a9c-ac40-e3146ef12350,19.05,1.1.7,18.6,Bronze,Theory of Planned Behaviour Intervention: respiratory disease in South India,72.84,68.25,64.29,HUB > BREATHE,7d23e729-72b0-4dd1-820d-07697b49acd0,Bronze,55.56
6620b221-6909-4106-a49e-f1b5820be2f3,15.87,1.1.7,16.28,Bronze,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,5ef75d71-73ce-4451-9d7a-a39dd82b712f,Silver,60.32
664513d6-d766-461d-a69e-206a928cd14f,30.16,1.1.7,25.58,Silver,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,83.64,83.34,92.86,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,d5049af5-e351-4b22-8f75-6f3dfc96419b,Silver,96.83
668eefeb-fb5c-46d8-a052-12fa8da4931b,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,46.84,44.45,28.57,ALLIANCE > HQIP,becd2624-9a01-4f01-bcf8-56e94545a49a,Not Rated,23.81
670dbf72-0140-4228-b2de-4ad1ba1c920d,55.56,1.1.7,53.49,Not Rated,Scotland Accident and Emergency,32.78,38.88,19.05,,05e6752e-3a0b-4809-aa14-207b4761ef60,Not Rated,33.33
672a54ba-0b41-4573-adf8-e97158fad9bc,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Biochemistry,32.78,38.88,19.05,,10ffac16-d0c2-4d53-ab6a-69a38e283223,Not Rated,33.33
674c290e-36c6-4d9b-a908-a23e89a6745c,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Haematology,32.78,38.88,19.05,,c294bb01-062b-494e-942b-1efe8cbac3dc,Not Rated,33.33
6762c371-8f4a-4511-910a-faf85760eab2,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),29.12,29.36,4.76,,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,Not Rated,4.76
67ab8a56-99d7-4951-aacb-5dca0b8ffa35,55.56,1.1.7,53.49,Not Rated,National Waiting List Clock Stops,32.78,38.88,19.05,,3f073707-50b4-48cf-93b6-76843519a5c0,Not Rated,33.33
67cd0c2b-3944-4bc4-a03a-4081ee67847f,12.7,1.1.7,11.63,Silver,Genetics of Asthma Severity & Phenotypes,84.66,79.37,80.95,HUB > BREATHE,6277abc6-c039-4886-8489-d4a2cdb8190c,Silver,71.43
682b4d85-732a-4440-922d-07191a604143,55.56,1.1.7,53.49,Not Rated,UK Renal Registry - AKI Lab Alerts Dataset,32.78,38.88,19.05,,c38541a7-cf43-4bfd-928d-75613abc8e3f,Not Rated,33.33
68906d25-384c-4152-86b5-50c5170ad94c,55.56,1.1.7,53.49,Not Rated,Epilepsy 12 - clinical audit,32.78,38.88,19.05,,1fcaf429-8762-454c-b999-c5fdd757b880,Not Rated,33.33
69220bf9-f223-4e88-91c8-8ae8eab9f438,55.56,1.1.7,53.49,Not Rated,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,32.78,38.88,19.05,,49e63323-e564-48ac-9f11-cf77bf0fe20b,Not Rated,33.33
693fd389-a3a9-4cc9-9a13-6218d84292fd,60.32,1.1.7,55.81,Not Rated,Business Insights and Conditions Survey (BICS),31.62,36.5,19.05,,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,Not Rated,33.33
69833273-2b81-4657-8d80-5bafb2c0834d,55.56,1.1.7,53.49,Not Rated,"Deaths – CHI, Community Health Index",32.78,38.88,19.05,,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,Not Rated,33.33
6a11bc97-b57a-458f-8a3e-98c71221cb5c,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,46.84,44.45,28.57,ALLIANCE > HQIP,8a3ec96a-0600-4c6d-8761-9d277f07b9da,Not Rated,23.81
6a390359-1e26-470f-a4e5-bfb31a5ed643,20.63,1.1.7,16.28,Gold,North West London Patient Index (NWL PI),88.29,88.1,92.86,HUB > DISCOVER NOW,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,Gold,96.83
6a63513f-92cb-43ce-b0dd-fdb1113150c9,36.51,1.1.7,32.56,Bronze,Mental Health Services Data Set,70.62,72.22,73.81,ALLIANCE > NHS DIGITAL,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,Bronze,80.95
6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,50.79,1.1.7,51.16,Not Rated,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,33.95,41.27,19.05,,7c087b3c-cc04-4d3d-894b-7ea5419fa714,Not Rated,33.33
6ae22437-38d7-4c47-b529-e100e15c81ab,26.98,1.1.7,25.58,Bronze,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,70.55,73.81,66.67,HUB > PIONEER,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,Bronze,74.6
6aebcd6d-10c6-44cd-80d6-b5a90791db4f,15.87,1.1.7,16.28,Bronze,York Tissue Bank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,71e898d1-db8c-4887-a605-dd6336b92a34,Silver,63.49
6af010f2-5973-486f-a44b-ef296455bee6,50.79,1.1.7,51.16,Not Rated,Moorfields AMD Dataset 002,33.95,41.27,19.05,,bf392537-82b4-4d71-ace0-e7bea3b167fb,Not Rated,33.33
6bc36f07-d55a-4a97-afab-29d93dc65bde,19.05,1.1.7,20.93,Bronze,Sheffield Brain Tissue Bank (SBTB),77.63,73.81,76.19,ALLIANCE > TISSUE DIRECTORY,bdda7221-7c02-4ced-b7a8-3806a073d981,Silver,66.67
6bca5d27-5b98-45e7-b834-6980ba5db5c9,15.87,1.1.7,16.28,Bronze,Leicester Respiratory Research Database,76.38,73.02,69.05,HUB > BREATHE,01c3d08c-6948-4059-a027-3437e4f5d53b,Silver,61.9
6bde3902-5d69-4c24-9d10-f84a63efdb22,15.87,1.1.7,16.28,Bronze,Leeds Breast Research Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,2dc1218d-df5f-4025-826c-cf5ca7d67882,Silver,60.32
6c12c555-c011-4f43-b98f-df0bfaad6b05,55.56,1.1.7,53.49,Not Rated,Moorfields Eye Image BioResource 001,32.78,38.88,19.05,,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,Not Rated,33.33
6cae7a61-568d-40b1-984a-1dd9365f9c71,46.03,1.1.7,46.51,Not Rated,Effects of second-hand smoke on pregnant women: a phenomenological study,29.12,29.36,4.76,,4a5c610f-019d-450a-90c5-0fe315027f56,Not Rated,4.76
6cd16bca-395b-4dbc-a817-15fd55a1a8e8,33.33,1.1.7,32.56,Not Rated,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,48.0,45.24,28.57,ALLIANCE > HQIP,03e77b9d-57b8-44d5-8d64-9b1325958b22,Not Rated,23.81
6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,20.63,1.1.7,20.93,Bronze,DARWIN1 Trial,75.25,71.43,71.43,ALLIANCE > TISSUE DIRECTORY,7f9672fa-dad5-479d-a929-52719e8cc2fa,Bronze,63.49
6dd170f2-c9fe-4496-9499-26783d84e3c2,46.03,1.1.7,46.51,Not Rated,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,29.12,29.36,4.76,,680a7d41-0fd1-4b32-a2cd-190e338f8ac7,Not Rated,4.76
6dd62b6b-d832-4c65-a101-20fe9edd75fc,20.63,1.1.7,20.93,Bronze,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",70.48,66.67,61.9,HUB > BREATHE,dae5b81c-db28-414b-9328-5596632a8732,Bronze,53.97
6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,15.87,1.1.7,16.28,Bronze,Wales Cancer Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,37886fb5-d0ae-400f-89eb-78664897bcf2,Silver,60.32
6e47173e-651a-404e-a0b2-1fa1cbd887b1,60.32,1.1.7,55.81,Not Rated,Covid-19 Second Generation Surveillance System,31.62,36.5,19.05,,fede31c6-a9c5-4cfb-9866-9b58b2199cff,Not Rated,33.33
6e5916d4-017c-4542-bc71-edf6d4c5a055,23.81,1.1.7,25.58,Not Rated,Biological samples,57.45,56.35,40.48,UK Biobank,41ac38b0-31cd-4865-a357-80ce557b2312,Not Rated,36.51
6e70b32a-dfbc-46d3-9784-479f3f09527e,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,46.84,44.45,28.57,ALLIANCE > HQIP,4b33fc6d-3cac-4404-adac-d693328456fa,Not Rated,23.81
6e92101b-a660-4854-9a19-040324b6c9b3,55.56,1.1.7,53.49,Not Rated,Annual District Death Daily (ADDD),32.78,38.88,19.05,,584bf8c8-d58f-44c6-9b65-e1611144fd54,Not Rated,33.33
6f348bdc-21e4-459b-b658-dc839a1e2133,26.98,1.1.7,23.26,Silver,Intensive Care National Audit and Research Centre,80.03,81.75,83.33,ALLIANCE > SAIL,fa8bf269-4769-491b-b398-fa63137d14ab,Silver,90.48
6f9a4cb1-7c5a-4671-838a-9554a6491266,55.56,1.1.7,53.49,Not Rated,National Early Inflammatory Arthritis Audit - patient survey,32.78,38.88,19.05,,e87410ec-a819-43db-99d1-f887c977e525,Not Rated,33.33
6fbdc930-be40-4492-ba79-82d06d49b539,55.56,1.1.7,53.49,Not Rated,"NHS Tayside A&E, Diagnosis dataset during A&E visit",32.78,38.88,19.05,,14a39e96-8ac3-4df3-b42b-07718121c585,Not Rated,33.33
6fd8abda-7e49-436c-9131-a1f607569c14,55.56,1.1.7,53.49,Not Rated,Covid-19 UK Non-hospital Antibody Testing Results,32.78,38.88,19.05,,a77e52cc-d404-45d6-835f-32e2dc46778a,Not Rated,33.33
6ffc7fd8-732f-4360-b38b-fa94dd75a13d,55.56,1.1.7,53.49,Not Rated,"NHS Tayside A&E, Diagnosis During A&E visit",32.78,38.88,19.05,,14a39e96-8ac3-4df3-b42b-07718121c585,Not Rated,33.33
7017aede-b38a-4b70-b7b2-aade001d0cc0,55.56,1.1.7,53.49,Not Rated,School Workforce Annual Census (SWAC),32.78,38.88,19.05,,5692eade-5738-48ed-8527-39be9caaa7b5,Not Rated,33.33
70491568-676d-43e4-b3c3-b1db4f1ff530,60.32,1.1.7,55.81,Not Rated,National Records of Scotland (NRS) - Stillbirth Data,31.62,36.5,19.05,,dca0c95b-ae7d-4163-8c3b-a881f779df02,Not Rated,33.33
705f86b8-4c2f-4ed5-b792-3a0d49d14c75,50.79,1.1.7,51.16,Not Rated,GoDARTS,33.95,41.27,19.05,,8ca05f55-af73-42bd-b682-851c2c54a6cc,Not Rated,33.33
708839a0-d003-4917-bbd9-92741f54ab75,55.56,1.1.7,53.49,Not Rated,National Waiting List Clock Starts,32.78,38.88,19.05,,2b847fd2-0f65-43b7-84e1-10cec99d699e,Not Rated,33.33
70ad0b2c-a8dd-4f91-a5b8-adca272bf215,60.32,1.1.7,55.81,Not Rated,BathTAP Switching Cohort 3,31.62,36.5,19.05,,a20643c7-ef15-4f7d-9e48-5a9f23a645c1,Not Rated,33.33
70b4d407-288a-4945-a4d5-506d60715110,17.46,1.1.7,18.6,Bronze,CASPS: A Phase II trial of Cediranib in ASPS patients,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,Bronze,60.32
70c318c4-b388-4102-924e-5419d44c1679,46.03,1.1.7,46.51,Not Rated,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,29.12,29.36,4.76,,009bcb87-05f3-46e6-8866-7e4df698cb19,Not Rated,4.76
719dd9c9-9aa5-426d-981a-57f0ad3f1480,50.79,1.1.7,51.16,Not Rated,Moorfields DMO Dataset 003,33.95,41.27,19.05,,120106fb-49b4-4bc0-b30c-50a59c5c6253,Not Rated,33.33
71b8569c-b582-499c-85aa-909b825f6ea6,15.87,1.1.7,16.28,Bronze,Avon Longitudinal Study of Parents and Children,78.77,74.6,73.81,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,255d70c6-9a50-4b62-adc0-44216606a216,Silver,65.08
7257d45c-6697-4c49-bbce-de0d456c0678,46.03,1.1.7,46.51,Not Rated,NIHR BioResource: SNP imputation data,29.12,29.36,4.76,,39d7ad29-be30-4e12-a7c8-d8757141de85,Not Rated,4.76
72eb9599-aa37-4c17-bc56-a7833e8038db,55.56,1.1.7,53.49,Not Rated,National Paediatric Diabetes Audit - survey of diabetes-related technologies,32.78,38.88,19.05,,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,Not Rated,33.33
72fe91de-b0c0-423a-ad68-bd7067b20ad8,36.51,1.1.7,37.21,Not Rated,Infoflex Cancer Registry,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,5505e91d-9e0a-4969-87d5-00f256d91306,Not Rated,14.29
730b3e54-1f59-4c07-b5d6-e6b63e4dda35,23.81,1.1.7,23.26,Silver,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",77.66,80.95,78.57,HUB > PIONEER,16a09f1b-3654-4ec3-9913-fb70cb1e2364,Silver,85.71
73462506-32c5-43a0-963e-06d67e967b97,11.11,1.1.7,9.3,Silver,UK BiLEVE Consortium Dataset,84.63,79.37,78.57,HUB > BREATHE,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,Silver,69.84
73941d19-6fcd-40e9-a7bd-ef0d91f93de9,60.32,1.1.7,55.81,Not Rated,Critical Care Minimum Dataset,31.62,36.5,19.05,,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,Not Rated,33.33
73f54071-62bf-48f5-8be1-569208b18ab8,39.68,1.1.7,34.88,Silver,HIC Hepatitis v2,80.18,80.16,95.24,NIHR Health Informatics Collaborative Viral Hepatitis Theme,66be725a-b950-4bf8-9a35-7e33ce765a25,Silver,100.0
74241b17-23b7-4233-b7b9-1a484aa053b0,15.87,1.1.7,16.28,Bronze,Myeloma XII clinical trial samples,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,576fbcf8-ff25-4230-ae69-e72ca02b95f1,Silver,60.32
747d57aa-a02b-411c-9403-2e3ec9d3e5b5,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Contact detail,32.78,38.88,19.05,,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,Not Rated,33.33
74b54e34-0e01-4447-be1d-e9da3e03cd2e,46.03,1.1.7,46.51,Not Rated,NIHR BioResource: Metabolite data,29.12,29.36,4.76,,dec09f2e-a93f-41e2-8217-72431ea4a19e,Not Rated,4.76
74be1c67-ab42-4716-a63b-be3f5de0d489,46.03,1.1.7,46.51,Not Rated,National Audit of Dementia Round 4 - casenote audit,29.12,29.36,4.76,,587a94e6-48a4-4e5e-8230-4018897bc7c7,Not Rated,4.76
75614b69-bc18-416b-9d27-fd8ca9fc4521,25.4,1.1.7,27.91,Not Rated,Cancer register,57.48,56.35,42.86,UK Biobank,a4751434-54ea-4d22-a66a-a5d32bd80c40,Not Rated,38.1
75dabfb3-69b7-4192-b257-d0d814e5872d,55.56,1.1.7,53.49,Not Rated,National Paediatric Diabetes Audit - core clinical dataset,32.78,38.88,19.05,,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,Not Rated,33.33
76535d6e-ce0c-407c-ba22-1b2420a1e654,50.79,1.1.7,51.16,Not Rated,National Exercise Referral Scheme,33.95,41.27,19.05,,131784c0-769d-4f7b-b7d0-b5f4b89886d4,Not Rated,33.33
77422eb1-7bdb-4205-b3d0-57d1add35317,50.79,1.1.7,51.16,Not Rated,Moorfields DMO Dataset Release 001,33.95,41.27,19.05,,120106fb-49b4-4bc0-b30c-50a59c5c6253,Not Rated,33.33
77824298-ef3b-40f7-a0a4-b6dedb2e7a02,15.87,1.1.7,13.95,Gold,The National COVID-19 Chest Imaging Database,90.64,92.06,95.24,NHSX,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,Gold,100.0
7793f54e-73be-4c97-a941-ba105b1b0480,15.87,1.1.7,16.28,Bronze,Leeds Multidisciplinary Research Tissue Bank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,7e60a651-b3d6-40ef-93dc-1f87dabee7be,Silver,63.49
77b48222-3a00-4dcc-b0ef-3f99dfae697e,55.56,1.1.7,53.49,Not Rated,Lifelong Learning Wales Record (LLWR),32.78,38.88,19.05,,cba62a8d-5917-4912-ad4d-340472f7b904,Not Rated,33.33
77dc7118-443c-4c85-a18c-e7bbe01e9e7a,60.32,1.1.7,55.81,Not Rated,1958 National Child Development Study - Pain data,31.62,36.5,19.05,,33092502-12ef-4bc0-8400-5f63915cbf33,Not Rated,33.33
77f4f3ec-31aa-4eb9-8896-a063ce831c9b,50.79,1.1.7,51.16,Not Rated,Maternity Indicators Dataset (MIDS),33.95,41.27,19.05,,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,Not Rated,33.33
7858978f-30e8-42e7-abe4-d9af5447c278,50.79,1.1.7,46.51,Not Rated,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),44.6,47.62,35.71,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,10ffac16-d0c2-4d53-ab6a-69a38e283223,Not Rated,46.03
7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,15.87,1.1.7,16.28,Bronze,UCL / UCLH Biobank for Studying Health and Disease,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,ce533c67-5565-4010-bedf-dca3863a9084,Silver,63.49
78ce070c-84db-4676-81c5-0c672f4e12e3,15.87,1.1.7,13.95,Gold,COVID-19 Symptom Tracker Dataset,90.64,92.06,95.24,ALLIANCE > SAIL,594cfe55-96e3-45ff-874c-2c0006eeb881,Gold,100.0
78fe2e13-7f40-406f-a584-04909d0ce060,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,efecbe58-4822-4f17-bf5c-92113d143db9,Not Rated,77.78
7964fc83-017a-4786-918e-bab61f7ddd99,55.56,1.1.7,53.49,Not Rated,CAPS,32.78,38.88,19.05,,a4c595a6-cb41-4743-bea3-feb4d4c72091,Not Rated,33.33
796d97b4-6f3d-4ee8-8966-9238efdcac2d,52.38,1.1.7,53.49,Not Rated,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,32.78,40.47,19.05,,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,Not Rated,33.33
79b02690-798b-462d-9ced-f53c9e39d624,17.46,1.1.7,18.6,Bronze,Central England Haemato-oncology and oncology Research Biobank (CEHRB),76.42,73.02,71.43,ALLIANCE > TISSUE DIRECTORY,314953f6-58e7-49c0-adfd-c60e623eba74,Silver,63.49
7aa02796-787a-42c2-b97e-d008fa77e4b8,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,Not Rated,77.78
7aa38c5c-771c-4157-a008-32051a5aed4b,60.32,1.1.7,55.81,Not Rated,Education Wales (EDUW),31.62,36.5,19.05,,204fa806-071d-4410-9c2c-143017d32d24,Not Rated,33.33
7ada943a-083d-44c5-a147-32e581e3ed20,55.56,1.1.7,53.49,Not Rated,NIHR BioResource: Contact detail,32.78,38.88,19.05,,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,Not Rated,33.33
7b0071f9-ca68-46b2-b7ad-bc9a70a9ea0b,55.56,1.1.7,53.49,Not Rated,Demography,32.78,38.88,19.05,,b88c2b24-b75d-4d28-9391-2dbac1605a17,Not Rated,33.33
7b922498-1757-418d-96ca-64980a50b647,46.03,1.1.7,46.51,Not Rated,NIHR BioResource: Whole Genome Sequencing,29.12,29.36,4.76,,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,Not Rated,4.76
7d313fa6-941f-48ca-93e1-05d912d183ac,50.79,1.1.7,51.16,Not Rated,GPES Data for Pandemic Planning and Research (COVID-19),33.95,41.27,19.05,,696cfc9f-090d-4328-94ac-140760a77c73,Not Rated,33.33
7d414fa8-565b-451b-bc9c-fe2965c2bc5b,50.79,1.1.7,51.16,Not Rated,Children In Need Census Wales (CINW),33.95,41.27,19.05,,e4f6d9a8-88d0-4781-b192-cd165451b272,Not Rated,33.33
7d6ec229-dbde-4e4e-91de-6b7d8111d02e,50.79,1.1.7,51.16,Not Rated,Welsh Results Reports Service (WRRS),33.95,41.27,19.05,,71d37610-ac55-432d-82a3-bdb04407acd8,Not Rated,33.33
7d98182a-18f8-4f2e-a59c-5048580557b5,55.56,1.1.7,53.49,Not Rated,National Early Inflammatory Arthritis Audit - clinical dataset,32.78,38.88,19.05,,b0797c05-352f-455f-8d27-150b6f6354cc,Not Rated,33.33
7daacbe5-082d-4c12-b801-0fb08932dada,50.79,1.1.7,51.16,Not Rated,COVID-19 Vaccination,33.95,41.27,19.05,,b0049073-3335-433d-bdb9-de22547698f8,Not Rated,33.33
7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,25.4,1.1.7,25.58,Not Rated,Effect of personal air pollution exposure on asthma control in children,61.02,57.94,47.62,HUB > BREATHE,57efab41-65fc-4069-8b9d-e5ced13cb4d3,Not Rated,41.27
7e780260-e8d3-4541-b51e-213233dfc349,26.98,1.1.7,27.91,Not Rated,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,58.67,56.35,45.24,HUB > BREATHE,36a5da45-772c-4c67-8ec3-84c9e67332d3,Not Rated,39.68
7ec7c8c4-770b-41f0-87d0-38ea232ae5bd,46.03,1.1.7,46.51,Not Rated,Next Steps,29.12,29.36,4.76,,0ad7a3dd-e720-49ef-9d27-c394a32b0326,Not Rated,4.76
7ed08209-f22e-4cdf-b8b5-e1d58b0bcaf9,50.79,1.1.7,51.16,Not Rated,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),33.95,41.27,19.05,,04cb9964-54fb-4529-b09b-735c3daa1c7b,Not Rated,33.33
7f4fb30c-2a09-4d75-bed2-114751e06723,25.4,1.1.7,23.26,Silver,UHB Eye Image Dataset Release 001,82.42,84.92,88.1,HUB > INSIGHT,21fb56d1-726f-40e3-a998-e4b34ba3e46f,Silver,95.24
7f7860ee-6235-4e7d-95f3-df692f5d9630,55.56,1.1.7,53.49,Not Rated,CDE Encounter,32.78,38.88,19.05,,3598723f-62fb-4377-9a8b-b264ced1aabd,Not Rated,33.33
7fdb684d-bb7a-4d0b-8666-9f10510f071f,30.16,1.1.7,25.58,Silver,GENOMICS ENGLAND 100K CANCER & COMMON,84.83,84.92,95.24,GENOMICS ENGLAND,702f0198-bdfe-401e-97f2-35f5d26357ad,Silver,100.0
80a7208f-c174-42bd-9127-e8f006de7c95,26.98,1.1.7,23.26,Silver,COVID-19 Test Trace and Protect [CTTP],76.47,77.78,76.19,ALLIANCE > SAIL,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,Silver,82.54
80e9c439-4909-4534-8bfe-6f01fdec7de7,15.87,1.1.7,13.95,Gold,Cervical Screening Wales,90.64,92.06,95.24,ALLIANCE > SAIL,b32325d7-7f00-4d20-9935-dd02e1bc6932,Gold,100.0
80fc6c81-dd24-4f5f-870e-6c1cb7a1766d,50.79,1.1.7,51.16,Not Rated,Outpatient Database for Wales (OPDW),33.95,41.27,19.05,,d331159b-b286-4ab9-8b36-db39123ec229,Not Rated,33.33
8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,50.79,1.1.7,51.16,Not Rated,Outpatient Dataset,33.95,41.27,19.05,,d331159b-b286-4ab9-8b36-db39123ec229,Not Rated,33.33
81a2abb5-e2b4-4224-8345-5aac1dc68a5d,33.33,1.1.7,32.56,Silver,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,75.38,78.58,83.33,ALLIANCE > CPRD,014e7973-b43e-4a4a-91b4-de3f353b71b9,Bronze,90.48
81c28c63-7cbb-49ce-86b4-c83e1c15fdba,55.56,1.1.7,53.49,Not Rated,Weekly SUS Outpatients Dataset,32.78,38.88,19.05,,572cd3e2-9119-40ff-ab2e-49e8a0a02ab8,Not Rated,33.33
81c54c5a-ceb1-487c-820a-437b4dd002ca,25.4,1.1.7,25.58,Silver,Risk and outcomes of coagulopathies in acutely unwell adults,75.31,79.36,76.19,HUB > PIONEER,bf3fe16c-5377-4571-b5a5-7aa7e796594c,Bronze,84.13
81f3bdfe-de6b-4831-ba9a-4e28a34a6ab4,31.75,1.1.7,30.23,Silver,HES Outpatient data for CPRD GOLD,76.55,78.57,83.33,ALLIANCE > CPRD,21dc2345-3983-4a46-960c-f17974bc7b71,Silver,88.89
8226b6fa-d815-4f15-9064-b56beb0fddb1,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,Not Rated,77.78
826114ca-2563-4c0c-b023-3417ead32956,19.05,1.1.7,20.93,Bronze,Research Donors Ltd,77.63,73.81,76.19,ALLIANCE > TISSUE DIRECTORY,fcb62cb3-c876-47a3-961e-fb27c6f718fa,Silver,66.67
8286eef9-0533-488e-bf19-8fc0fa1dd00b,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Immunology (Extractable),32.78,38.88,19.05,,39055449-c074-4b58-adb2-b1c0d2441c4d,Not Rated,33.33
828bc515-6b42-4492-a77e-cf20226ba041,46.03,1.1.7,46.51,Not Rated,Reasons for delay in seeking care for pneumonia in children under five,29.12,29.36,4.76,,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,Not Rated,4.76
82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,15.87,1.1.7,16.28,Bronze,Northern Ireland Biobank (NIB),77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,c6e1ea88-f5bf-4a57-953f-688f313fcb04,Silver,63.49
830c22bb-4321-4fa3-ba04-be9b30518877,46.03,1.1.7,46.51,Not Rated,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,29.12,29.36,4.76,,574cf7bc-dd70-4508-a66d-ac59d8d06639,Not Rated,4.76
83e177bb-5a05-4ec1-be22-272a0f985957,46.03,1.1.7,46.51,Not Rated,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,29.12,29.36,4.76,,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,Not Rated,4.76
842e8c5c-a298-4942-9ac4-f95d1a5f87b3,26.98,1.1.7,27.91,Not Rated,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,67.0,64.29,61.9,HUB > BREATHE,b0a68ee7-742d-45dc-aae9-4be4e1655fc0,Bronze,55.56
844f3be0-f50d-4a88-9783-0928ad1c2aad,34.92,1.1.7,32.56,Silver,HIC Acute Coronary Syndromes,81.34,82.54,95.24,NIHR Health Informatics Collaborative Cardiovascular Theme,869a9b4e-3537-449f-9a59-a0eac523c4e4,Silver,100.0
8466ec6f-8a4c-4286-8138-04c35e12b1f8,15.87,1.1.7,16.28,Bronze,"Oncology Clinical Trials Office, University of Oxford",76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,Silver,60.32
849d46e6-49a6-4456-a5ae-990c02012bf2,34.92,1.1.7,34.88,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,46.84,44.45,28.57,ALLIANCE > HQIP,c3e63860-bd61-4154-ab5f-ca927fb029c4,Not Rated,23.81
84b6d047-2a05-4fc0-8537-809dbb3d18ed,22.22,1.1.7,23.26,Not Rated,COMPARE,60.99,58.73,45.24,OTHER > The University of Cambridge,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,Not Rated,39.68
84de0d13-f5bd-4c22-83d3-e1adb00d5a72,36.51,1.1.7,37.21,Not Rated,CRIS,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,67cea834-33f5-4ed7-9dc2-072ad077de07,Not Rated,14.29
850f99cb-f091-4f10-86ee-06a3eaa7df53,22.22,1.1.7,18.6,Gold,North West London Coordinate My Care (NWL CMC),87.13,87.31,92.86,HUB > DISCOVER NOW,c853b41b-fbd1-4896-b0fb-85303109fec4,Gold,96.83
8638e095-a609-463f-b36e-c4cac4519660,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Tendon Rupture,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,4fcc8b11-2b9b-4f68-b51a-978749d89acc,Gold,100.0
865f0e79-f862-493b-b863-b39b777d60ca,17.46,1.1.7,18.6,Bronze,Oxford Musculoskeletal Biobank,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,ccd6e59d-3582-4f47-a4cd-f5845192d75c,Bronze,60.32
8665b36e-f9a5-4062-ba56-d33fecfe3376,12.7,1.1.7,11.63,Silver,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),83.47,77.78,78.57,HUB > BREATHE,cc6f926a-90cf-4083-84e7-131d1e63813b,Silver,68.25
86d7088b-7a15-4e9a-b2b0-857a67e04650,41.27,1.1.7,37.21,Bronze,HES:Civil Registration (Deaths) bridge,63.54,67.46,64.29,ALLIANCE > NHS DIGITAL,21aec912-444f-447d-b3c4-6791a6c82667,Not Rated,76.19
88155e0d-a88f-4a72-ba3f-45d4e352439a,33.33,1.1.7,32.56,Silver,Cancer registration data for CPRD GOLD,75.38,78.58,83.33,ALLIANCE > CPRD,e2f5d637-94b3-447b-b7eb-ea957ce449b6,Bronze,90.48
8821748d-9d8b-4787-91cc-0a58c5ab890d,23.81,1.1.7,23.26,Not Rated,EMEP4UK Pollution,62.18,58.73,47.62,HUB > BREATHE,eb76598f-e228-413c-82f3-231809062611,Not Rated,41.27
88576066-fb5f-43e2-8af4-0904630b2f1b,15.87,1.1.7,16.28,Bronze,University of Southampton Faculty of Medicine Tissue Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,786563e9-5377-4d18-8d32-65ff14d53987,Silver,60.32
8895d3d9-78bd-4216-986a-3bb7f864c382,31.75,1.1.7,30.23,Silver,HES Accident and Emergency data for CPRD GOLD,76.55,79.37,83.33,ALLIANCE > CPRD,733b1060-f958-4c3e-ab6a-2b87901d9a9a,Silver,90.48
895e5c2f-e484-4d08-91c6-35ac2f85c231,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v2.6 (Non-Sensitive),60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,702201ff-e729-4e29-a428-32953c9a0332,Not Rated,77.78
89aac17d-f8a1-4ddc-9495-4adc278234a9,15.87,1.1.7,16.28,Bronze,Human Biomaterials Resource Centre,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,Silver,60.32
89f76cff-03dd-47a1-b6fc-29e42b78e7a5,28.57,1.1.7,27.91,Silver,Hospital Episode Statistics Admitted Patient Care,75.33,78.57,78.57,ALLIANCE > NHS DIGITAL,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,Bronze,85.71
8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,50.79,1.1.7,51.16,Not Rated,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",33.95,41.27,19.05,,02397c83-62e6-4ec2-8366-89d211739564,Not Rated,33.33
8a4d097a-3ef2-4452-b6e0-98e2baebb427,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Primary Knee Replacement dataset,32.78,38.88,19.05,,d517e6fc-9a88-4647-b787-dcbed3635885,Not Rated,33.33
8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,20.63,1.1.7,16.28,Gold,COVID-19 Consolidated Deaths,89.48,89.69,95.24,ALLIANCE > SAIL,70e37f44-5c3e-4c83-a42a-89b3476d1d45,Gold,100.0
8bbfbc8c-dad2-4a0b-b255-4aae3687a371,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Revision Ankle Replacement dataset,32.78,38.88,19.05,,b4f076d2-c9a3-49ba-84f4-94148dc8511a,Not Rated,33.33
8c7abca7-4292-4d1f-b311-c132a7adf109,38.1,1.1.7,39.53,Not Rated,Sectra PACS,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,10bf4c08-6702-44fe-8faa-1280dea6b0c9,Not Rated,15.87
8c8cf129-e87c-46b3-8812-19e07578ee89,34.92,1.1.7,34.88,Not Rated,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,46.84,44.45,28.57,ALLIANCE > HQIP,d94a604c-5733-4f07-93bb-e77b6ea2313f,Not Rated,23.81
8d06cb09-640c-40db-8387-adf7fab54c3b,25.4,1.1.7,25.58,Silver,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),77.69,81.75,80.95,ALLIANCE > CPRD,83059be4-071b-4a36-8ab1-9fde1e32e75e,Silver,88.89
8d24889c-ac3c-4b9d-a8bd-cf9effd64370,25.4,1.1.7,25.58,Silver,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),77.69,81.75,80.95,ALLIANCE > CPRD,3bc43876-507b-4dff-bd2b-7df147322e15,Silver,88.89
8d33b7a7-151a-4e2e-b87f-b14371e0cb37,55.56,1.1.7,53.49,Not Rated,Deaths – Date of Death,32.78,38.88,19.05,,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,Not Rated,33.33
8d3f80d4-aeae-46f0-809b-cd6c51e24f75,42.86,1.1.7,39.53,Bronze,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,62.38,67.46,64.29,ALLIANCE > NHS DIGITAL,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,Not Rated,77.78
8da6766c-df44-4414-a858-4415e473ea76,46.03,1.1.7,46.51,Not Rated,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,29.12,29.36,4.76,,216924f0-585e-4842-a165-78cf9e0af0aa,Not Rated,4.76
8daf5886-4813-465d-9145-3585a8c584bb,46.03,1.1.7,46.51,Not Rated,National Asthma and COPD Audit Programme (NACAP): Wales primary care dataset,29.12,29.36,4.76,,8a3ec96a-0600-4c6d-8761-9d277f07b9da,Not Rated,4.76
8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,38.1,1.1.7,32.56,Not Rated,REal-time Assessment of Community Transmission (REACT-2),64.67,65.87,61.9,ALLIANCE > IMPERIAL COLLEGE LONDON,25003f25-384c-4264-9c8f-dd8734ee5595,Not Rated,69.84
8e75e0f9-40ed-4505-a8e8-20f21c69ddea,55.56,1.1.7,53.49,Not Rated,Children Receiving Care and Support Census (CRCS),32.78,38.88,19.05,,fb3fac03-a428-4b3f-8058-5622e1fd57d8,Not Rated,33.33
8eace3c2-1dc8-4708-9350-ad129b7d2bc9,30.16,1.1.7,32.56,Not Rated,Mental Health Services Data Set - Inpatients,57.53,57.94,47.62,ALLIANCE > NHS DIGITAL,275ac6a4-798b-4f49-a25e-008245050bbc,Not Rated,46.03
8f2cb486-6a3b-418e-8fb4-b85bc454eaf3,50.79,1.1.7,51.16,Not Rated,Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care,33.95,41.27,19.05,,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,Not Rated,33.33
8f54b1ad-b8cd-44a3-94d7-c98133ca913d,50.79,1.1.7,51.16,Not Rated,Unscheduled Care Data Mart,33.95,41.27,19.05,,a265af2e-40fc-4759-af61-eab293cdad5a,Not Rated,33.33
8fac682b-96be-4e21-a2a9-5fe66c3b35ff,25.4,1.1.7,25.58,Silver,The impact of hospitalised patients with COPD: from admission to outcome,75.31,79.36,76.19,HUB > PIONEER,780bf7d0-9ee1-4641-a74f-dc148e361970,Bronze,84.13
8fc6bf25-df25-429f-be41-b7d5ffd4ff15,50.79,1.1.7,51.16,Not Rated,Eye images and retinopathy grades in diabetic eye screening,33.95,41.27,19.05,,3b1bb176-e22f-402a-b863-730d05b22021,Not Rated,33.33
90ace555-da01-4940-a3ef-78bb83976ff0,55.56,1.1.7,53.49,Not Rated,COVID-19 COG-UK Viral Genome (variant strain data),32.78,38.88,19.05,,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,Not Rated,33.33
90db47a7-d082-4778-884c-78f9b6c7e57f,65.08,1.1.7,58.14,Not Rated,RAPID (Hospital Stay Level Data),30.45,34.12,19.05,,1fc57971-5af5-499e-a500-4ffbb087f0c4,Not Rated,33.33
90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,50.79,1.1.7,51.16,Not Rated,Prescribing Information System (PIS),33.95,41.27,19.05,,22e3943e-edb5-44a1-9e4e-22b0f7a31767,Not Rated,33.33
914321d0-1d86-4974-a38d-97469f9ff2cd,15.87,1.1.7,16.28,Bronze,Bloodwise Childhood Leukaemia Cell Bank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,93baeb13-cc4b-47fd-9dae-5ae5277cba54,Silver,63.49
91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,46.84,44.45,28.57,ALLIANCE > HQIP,3afbb83d-d47b-43b3-a202-0d3081e5d294,Not Rated,23.81
91f1aef1-7dfe-4cb3-86ab-15e09f91e969,23.81,1.1.7,23.26,Not Rated,Seasonal Influenza Vaccine Effectiveness II,68.13,64.28,59.52,HUB > BREATHE,50b47298-d935-4990-a002-e26b6bb26d30,Bronze,52.38
922f72c0-e3cb-4d89-a56f-50d938a87630,46.03,1.1.7,46.51,Not Rated,"Estimate the cost of care, quality of life and wider societal burden due to COPD",29.12,29.36,4.76,,ee6013d6-5584-4275-b124-3113ee5ad37d,Not Rated,4.76
925feb2c-195f-460c-bae7-f17ea652fd5d,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Revision Elbow Replacement dataset,32.78,38.88,19.05,,12babf2b-42e8-4b1e-9143-3475a07bb343,Not Rated,33.33
927beb63-f650-4972-a3ad-af8e29dc26a5,46.03,1.1.7,46.51,Not Rated,Omega 3 Cohort,29.12,29.36,4.76,,a1bcea4c-89dd-4cdb-978c-43db676ed73c,Not Rated,4.76
931efe47-04eb-4ff3-aa62-97e2e4007aed,26.98,1.1.7,20.93,Silver,Yorkshire Specialist Register of Cancer in Children and Young People,85.97,84.92,92.86,HUB > DATA-CAN,93582beb-e45a-47b6-aeab-d26f583e4c3b,Silver,96.83
9360bc6c-2a7d-4415-869d-3e853c558f4d,22.22,1.1.7,18.6,Gold,National Survey for Wales,88.32,88.89,95.24,ALLIANCE > SAIL,bcca421a-9077-4c47-9daa-b1bc030d3dee,Gold,100.0
93aeac00-2e6d-44d7-8643-092c587c241a,28.57,1.1.7,25.58,Silver,South West Primary Care Dataset,77.69,79.37,80.95,HUB > DATA-CAN,a47a8c77-3ced-43a0-acf0-3997c4eb5a29,Silver,87.3
93d26255-7199-4ea7-997d-f74890d12b87,23.81,1.1.7,25.58,Not Rated,Imaging,56.26,55.55,38.1,UK Biobank,32a2dcb1-1e18-44ba-ad49-b3da312ca447,Not Rated,34.92
94188672-a44d-4ae3-8bb3-f249891a5af7,46.03,1.1.7,46.51,Not Rated,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,29.12,29.36,4.76,,64f78a5f-268f-4951-9c91-f7e7130baffa,Not Rated,4.76
9445e723-655a-43d0-a4e5-50313d98eac0,17.46,1.1.7,18.6,Bronze,National Unified Renal Translational Research Enterprise (NURTuRE),75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,Bronze,60.32
94c7dca9-a96f-4e77-b156-96676a701834,60.32,1.1.7,55.81,Not Rated,Covid Vaccination Dataset (CVVD),31.62,36.5,19.05,,471f101c-a45e-4620-8710-be3036a46fba,Not Rated,33.33
94e28efd-a976-4748-81fd-956a598c26cb,15.87,1.1.7,16.28,Bronze,BioDock,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,ecb82441-286f-408d-880c-9239a25fb5cd,Silver,60.32
94f983ec-af41-451a-af5d-657ac58207c6,20.63,1.1.7,20.93,Silver,Unscheduled Care Datamart,80.01,83.34,80.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,a265af2e-40fc-4759-af61-eab293cdad5a,Silver,87.3
94fab6d3-9753-4ffd-ade2-02d199d93f94,15.87,1.1.7,16.28,Bronze,RAPPER,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,76d26f0f-0136-4ae5-8be9-37782a70bac5,Silver,63.49
953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,50.79,1.1.7,51.16,Not Rated,GP dataset - Welsh Primary Care,33.95,41.27,19.05,,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,Not Rated,33.33
9552365b-7b9a-4d04-a857-358d0e171424,34.92,1.1.7,32.56,Silver,Pregnancy Register for CPRD GOLD,74.19,76.98,80.95,ALLIANCE > CPRD,14aaf184-5922-4459-affb-6c9e55c12176,Bronze,88.89
95b26238-3379-4188-ad6c-a09657b77648,46.03,1.1.7,46.51,Not Rated,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",29.12,29.36,4.76,,a6ea6185-2e2e-4738-b7f1-dc052eae902e,Not Rated,4.76
96c73136-da1b-43de-9fd1-9d5e63631b14,33.33,1.1.7,30.23,Bronze,VIVALDI 2,64.64,68.25,59.52,OTHER > UNIVERSITY COLLEGE LONDON,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,Not Rated,69.84
9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,23.81,1.1.7,23.26,Silver,SAIL Dementia e-Cohort,80.03,83.34,83.33,ALLIANCE > SAIL,f48b7c05-6a44-480c-84c6-4f7a684f29f8,Silver,90.48
97771ec7-2abb-4d6e-b630-77c61a5e314a,46.03,1.1.7,46.51,Not Rated,FFFAP -  National Hip Fracture Database Facilities Survey 2019,29.12,29.36,4.76,,025c9e8a-938b-4886-9e03-fcad90fe7157,Not Rated,4.76
977ca75e-32da-4e60-a2e5-2bdf534a5986,55.56,1.1.7,53.49,Not Rated,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,32.78,38.88,19.05,,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,Not Rated,33.33
97a5f21e-c0a9-4a04-978b-9f054d7b6bcf,46.03,1.1.7,46.51,Not Rated,"Resilience, Ethnicity & Adolescent Mental Health (REACH)",29.12,29.36,4.76,,0f754b8b-353e-4e8d-9ff0-03d5e0817e02,Not Rated,4.76
97ae3443-b60b-4b33-b861-83663caea1dc,31.75,1.1.7,30.23,Silver,HES Admitted Patient Care data for CPRD GOLD,77.74,80.16,85.71,ALLIANCE > CPRD,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,Silver,92.06
97fa09e6-5ea5-41cd-baf8-20366db13a3f,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,eab996ed-b268-439a-bff4-19925698336a,Not Rated,77.78
9836e0e1-5ea2-4dc4-be5a-24e390b7fa33,50.79,1.1.7,51.16,Not Rated,Characterisation of hospitalised COPD exacerbations using real world data,33.95,41.27,19.05,,f6f2978d-4a49-4dd9-8615-78d28e6dc83c,Not Rated,33.33
99812cec-ea1c-4979-8e00-32df5bad000b,17.46,1.1.7,18.6,Bronze,RATHL Trial,77.61,73.02,73.81,ALLIANCE > TISSUE DIRECTORY,e5ec63dd-4da5-4119-99c8-5cc79045618c,Silver,63.49
99b505ee-44c6-497d-b30b-3ce80eba4047,55.56,1.1.7,53.49,Not Rated,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),32.78,38.88,19.05,,8e0221d4-dcfa-4580-834b-f44421fca3b5,Not Rated,33.33
9a5fdb85-7bd6-4073-9058-e45667d497a8,30.16,1.1.7,27.91,Silver,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),76.52,79.37,80.95,ALLIANCE > CPRD,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,Silver,88.89
9a836aa8-60c7-4911-943e-477b0ae8bbb8,46.03,1.1.7,46.51,Not Rated,Blended learning for primary care physicians on COPD in Bangladesh,29.12,29.36,4.76,,3907a55f-104b-4533-ba21-69bd5f08ce8f,Not Rated,4.76
9abb8804-de89-4aba-8877-0e9a405870fe,55.56,1.1.7,53.49,Not Rated,Systemic Anti-Cancer Therapy Dataset [SACT],32.78,38.88,19.05,,6c4ed998-0f05-415c-a3e4-42430bb62d24,Not Rated,33.33
9b356432-2650-4ded-aa75-657871b38fe3,50.79,1.1.7,51.16,Not Rated,Neovascular age related macular degeneration at University Hospitals Birmingham,33.95,41.27,19.05,,89c2c798-2e0f-4235-9cd9-e2347f2dfc50,Not Rated,33.33
9b7d2306-35e2-44a3-a97d-0b0e03a15336,34.92,1.1.7,34.88,Not Rated,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),46.84,44.45,28.57,ALLIANCE > HQIP,2b640175-725a-465f-9aec-6794e6d27791,Not Rated,23.81
9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,30.16,1.1.7,32.56,Not Rated,Mental Health Services Data Set - Currencies,57.53,57.94,47.62,ALLIANCE > NHS DIGITAL,add485fa-4c54-4a3e-8676-abe2ff4725a5,Not Rated,46.03
9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,30.16,1.1.7,27.91,Silver,PHM and Cancer Outcomes in the WYH Cancer Alliance,75.33,77.78,78.57,HUB > DATA-CAN,bc839e9c-e303-4c3c-9c2c-9975602376e2,Bronze,85.71
9c2356fe-409f-4a34-9fbf-663d2add3902,50.79,1.1.7,51.16,Not Rated,Domiciliary Social Care Worker (DSCW),33.95,41.27,19.05,,0e38bbf4-c788-4a1a-9af8-a24821250154,Not Rated,33.33
9c31bd50-e999-4d4d-bb9d-545c00fcf23e,50.79,1.1.7,51.16,Not Rated,Optimum Patient Care Research Database (OPCRD),33.95,41.27,19.05,,ac755244-4143-4629-9170-a9e8fc98bb1e,Not Rated,33.33
9ca6e8d2-98d2-4757-84e1-287585400e55,22.22,1.1.7,18.6,Gold,"Extended Cohort for E-health, Environment and DNA (EXCEED)",88.32,88.89,95.24,HUB > BREATHE,e22ddf52-7f9e-4072-ae61-cb722461b37d,Gold,100.0
9cb83fb7-e8d7-436b-b847-e4759b9589c5,55.56,1.1.7,53.49,Not Rated,National Survey for Wales Dataset (NSWD),32.78,38.88,19.05,,bcca421a-9077-4c47-9daa-b1bc030d3dee,Not Rated,33.33
9cc82b97-d508-4cb9-98ca-0105aa897bb6,55.56,1.1.7,53.49,Not Rated,UK Renal Registry - Kidney PREM dataset,32.78,38.88,19.05,,ea068fd4-1a96-4ed5-a010-8930afb968bb,Not Rated,33.33
9d4f445e-f81e-45d7-bd83-7e9f68199b4f,23.81,1.1.7,20.93,Silver,IBD NIHR BioResource: Sample holding,84.78,85.72,90.48,HUB > GUT REACTION,f2af20f9-af84-40ce-8a07-7d095948653e,Silver,95.24
9da5acec-1749-46a6-bf93-51457bbaa52c,55.56,1.1.7,53.49,Not Rated,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,32.78,38.88,19.05,,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,Not Rated,33.33
9de20d42-8e9b-45c8-8574-52a49fba826c,25.4,1.1.7,25.58,Not Rated,Respiratory social media database,63.4,59.52,52.38,HUB > BREATHE,43fc768a-9d2c-4c6d-952f-d8570c487b4a,Not Rated,44.44
9e67001e-7c77-4bc0-9af2-5138b5d638e4,20.63,1.1.7,16.28,Gold,Annual District Death Daily,89.48,89.69,95.24,ALLIANCE > SAIL,584bf8c8-d58f-44c6-9b65-e1611144fd54,Gold,100.0
9ea7a624-ce4c-460e-b68f-0655dac36765,50.79,1.1.7,51.16,Not Rated,Radiotherapy Dataset (RTDS),33.95,41.27,19.05,,f102ca50-d1e4-44ec-924e-be89446652af,Not Rated,33.33
9f7608a0-2424-457d-ba50-f51a4444403b,26.98,1.1.7,27.91,Silver,Patient postcode linked deprivation measures for CPRD GOLD,75.33,80.16,78.57,ALLIANCE > CPRD,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,Bronze,87.3
9fe99176-1cbf-41f7-901d-245051dbe410,50.79,1.1.7,51.16,Not Rated,Granular ICU data focussing on the impact of lactate readings on outcomes,33.95,41.27,19.05,,edfc20b7-5a5e-40c4-afd0-a7a5bba77003,Not Rated,33.33
a0292641-9e1a-495d-a7f2-d9ce87ff0b88,55.56,1.1.7,53.49,Not Rated,Outpatient Referral (OPRD),32.78,38.88,19.05,,7465c65e-c321-42e9-a2f4-6bc664caf1fc,Not Rated,33.33
a03b66c6-f56d-40f8-bb9b-06751d97864c,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Revision Shoulder Replacement dataset,32.78,38.88,19.05,,9623e62b-3c50-44aa-8923-0bbb94e7ad61,Not Rated,33.33
a04b16f3-dd24-47de-8c20-699b88eb4da0,55.56,1.1.7,53.49,Not Rated,National Neonatal Research Database (NNRD),32.78,38.88,19.05,,67020745-9def-4c6e-b5ac-bb273bd0a20e,Not Rated,33.33
a06afa88-caba-4354-ac70-d05c67b34dfc,15.87,1.1.7,16.28,Bronze,UK CLL Trials Biobank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,636e216a-072b-4c8b-b867-23b7666d2cb2,Silver,60.32
a0e0c0c2-072a-47ac-9252-e27b37ac024f,41.27,1.1.7,37.21,Silver,HIC Transplantation,77.83,78.57,92.86,NIHR Health Informatics Collaborative Renal Transplantation Theme,359a322e-3781-4796-b6b2-81962fa19b7a,Silver,98.41
a1164dbd-4057-45a2-9860-cbb69696bd7c,30.16,1.1.7,27.91,Silver,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,76.52,78.57,80.95,ALLIANCE > CPRD,2439a88e-d961-4152-a7b5-042097946209,Silver,87.3
a11a234b-8b59-41e8-920a-f8f1799d3c77,23.81,1.1.7,25.58,Not Rated,Biological sample assays,56.26,55.55,38.1,UK Biobank,14c697a5-2d41-4d86-bf17-2e596d07418b,Not Rated,34.92
a1a67182-e81b-4144-ac51-92a86f277eb2,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,7b31b427-b447-432e-9a6c-ad2099343491,Not Rated,77.78
a1d41f64-76e1-4576-a906-f64a7fe664c4,34.92,1.1.7,34.88,Not Rated,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,46.84,44.45,28.57,ALLIANCE > HQIP,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,Not Rated,23.81
a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,15.87,1.1.7,13.95,Gold,Brecon dataset,90.64,92.06,95.24,ALLIANCE > SAIL,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,Gold,100.0
a2226588-3fce-4103-8960-6bb0b22631fb,50.79,1.1.7,51.16,Not Rated,Cafcass England (CAFE),33.95,41.27,19.05,,8ee61578-e298-423a-be22-cb0438023e5c,Not Rated,33.33
a25181ec-a00c-4031-9f35-5cb072477e64,55.56,1.1.7,53.49,Not Rated,National Asthma & COPD Audit:COPD and adult asthma organisational dataset,32.78,38.88,19.05,,1982d9ef-890a-41ff-a86a-de61d65aaa09,Not Rated,33.33
a2a324f8-ccd3-405b-a146-34bbb85cc34a,50.79,1.1.7,51.16,Not Rated,Enhanced Prescribing Database,33.95,41.27,19.05,,2843087f-23a4-4cfe-8e72-53f2b9562cc3,Not Rated,33.33
a337845e-1dde-445b-90cf-91d8b825e3a5,26.98,1.1.7,20.93,Gold,Comprehensive Patient Records for Cancer Outcomes,87.16,86.51,95.24,HUB > DATA-CAN,ce4582a8-0985-46c6-b95f-29a5de862d4a,Gold,100.0
a45acd02-82d7-4bfe-9845-6b4df683bba8,15.87,1.1.7,13.95,Gold,Care Home Dataset,90.64,92.06,95.24,ALLIANCE > SAIL,aae02f9e-1bad-415d-9730-c46a07a990aa,Gold,100.0
a4936ec2-002e-4927-9a46-29ae9b5d695f,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Demographic,32.78,38.88,19.05,,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,Not Rated,33.33
a4a26b35-7014-42f0-bda9-97ac3a01a399,55.56,1.1.7,53.49,Not Rated,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - England,32.78,38.88,19.05,,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,Not Rated,33.33
a4eb97a6-6a61-415b-9dfb-65503675ed00,25.4,1.1.7,23.26,Silver,Health & Attainment of Pupils in a Primary Education Network [HAPN],76.47,77.78,76.19,ALLIANCE > SAIL,464d8653-4e69-406b-93fd-d68c29d5dfdc,Silver,80.95
a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,33.33,1.1.7,32.56,Not Rated,Paediatric Intensive Care Audit Network - core dataset (referral),48.0,45.24,28.57,ALLIANCE > HQIP,79ae4881-6223-471a-a278-6b2d3b84f971,Not Rated,23.81
a5163bce-7c03-4e61-8ebc-024939c047a8,15.87,1.1.7,16.28,Bronze,UK ME/CFS Biobank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,d0694e15-b6ba-4a95-962a-dbf627ca207c,Silver,63.49
a53b2f7a-c4a6-4914-9adb-17946c58afad,28.57,1.1.7,30.23,Silver,Rural-Urban classification for CPRD GOLD,72.98,78.57,76.19,ALLIANCE > CPRD,a7d8c6a8-0825-4e73-8f29-3d76194d7114,Bronze,85.71
a5a4a55c-c311-445d-a21f-0e4acb42f227,60.32,1.1.7,55.81,Not Rated,ISARIC4C COVID-19 Clinical Information Network (CO-CIN),31.62,36.5,19.05,,84336be3-23bd-466e-b29b-df48db897665,Not Rated,33.33
a5b41636-a112-4631-aaee-215bc4cf200e,46.03,1.1.7,46.51,Not Rated,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,29.12,29.36,4.76,,95f385b1-4f5c-4a88-8e79-9613acc66938,Not Rated,4.76
a5c088cd-dae6-4c58-b381-a0d273585f4d,34.92,1.1.7,34.88,Not Rated,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,46.84,44.45,28.57,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,d472a895-8587-4503-956e-3bd66d990979,Not Rated,23.81
a5d1a44f-9e9d-4c6d-9ce0-53889d579781,50.79,1.1.7,51.16,Not Rated,Patient Medical Card Registration (NI),33.95,41.27,19.05,,4e5ba567-c452-4979-8e2e-865f7df20252,Not Rated,33.33
a6252de5-4fc3-4dc7-950b-2f2528f58533,55.56,1.1.7,53.49,Not Rated,Scottish Stillbirth and Infant Death Survey,32.78,38.88,19.05,,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,Not Rated,33.33
a6472a29-17db-477c-bb6e-264686c8fc26,17.46,1.1.7,18.6,Bronze,plasmaMATCH,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,Bronze,60.32
a69493b6-991d-40b5-ba81-2f70c424c557,50.79,1.1.7,51.16,Not Rated,Child Health Systems Programme - First Visit,33.95,41.27,19.05,,dec04153-f595-41ce-9d7e-5ef0c3fe8289,Not Rated,33.33
a7447f01-c3fd-43f1-8fc4-3e6f3b6e59ef,46.03,1.1.7,46.51,Not Rated,National Records of Scotland (NRS) - Births Data,29.12,29.36,4.76,,3b87eef0-bfb6-4bf4-84b9-29880197fec9,Not Rated,4.76
a74f72ad-bf70-42e4-8933-069c7b53c7f9,36.51,1.1.7,37.21,Not Rated,LIMS,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,df70b490-3c00-458e-a6dd-ea3242a3ebac,Not Rated,14.29
a79944dc-2696-4326-b378-dbd9224635f1,30.16,1.1.7,27.91,Silver,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,76.52,78.57,80.95,ALLIANCE > CPRD,7958450d-bd25-42c4-b79e-0e3d0806ac21,Silver,87.3
a8364fd6-2247-4ef0-af8c-51c7b3ec24cd,46.03,1.1.7,46.51,Not Rated,The 1970 British Cohort Study (BCS70),29.12,29.36,4.76,,929186f3-e230-4b52-a9f5-0c20af7f5ce2,Not Rated,4.76
a889651d-a26e-4907-86a3-a06d100d13f5,46.03,1.1.7,46.51,Not Rated,NIHR BioResource: NHS Trust data,29.12,29.36,4.76,,3731006a-ee7c-4d15-bc07-4eeb29a3d031,Not Rated,4.76
a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,17.46,1.1.7,16.28,Gold,Healthcare Workers Risk Assessment,88.29,90.47,92.86,ALLIANCE > SAIL,ed131fee-0635-4613-a453-a383d5dd7cec,Gold,98.41
a8bfd0c4-1aec-47cc-9e45-00a713482fa2,33.33,1.1.7,32.56,Not Rated,Paediatric Intensive Care Audit Network - core dataset (transport),48.0,45.24,28.57,ALLIANCE > HQIP,45310176-6331-4bdd-bc53-d9194e212a35,Not Rated,23.81
a8c8978f-b5dc-448c-9a03-4d961d79a863,46.03,1.1.7,46.51,Not Rated,Scottish Immunisation Recall System (SIRS),29.12,29.36,4.76,,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,Not Rated,4.76
a8f5117e-7523-452f-abf3-ced72f03cb2e,19.05,1.1.7,18.6,Bronze,Salford Lung Study,71.65,68.25,61.9,HUB > BREATHE,86838cad-d5d3-4b65-9c37-29b0c8c36309,Bronze,55.56
a9b50e33-9974-4635-8e52-9c9b3cb87eb2,25.4,1.1.7,25.58,Silver,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",74.12,78.57,73.81,HUB > PIONEER,ddf7f82f-b453-442d-b562-bb0157593831,Bronze,82.54
a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,22.22,1.1.7,18.6,Gold,North West London Primary Care Events Data (NWL PCE),87.13,87.31,92.86,HUB > DISCOVER NOW,0f930154-0a0e-4bef-9464-59e657b904d6,Gold,96.83
aa019da2-0f2f-493c-95e8-7263ee735f46,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,348b12fb-7718-477e-a572-4fc3c716152d,Not Rated,77.78
aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,31.75,1.1.7,25.58,Silver,ONS 2011 Census Wales (CENW),77.69,78.57,80.95,ALLIANCE > SAIL,fc24482c-0f9b-445f-af7a-8598627c3b15,Silver,88.89
aa25e5e4-9d53-4f7b-a7fb-228835f6bfd8,55.56,1.1.7,53.49,Not Rated,Death Registration Data - Provisional Monthly Extracts,32.78,38.88,19.05,,487222b7-5c13-4a92-8b41-044796048720,Not Rated,33.33
aabb918b-b15f-4c1e-a50a-8ceee6993d70,55.56,1.1.7,53.49,Not Rated,Critical Care Dataset (CCDS),32.78,38.88,19.05,,1789286a-deaf-49df-88cd-660e92934af6,Not Rated,33.33
aad2340a-ab87-40ee-bfbe-c56adb01fd47,46.03,1.1.7,46.51,Not Rated,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,29.12,29.36,4.76,,bfa012ad-e609-4d15-a824-6d143758ca4d,Not Rated,4.76
ab0f56e2-681f-4e43-b798-94685ddc3c4a,55.56,1.1.7,53.49,Not Rated,Weekly SUS ECDS Dataset,32.78,38.88,19.05,,f75b02f0-a45f-433a-a669-420c8bd40720,Not Rated,33.33
ab2dafd8-b513-4b33-9365-5eb74f32f9d1,46.03,1.1.7,46.51,Not Rated,Developing Patient and Public Involvement in Research in Malaysia,29.12,29.36,4.76,,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,Not Rated,4.76
ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,46.03,1.1.7,46.51,Not Rated,GOAL,29.12,29.36,4.76,,563c0bfc-437e-4c10-b144-b392d983017c,Not Rated,4.76
ac057e24-22d8-478e-8988-89fe4ee67b6c,50.79,1.1.7,51.16,Not Rated,Walker Study Data,33.95,41.27,19.05,,245bffa9-07c3-40b6-916b-161062cdf674,Not Rated,33.33
ac7927ca-ef8b-47d7-abce-33a03baaac5c,55.56,1.1.7,53.49,Not Rated,Tayside Bowel Screening Dataset,32.78,38.88,19.05,,00201dde-1faf-41d3-b282-5c24c0ca3697,Not Rated,33.33
acafb160-b18a-436e-90f1-dc4530a90267,39.68,1.1.7,39.53,Bronze,Mental Health Minimum Data Set,61.19,67.46,61.9,ALLIANCE > NHS DIGITAL,285ae0ae-196b-4a75-b1f1-78b07162acfa,Not Rated,74.6
ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,28.57,1.1.7,25.58,Silver,COVID-19 SARI-Watch (formerly CHESS),75.31,77.78,76.19,ALLIANCE > NHS DIGITAL,f61f116d-f732-450e-9d34-c6ae00e3fd1e,Bronze,84.13
ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,50.79,1.1.7,51.16,Not Rated,2019 UK Parkinson's Audit - Elderly care and neurology,33.95,41.27,19.05,,0cac3870-dd13-44fc-97c2-4bdb67550b39,Not Rated,33.33
ad638da8-366b-481f-995e-fc326301eb16,23.81,1.1.7,20.93,Silver,IBD NIHR BioResource: Contact detail,83.58,84.12,88.1,HUB > GUT REACTION,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,Silver,92.06
adbee090-9634-455e-9be1-62843158fb08,15.87,1.1.7,16.28,Bronze,Cardiff School of Dentistry Tooth Bank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,0d4f0103-82d8-43f4-8058-4aec80ea562f,Silver,60.32
adce90ad-d576-4c98-9de9-dca19f7f4d41,22.22,1.1.7,18.6,Gold,North West London Admitted Patient Care Data (NWL APC),87.13,87.31,92.86,HUB > DISCOVER NOW,788857b5-6a5b-4ec2-825e-d965e291cf45,Gold,96.83
ae2022bc-2083-4e57-b825-1fb610d910ee,15.87,1.1.7,16.28,Bronze,Biobank for patients with retinal degenerations & dystrophies,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,cee932f8-151c-4834-ac6d-61d842f9d170,Silver,60.32
ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,55.56,1.1.7,53.49,Not Rated,COVID antigen testing - Pillar 2,32.78,38.88,19.05,,c8f2ee14-2831-445d-a207-2f7f932f4735,Not Rated,33.33
ae788191-69e5-4a03-b11b-bd25574b0e4f,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient NTM culture,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,Gold,100.0
ae9e8a9f-533f-4823-8e00-84e39ad2c266,38.1,1.1.7,39.53,Not Rated,Community Services Dataset,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,Not Rated,15.87
aecc1328-3c30-4eff-9f56-ae1278846ef9,20.63,1.1.7,20.93,Not Rated,Accelerometer,68.1,65.08,57.14,ALLIANCE > UK BIOBANK,ceab57e8-1e13-499b-a8f4-6ad60dad3721,Bronze,50.79
af2b3e6d-718e-464a-8c0d-5882fa1d869f,15.87,1.1.7,16.28,Bronze,Manchester Cancer Research Centre (MCRC) Biobank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,095d805c-4b62-4726-b968-bb2f1c463701,Silver,63.49
af2ecff2-398c-437f-8c45-adef2406ce43,15.87,1.1.7,16.28,Bronze,Cardiff University Biobank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,097540aa-a0ed-492e-853b-9ebcfd061dea,Silver,63.49
af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,15.87,1.1.7,16.28,Bronze,NIHR Exeter Clinical Research Facility,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,Silver,60.32
afc74c32-efdf-4aab-a0bb-fe5586f4af78,55.56,1.1.7,53.49,Not Rated,National Audit of Care at the End of Life - organisational level audit,32.78,38.88,19.05,,a290592c-a6f5-4874-b283-1d33e923c487,Not Rated,33.33
b009b68f-730a-4d72-9a3c-c917b1ff715d,46.03,1.1.7,46.51,Not Rated,Childhood Pneumonia Governance in Bangladesh,29.12,29.36,4.76,,5df03d24-ad95-4d64-96df-0684a4f26e58,Not Rated,4.76
b02e2091-f48a-4d50-91a0-de8c76f76c18,30.16,1.1.7,27.91,Silver,HES Diagnostic Imaging Dataset for CPRD GOLD,76.52,78.57,80.95,ALLIANCE > CPRD,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,Silver,87.3
b0319b9b-14ba-4e23-86ff-89363d4d69a7,50.79,1.1.7,51.16,Not Rated,COVID antigen testing - Pillar 1,33.95,41.27,19.05,,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,Not Rated,33.33
b04e89c3-3c56-4ad9-b929-d3937874df52,60.32,1.1.7,55.81,Not Rated,Emergency Care Dataset (ECDS),31.62,36.5,19.05,,57fa56f2-78d1-49af-ab8d-e8146d711868,Not Rated,33.33
b05cb16b-80dc-4e16-8d86-8ee741a5e051,55.56,1.1.7,53.49,Not Rated,National Audit of Care at the End of Life - case note review,32.78,38.88,19.05,,d8c67899-2d81-48c2-8482-31cd33973a36,Not Rated,33.33
b07485ca-2d45-483d-9336-32cca4504712,60.32,1.1.7,55.81,Not Rated,SICSAG Episodes (Scottish Intensive Care Audit Group),31.62,36.5,19.05,,6f8182d2-2993-400d-829d-b52cdb324bf3,Not Rated,33.33
b132812c-7a5c-4d2d-aca2-fdcdb890283a,50.79,1.1.7,51.16,Not Rated,HIV-POGO,33.95,41.27,19.05,,e171a080-a4cd-4e64-9c2b-e72beb7cac78,Not Rated,33.33
b27afede-a51d-4aae-8bf7-ce94888fe898,23.81,1.1.7,25.58,Not Rated,Primary-care data,56.26,55.55,38.1,UK Biobank,439e71c7-33b5-4e85-98ce-4b068f2523ad,Not Rated,34.92
b2f48da1-d3c6-4126-a74b-e87c2f629ef8,46.03,1.1.7,46.51,Not Rated,Lothian Birth Cohort 1936 (LBC1936),29.12,29.36,4.76,,e63613a9-92e9-4147-8a76-40e4a87ec131,Not Rated,4.76
b2fb79c5-26db-484b-8e93-1c56d7654f57,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Transplants,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,bea354e8-c552-41ef-80c2-a76ca5767e4b,Gold,100.0
b3004f9b-11a0-482b-9cec-791b28fd492e,55.56,1.1.7,53.49,Not Rated,Fife Microbiology: Tests,32.78,38.88,19.05,,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,Not Rated,33.33
b40777a2-468b-4b45-8b7d-2f62f912e950,39.68,1.1.7,34.88,Silver,HIC ICU 8.3.2,80.18,80.16,95.24,NIHR Health Informatics Collaborative Critical Care Theme,4f546f1e-433c-4884-a090-2a4520c878ac,Silver,100.0
b41215cd-afe1-4463-9786-ed86812143e2,55.56,1.1.7,53.49,Not Rated,CPRD GOLD,32.78,38.88,19.05,,a29feafa-7bdd-44e9-b977-c9d26425e67f,Not Rated,33.33
b43309eb-7860-49b7-9f11-1a7a0fd5532e,31.75,1.1.7,25.58,Silver,UK Cystic Fibrosis Registry (CYFI),77.69,78.57,80.95,ALLIANCE > SAIL,0628fb77-057d-4838-b80e-18245a8f535d,Silver,88.89
b5033be2-0744-49c5-a398-a4d3ed4e1deb,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Chronic Medication,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,0ad31772-0893-4cf7-bab0-683e80302201,Gold,100.0
b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,58.86,62.69,61.9,ALLIANCE > NHS DIGITAL,ef22c16c-c294-46e1-abf9-5204212e9053,Not Rated,74.6
b589b19b-b43f-4344-affb-5d7ea328c909,25.4,1.1.7,25.58,Silver,Radiotherapy Dataset,78.88,82.54,83.33,ALLIANCE > SAIL,f102ca50-d1e4-44ec-924e-be89446652af,Silver,90.48
b63aadf4-da85-478e-a171-05714ef9057e,55.56,1.1.7,53.49,Not Rated,National Vascular Registry - Lower Limb Angioplasty clinical dataset,32.78,38.88,19.05,,c8b6c319-239b-4792-9898-644a63d07ab5,Not Rated,33.33
b670cfe7-d4e2-46e5-b3e9-dccfd05c02d2,46.03,1.1.7,46.51,Not Rated,DataLoch Core,29.12,29.36,4.76,,d62939c4-e4a8-4fca-91ed-54f7f87fb89e,Not Rated,4.76
b6a60be1-5d94-41f9-a426-5f9523a98d50,19.05,1.1.7,18.6,Bronze,Development of spirometry predictive values for Indian population,75.22,69.84,69.05,HUB > BREATHE,59521b01-6adb-4dd3-8b40-dbeb51171e4f,Bronze,58.73
b6f26b11-da8d-402a-91c7-3b7122be274c,50.79,1.1.7,51.16,Not Rated,Welsh Demographic Service (WDSD),33.95,41.27,19.05,,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,Not Rated,33.33
b6fe3b50-aff3-435d-9c57-8b46eaa34671,50.79,1.1.7,51.16,Not Rated,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),33.95,41.27,19.05,,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,Not Rated,33.33
b70900e9-85e9-4dd2-ae4b-02523be4219d,15.87,1.1.7,13.95,Gold,Cafcass England,90.64,92.06,95.24,ALLIANCE > SAIL,8ee61578-e298-423a-be22-cb0438023e5c,Gold,100.0
b789c975-7042-445c-bfa6-c24e5ca8a983,55.56,1.1.7,53.49,Not Rated,UHB 100K Genomics patient clinical data including their acute care contacts,32.78,38.88,19.05,,ceae4fe0-4e98-4e3c-85db-e86539aade81,Not Rated,33.33
b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,15.87,1.1.7,16.28,Bronze,Public Health England Seroepidemiology Unit,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,89497432-17e0-49f4-96a4-65ef57d07701,Silver,60.32
b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,46.03,1.1.7,46.51,Not Rated,COVID-19 Detection from Chest X-Rays using Deep Learning,29.12,29.36,4.76,,57526718-0a9a-42ad-8b7a-582d9ef96d13,Not Rated,4.76
b9642fb3-3bee-491b-8d83-22f9de0fd77f,17.46,1.1.7,18.6,Bronze,ESPAC-TPlus,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,47f979bc-da9d-4e9e-9f2b-15e09366db04,Bronze,60.32
b97ff350-f84d-4739-a4d6-f3a607063799,55.56,1.1.7,53.49,Not Rated,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),32.78,38.88,19.05,,6a6c4568-59e9-4760-89d6-07558a24944c,Not Rated,33.33
b988b8bc-fbc5-40a7-8123-76ea5286b8c7,50.79,1.1.7,51.16,Not Rated,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,33.95,41.27,19.05,,0d556d7e-be27-4979-a09e-d419b2e838f3,Not Rated,33.33
b9b4ee9a-3ffa-483d-8e46-16f862c83740,33.33,1.1.7,32.56,Not Rated,Paediatric Intensive Care Audit Network - customised data collection,48.0,45.24,28.57,ALLIANCE > HQIP,6c78af2c-3898-435e-b1f4-e6a44682dc71,Not Rated,23.81
b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,46.03,1.1.7,46.51,Not Rated,Pneumonia case management practices in selected communities in Pakistan,29.12,29.36,4.76,,cf190350-74c6-45f2-8ede-69ace62eb88d,Not Rated,4.76
ba071b0b-5ef4-457b-b194-3a69c2c71a06,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,3adeb2f4-a924-49cb-9537-84a9a4242a62,Not Rated,77.78
ba0bf718-05ab-4a6c-9419-1d04991d9ee9,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Primary Elbow Replacement dataset,32.78,38.88,19.05,,b06415af-9151-4ccc-83a1-ab859943fb2b,Not Rated,33.33
ba30a8b6-bfc7-4105-b094-11f187c7b293,55.56,1.1.7,53.49,Not Rated,Emergency Department (Symphony),32.78,38.88,19.05,,8002b4d7-ff3b-4402-b805-a6a0022836fd,Not Rated,33.33
ba936454-e65e-491d-a16d-79115a4da09a,60.32,1.1.7,55.81,Not Rated,BathTAP Updating Cohort 1,31.62,36.5,19.05,,90131a34-3cc8-4a74-b72f-d9600cfa2808,Not Rated,33.33
bac86432-1ad7-4ff9-903d-26e28bf4ef97,50.79,1.1.7,51.16,Not Rated,CPRD Aurum,33.95,41.27,19.05,,1d574c14-1af0-490d-9c4e-be88cfd0e345,Not Rated,33.33
bb04212f-0626-4cbe-8863-a2cc1df40683,50.79,1.1.7,51.16,Not Rated,COVID-19 Symptom Tracker Dataset (CVST),33.95,41.27,19.05,,594cfe55-96e3-45ff-874c-2c0006eeb881,Not Rated,33.33
bb61567b-431f-4e30-b906-654490ea14c7,55.56,1.1.7,53.49,Not Rated,IBD NIHR BioResource: Case report form,32.78,38.88,19.05,,877a7275-b99d-4ed4-9691-de577e0ab49e,Not Rated,33.33
bb833f51-bc38-4489-b693-6658ea772393,55.56,1.1.7,53.49,Not Rated,CDE Clinical Events,32.78,38.88,19.05,,e3b36044-e1fb-418b-946a-b83626bf2e3f,Not Rated,33.33
bbd0a590-f4ee-4133-abe0-696cb247b3e0,55.56,1.1.7,53.49,Not Rated,Labour Force Survey (Longitudinal),32.78,38.88,19.05,,4ac15572-fe9a-46d3-860d-a46b616181f7,Not Rated,33.33
bbed7a4e-0c38-48b8-b4f8-b617ec307f59,46.03,1.1.7,46.51,Not Rated,1958 National Child Development Study (NCDS),29.12,29.36,4.76,,0ceaaedc-4904-4820-8b74-d6a8e679fb11,Not Rated,4.76
bc236fba-2935-4406-aaa9-0006cbbf693d,34.92,1.1.7,34.88,Not Rated,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),46.84,44.45,28.57,ALLIANCE > HQIP,ac7016ce-f7a9-4c71-bebb-6af6efa27844,Not Rated,23.81
bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,22.22,1.1.7,23.26,Not Rated,UK Biobank Assessment Centre,58.61,57.14,40.48,UK Biobank,2775b97f-1606-490e-81ef-35bad050434a,Not Rated,36.51
bd87cdf4-ec39-41f6-bb07-c19f10372840,26.98,1.1.7,23.26,Silver,Education Daily Attendance Dataset,80.03,81.75,83.33,ALLIANCE > SAIL,17056e83-ee5a-4fe7-86e1-f09563256be1,Silver,90.48
bd90290d-d60b-499f-b30d-88332274cc46,25.4,1.1.7,25.58,Silver,Cancer Patient Experience Survey (CPES) for CPRD GOLD,77.69,81.75,80.95,ALLIANCE > CPRD,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,Silver,88.89
bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,3d348613-2d66-4814-a294-7e0c365f43f8,Not Rated,77.78
be1368c6-c97f-4ce0-8322-f97ccb28b9c3,31.75,1.1.7,27.91,Bronze,Oxford Healthcare Workers,65.81,68.25,59.52,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,9de2f365-4c5d-4252-acee-6270b113aa93,Not Rated,68.25
be77a483-2eff-4c05-8091-035fe79b3c8a,19.05,1.1.7,18.6,Bronze,Barts CTU,75.22,70.64,69.05,ALLIANCE > TISSUE DIRECTORY,22aa219f-f3c8-4a25-822e-aa2504f6f29a,Bronze,60.32
be8ec01c-20ea-4863-ba7c-6d103df85a42,60.32,1.1.7,55.81,Not Rated,2011 Census - COVID19 Research Database Subset,31.62,36.5,19.05,,a05aef07-c3fa-4331-905a-6b6f58eac3d5,Not Rated,33.33
bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,22.22,1.1.7,23.26,Not Rated,Online questionnaires,57.42,56.35,38.1,UK Biobank,8ef26f38-d1b3-4b24-b80a-717f216c6aea,Not Rated,34.92
bf83ada4-b72e-4789-b177-12a53aa763ea,38.1,1.1.7,39.53,Not Rated,TheatreEvents,38.57,38.09,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,2c6adf80-f30b-46c9-b9d4-fe3e68622469,Not Rated,14.29
bfbd3c63-8902-4242-97d5-ca935591e8cb,60.32,1.1.7,55.81,Not Rated,EU Farm Structure Survey Wales (EUFS),31.62,36.5,19.05,,cc7aa34f-81df-42f8-ad69-80e136c48bf1,Not Rated,33.33
c01fbdae-33e3-4839-b842-3b61a722a925,55.56,1.1.7,53.49,Not Rated,"Ventilatory strategies, medications and outcomes for patients with COVID",32.78,38.88,19.05,,55a744c4-a2d4-4ea0-b0eb-1af6e1465383,Not Rated,33.33
c03468f4-ba51-4d9f-a785-f041adb84724,17.46,1.1.7,18.6,Bronze,Daisy Tumour Bank,76.42,73.02,71.43,ALLIANCE > TISSUE DIRECTORY,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,Silver,63.49
c1682cb7-8f43-49fa-b66a-0a4a205885d3,25.4,1.1.7,18.6,Gold,Cystic Fibrosis Patient Demographics,88.32,87.3,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,19bc55c2-13d7-4488-a52c-35287483ea4e,Gold,100.0
c230a8d8-bf78-4713-8f2f-312162e92e55,55.56,1.1.7,53.49,Not Rated,COVID-19 Vaccination Status,32.78,38.88,19.05,,98372a87-f3e6-475d-be12-46c0f9587413,Not Rated,33.33
c2c77d1a-d4d8-40cd-95f3-31912d4bd561,17.46,1.1.7,18.6,Bronze,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,ba0edcaf-854d-4907-851a-280b56128b3b,Bronze,60.32
c2ddca9f-f144-437b-ac7a-0a628a50ba1a,20.63,1.1.7,16.28,Gold,Outpatient Referral,89.48,89.69,95.24,ALLIANCE > SAIL,7465c65e-c321-42e9-a2f4-6bc664caf1fc,Gold,100.0
c2e112a0-a198-46b0-9a0c-ec91edfb6839,26.98,1.1.7,25.58,Silver,National Diabetes Audit,77.69,80.16,80.95,ALLIANCE > NHS DIGITAL,9a434a5c-563b-4da1-9133-9994960ade54,Silver,87.3
c303bdc0-fa5d-4c22-84ca-83577446062d,65.08,1.1.7,58.14,Not Rated,Covid Lateral Flow Test (CVLF),30.45,34.12,19.05,,ce60d677-6263-4d41-9d45-d3c7ebb3ee36,Not Rated,33.33
c3b4f4f2-953e-4470-bedd-9d09fd30a508,17.46,1.1.7,18.6,Bronze,TRICON8,76.42,73.02,71.43,ALLIANCE > TISSUE DIRECTORY,85113a93-89ed-40e3-a479-33b461b91858,Silver,63.49
c4426ec2-fbf0-45b2-9f68-0477527257a0,33.33,1.1.7,27.91,Silver,2011 Census variables (and variable breakdowns),75.33,76.98,78.57,ALLIANCE > PUBLIC HEALTH SCOTLAND,a05aef07-c3fa-4331-905a-6b6f58eac3d5,Bronze,87.3
c474492c-1c9d-4e94-bc85-270aab69a74d,55.56,1.1.7,53.49,Not Rated,Diagnostic and Therapy Services Waiting Times (DATW),32.78,38.88,19.05,,97896866-ab5e-408a-ac5a-072802db9faf,Not Rated,33.33
c47f463f-6e7e-4abb-b9bc-010ae68156b7,55.56,1.1.7,53.49,Not Rated,National Waiting List Open Pathways,32.78,38.88,19.05,,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0,Not Rated,33.33
c66f943f-4307-4486-817c-49f6d8b9fd6b,36.51,1.1.7,30.23,Not Rated,PANTHER study,63.45,65.08,57.14,ALLIANCE > UNIVERSITY OF NOTTINGHAM,596077a9-298b-44cc-aa7a-81f04cf5dcb3,Not Rated,66.67
c6859b1b-4d5b-46bd-8532-089cff743be7,50.79,1.1.7,51.16,Not Rated,Child Health Systems Programme - 4-5 year review,33.95,41.27,19.05,,5844bde6-628d-4e76-bb56-3534e2728eb6,Not Rated,33.33
c6e2fffb-4817-462e-ba7e-ff546728f3d1,25.4,1.1.7,25.58,Not Rated,Exogenous sex steroid hormones and asthma in females of reproductive age,64.59,61.11,54.76,HUB > BREATHE,bc5d6d69-ec03-42fe-a63b-638c25c5258c,Not Rated,47.62
c713773c-e961-400e-b44a-947002deb073,49.21,1.1.7,44.19,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,334afc50-a05a-43b9-aa1e-a012a22733e0,Not Rated,77.78
c78122ae-8be1-40d7-8567-b83059941c16,19.05,1.1.7,20.93,Bronze,SCOT translational sample collection,77.63,73.81,76.19,ALLIANCE > TISSUE DIRECTORY,b3b790a7-a455-4efb-9c68-60e7131cb836,Silver,66.67
c8654ef8-585c-4ac4-ac0e-33a875d407a1,50.79,1.1.7,51.16,Not Rated,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,33.95,41.27,19.05,,865c99c4-bbe9-45de-83b9-290fb54d5470,Not Rated,33.33
c8db5528-7ba5-40fe-8c5f-2c86a9637c73,55.56,1.1.7,53.49,Not Rated,CPRD Cardiovascular Disease Synthetic Dataset,32.78,38.88,19.05,,780c0a71-0264-4843-939d-1336eee60d40,Not Rated,33.33
c8edcbd8-40e6-4c34-b138-307a94c19cc0,50.79,1.1.7,51.16,Not Rated,Admissions and Discharges,33.95,41.27,19.05,,1d5b9205-dae4-4b0e-a3d3-04707875edf8,Not Rated,33.33
c9322345-9fe2-404e-8dcb-0b4d8856459b,55.56,1.1.7,53.49,Not Rated,Emergency Department Dataset Daily (EDDD),32.78,38.88,19.05,,fa257aa8-51fc-4eb7-a448-e473fa54686d,Not Rated,33.33
c93ff611-458c-4fc8-bb94-5274988f7f7f,55.56,1.1.7,53.49,Not Rated,Annual District Death Extract (ADDE),32.78,38.88,19.05,,15cf4241-abad-4dcc-95b0-8cd7c02be999,Not Rated,33.33
c960ffab-a94c-45e3-96a0-598719acfbf5,15.87,1.1.7,16.28,Bronze,National Diet and Nutrition Survey (NDNS),76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,f86400cb-7cab-4e34-aab6-57138b6a96c2,Silver,60.32
c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,01c88a30-b14d-401e-82bb-165cbde81942,Not Rated,77.78
c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,50.79,1.1.7,51.16,Not Rated,COVID-19 Test Results (PATD),33.95,41.27,19.05,,f5f6d882-163d-4ef1-a53e-000fba409480,Not Rated,33.33
ca05a688-c305-4ebd-967f-facb010c29bf,26.98,1.1.7,27.91,Silver,Secondary Uses Services Payment By Results,72.95,76.98,73.81,ALLIANCE > NHS DIGITAL,2004c512-f7c9-4995-b820-55f36aa3fad2,Bronze,80.95
ca2c6ec0-00ce-42fc-a077-88911259576c,25.4,1.1.7,18.6,Gold,Cystic Fibrosis Patient Annual Review Encounters,88.32,87.3,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,11360490-8da3-4a25-bb87-4fcc249b9af5,Gold,100.0
ca8c912d-82c4-481e-b17a-b567e3bf3c72,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Haematology (Lab Data Restructured),32.78,38.88,19.05,,c294bb01-062b-494e-942b-1efe8cbac3dc,Not Rated,33.33
caa644b6-a50d-455b-bee1-96232443e2b9,30.16,1.1.7,20.93,Silver,Cystic Fibrosis Patient Liver Enzyme,87.16,84.92,95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,f72e80fc-dcd3-4457-ae91-dd14449002dd,Gold,100.0
caab69a0-b560-4320-ac61-557f81f37ae3,46.03,1.1.7,46.51,Not Rated,The Million Women Study,29.12,29.36,4.76,,97ac8a7d-30b9-4fa6-84db-b4f9430fc1d6,Not Rated,4.76
cace4854-a8de-4487-9c43-fe580b341d26,50.79,1.1.7,51.16,Not Rated,Northern Ireland Regional Maternity system (NIMATS),33.95,41.27,19.05,,be7efa4f-e500-4a54-8157-6c4442a7e8a8,Not Rated,33.33
cb7370a6-a1b0-4473-a32f-ec85ec0155a5,19.05,1.1.7,18.6,Bronze,UKCTOCS Longitudinal Women's Cohort (UKLWC),76.42,72.22,71.43,ALLIANCE > TISSUE DIRECTORY,e0b951ba-0f7d-4743-9374-b965042accdd,Silver,63.49
cbab40e4-9e61-4466-b706-db47771d2512,50.79,1.1.7,51.16,Not Rated,Congenital Anomaly Register and Information Service (CARIS),33.95,41.27,19.05,,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,Not Rated,33.33
cbb0568c-510e-49de-af43-edb9345535a8,55.56,1.1.7,53.49,Not Rated,Falls & Fragility Fracture Audit  Fracture Liaison Service  clinical dataset,32.78,38.88,19.05,,d94a604c-5733-4f07-93bb-e77b6ea2313f,Not Rated,33.33
cc1a15ea-1bca-42c5-9915-8e6bfd733d6e,60.32,1.1.7,55.81,Not Rated,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland,31.62,36.5,19.05,,69a356d6-599e-4d02-8241-066ce3c297bd,Not Rated,33.33
cc383a3f-1c47-4b7d-99cf-be8ee0afe401,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,Not Rated,77.78
cde234d0-748b-4df6-a59d-3268cc7e8c1d,19.05,1.1.7,20.93,Bronze,RIO,76.44,72.22,73.81,ALLIANCE > TISSUE DIRECTORY,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,Silver,63.49
ce192e2e-4f31-4bb0-9c1f-5c4173c03011,20.63,1.1.7,16.28,Gold,Postponed Admitted Procedures,88.29,88.89,92.86,ALLIANCE > SAIL,bff94600-a254-4111-82f7-6167084d81ca,Gold,98.41
ce1bcddb-a6af-4511-84c6-2a252d3eb202,38.1,1.1.7,39.53,Not Rated,Maternity Services Dataset,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,173d07ab-5930-4d19-b3de-dcca193e62fd,Not Rated,15.87
ce896b89-5f4a-407c-bb10-7eec51089458,26.98,1.1.7,20.93,Silver,North West London Community Data (NWL COM),85.97,84.92,92.86,HUB > DISCOVER NOW,65dad445-ed81-4005-9f5a-4f8a7164043e,Silver,96.83
cea328df-abe5-48fb-8bcb-c0a5b6377446,15.87,1.1.7,13.95,Gold,Welsh Demographic Service (WDS),90.64,92.06,95.24,ALLIANCE > SAIL,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,Gold,100.0
cf1feb84-837e-4f51-8320-6171f4970a5f,30.16,1.1.7,27.91,Silver,Death Registration data for CPRD GOLD,78.9,80.95,85.71,ALLIANCE > CPRD,1d35e229-13eb-4be1-9dae-4752b6c27c4a,Silver,92.06
cf64602c-7703-4f29-bd90-e0d511e2b24e,17.46,1.1.7,16.28,Bronze,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,77.58,71.43,71.43,HUB > BREATHE,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,Silver,60.32
cf867e7f-51b9-4627-828d-dd4fd420b37e,60.32,1.1.7,55.81,Not Rated,The Airwave Health Monitoring Study,31.62,36.5,19.05,,98bfe17f-be12-47b1-943a-2d3a621b7618,Not Rated,33.33
cfdb9fbd-9f67-435c-b257-6b51430451bb,20.63,1.1.7,16.28,Gold,Referral to Treatment Times,88.29,88.89,92.86,ALLIANCE > SAIL,0bf54842-c1db-4bdb-9f55-c5be490bf758,Gold,98.41
cfea1343-daea-43cf-b73c-c4eebecee182,60.32,1.1.7,55.81,Not Rated,Labour Force Survey (Household),31.62,36.5,19.05,,0b630200-1e7c-4b19-ad53-bcc8863f7ade,Not Rated,33.33
d006821e-a507-4699-b560-b5d023e09d4b,15.87,1.1.7,16.28,Bronze,Cancer Group CTR Cardiff trials,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,cd833805-f0a8-4ddb-a50d-b12695c92120,Silver,60.32
d07f2709-ccc7-410b-9b73-a45918e21fed,50.79,1.1.7,51.16,Not Rated,Child Health Systems Programme - 6-8week review,33.95,41.27,19.05,,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,Not Rated,33.33
d094b10a-b1b4-4805-9424-33547e9c46ba,55.56,1.1.7,53.49,Not Rated,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,32.78,38.88,19.05,,f857055b-c29e-4c7f-99ce-65f4ed59648e,Not Rated,33.33
d0f5761c-66af-4a1c-81c3-eae0f87724b1,30.16,1.1.7,27.91,Silver,Death Registration data for CPRD Aurum,77.71,80.16,83.33,ALLIANCE > CPRD,ad8f07ef-a984-449b-8a60-d1dd564cc36d,Silver,90.48
d15b6d4a-a5de-4df4-8f29-4a8926af8024,34.92,1.1.7,34.88,Not Rated,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,46.84,44.45,28.57,ALLIANCE > HQIP,a464c126-8591-4af6-a10f-99c020f59527,Not Rated,23.81
d27f265d-8931-4f76-83a2-cb47189a53f0,17.46,1.1.7,16.28,Gold,Welsh Dispensing Dataset,88.29,90.47,92.86,ALLIANCE > SAIL,50ef6443-ed4b-40f9-97fb-1cfd53be6579,Gold,98.41
d2981964-3ff7-47e2-91e1-ac5812227a80,55.56,1.1.7,53.49,Not Rated,NIHR IBD BioResource: Case report form,32.78,38.88,19.05,,877a7275-b99d-4ed4-9691-de577e0ab49e,Not Rated,33.33
d2af6a29-291b-4444-a17c-40f4208f1e1b,53.97,1.1.7,51.16,Not Rated,Patient Reported Outcome Measures,41.09,46.03,33.33,ALLIANCE > NHS DIGITAL,55614ed3-2484-4408-a4e9-e5fffed9e8e4,Not Rated,46.03
d2da2750-7482-4ce9-ae5c-2ab393408a67,25.4,1.1.7,18.6,Gold,Education - Wales,88.32,87.3,95.24,ALLIANCE > SAIL,204fa806-071d-4410-9c2c-143017d32d24,Gold,100.0
d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,55.56,1.1.7,53.49,Not Rated,Cancer Network Information System - CNIS / CANISC,32.78,38.88,19.05,,da91f0eb-1761-485b-8b7f-9121b6a1d004,Not Rated,33.33
d3fd4dac-2d15-401c-8185-905ee108d9ce,36.51,1.1.7,37.21,Not Rated,JANUS,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,6590f79d-cfea-4695-9fe0-dc5f85e6d273,Not Rated,14.29
d42aa93a-ecc3-480b-a55b-d089dbc11413,55.56,1.1.7,53.49,Not Rated,Annual District Birth Extract (ADBE),32.78,38.88,19.05,,12a77014-4a77-4eb1-8b26-f49689352d1b,Not Rated,33.33
d4683e8d-9c3f-4e5e-874c-80333a1ef719,50.79,1.1.7,51.16,Not Rated,National Neonatal Audit Programme - clinical audit,33.95,41.27,19.05,,49b67625-4c9a-4101-a982-e733e7db20ca,Not Rated,33.33
d524cd6b-14be-44a5-868c-f3e187d4e5d8,55.56,1.1.7,53.49,Not Rated,Follow-COVID,32.78,38.88,19.05,,e50d2b20-ef95-43fe-bbf0-83224d88e480,Not Rated,33.33
d57a096a-4fa3-4529-b508-0b9df0f1893c,36.51,1.1.7,37.21,Not Rated,OUH Patient Master Index,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,5d7465f6-ced8-434b-9907-d357ad125024,Not Rated,14.29
d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,22.22,1.1.7,23.26,Not Rated,INTERVAL,62.18,60.32,47.62,OTHER > The University of Cambridge,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,Not Rated,42.86
d5af13e0-cbcc-47f9-8d85-21867f198051,46.03,1.1.7,46.51,Not Rated,Use of digital auscultation to improve diagnosis of paediatric pneumonia,29.12,29.36,4.76,,198bd2cc-ca40-4dff-992c-a9480703fc37,Not Rated,4.76
d614f4fc-fae9-4775-86d9-4d4710017cf4,34.92,1.1.7,30.23,Not Rated,TRACK-COVID,61.08,63.49,52.38,OTHER > UNIVERSITY OF CAMBRIDGE,9e89af6b-bfa8-43dc-a2d4-5540c899a670,Not Rated,61.9
d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,17.46,1.1.7,18.6,Bronze,UNIRAD UK Sample collection,75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,Bronze,60.32
d6d1588d-b65c-479d-8f15-7fddf5ed4cc0,55.56,1.1.7,53.49,Not Rated,NACAP Pulmonary rehabilitation - clinical audit,32.78,38.88,19.05,,3afbb83d-d47b-43b3-a202-0d3081e5d294,Not Rated,33.33
d7f1b4ab-ae3c-4318-afc9-1b561d46d442,46.03,1.1.7,46.51,Not Rated,Research on use of an online learning platform on under-five pneumonia,29.12,29.36,4.76,,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,Not Rated,4.76
d864c698-b98c-4a1e-9c6a-7b941d61a35c,60.32,1.1.7,55.81,Not Rated,BathTAP Headache Cohort 1,31.62,36.5,19.05,,9cff3fc9-25d6-49fe-8218-dbbc3b3bc1ab,Not Rated,33.33
d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,55.56,1.1.7,53.49,Not Rated,HIV PiNS,32.78,38.88,19.05,,1abc859e-4ac6-431a-b550-af1afb36df1b,Not Rated,33.33
d95be3ed-f767-4ea5-9e4d-295446f68eb5,46.03,1.1.7,46.51,Not Rated,Generation Scotland: Scottish Family Health Study,29.12,29.36,4.76,,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,Not Rated,4.76
d977abd8-a966-4b4c-99f0-7a4c368f9934,55.56,1.1.7,53.49,Not Rated,National Vascular Regsitry - Oragnisational Audit dataset,32.78,38.88,19.05,,3c661240-e4d2-456c-a809-133c23f9c469,Not Rated,33.33
d9fc7ff7-6de4-4757-a2e3-d49f222ea1dd,60.32,1.1.7,55.81,Not Rated,CDE Documentation,31.62,36.5,19.05,,f866b225-10b8-4df4-9c32-072411f816d8,Not Rated,33.33
da191840-9037-4e1f-8e6c-ec66eb80b798,46.03,1.1.7,46.51,Not Rated,Child Health Systems Programme - School,29.12,29.36,4.76,,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,Not Rated,4.76
da5098df-414f-48e0-aaa7-7e2277f80eb7,15.87,1.1.7,13.95,Gold,Looked After Children Wales,90.64,92.06,95.24,ALLIANCE > SAIL,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,Gold,100.0
da9cdc4c-2790-47f4-b4b5-76e87ce450ae,15.87,1.1.7,16.28,Bronze,King's Health Partners Cancer Biobank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,a218d0b4-0273-4a04-ba17-c01dae6dcf33,Silver,60.32
db113fcd-69a0-4357-9c6d-250085deb3f5,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Events,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,a1154967-a80e-41da-a9ae-6183584ecf6b,Not Rated,77.78
db53c086-db48-4f7e-9264-ed44a9154753,55.56,1.1.7,53.49,Not Rated,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,32.78,38.88,19.05,,03e77b9d-57b8-44d5-8d64-9b1325958b22,Not Rated,33.33
db89a123-0402-4962-8a8f-78557ba4d84f,11.11,1.1.7,9.3,Silver,UK Lung Volume Reduction Surgery,85.83,80.16,80.95,HUB > BREATHE,9f98a674-12f6-42f4-b1a5-322b3b75eef1,Silver,71.43
dba474a3-90c4-423d-beb0-5ef79c490d24,36.51,1.1.7,37.21,Not Rated,"NHS Tayside, A&E Drugs given during an A&E visit",42.11,40.48,21.43,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,acfbef89-344c-49a5-8079-7344f4316e0f,Not Rated,17.46
dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,46.03,1.1.7,46.51,Not Rated,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,29.12,29.36,4.76,,51d41006-727e-43d4-bdb6-f8b427c295c6,Not Rated,4.76
dc5507d0-807e-4981-906b-731690a5e085,50.79,1.1.7,51.16,Not Rated,Outpatient Dataset (OPDW),33.95,41.27,19.05,,d331159b-b286-4ab9-8b36-db39123ec229,Not Rated,33.33
dcb4c87b-5884-41c0-b9af-d7d094dd0922,15.87,1.1.7,16.28,Bronze,NHS Greater Glasgow & Clyde Bio-Repository,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,762976cc-83d0-4b31-a879-37f87f947406,Silver,63.49
dcd6f957-1fcc-481a-bbd2-89abfe933449,55.56,1.1.7,53.49,Not Rated,Prescribing,32.78,38.88,19.05,,6d044471-62d2-4190-b315-503f77d33ef2,Not Rated,33.33
dd6e4344-9cee-41f3-8062-6bb9cdfda012,46.03,1.1.7,46.51,Not Rated,Decode-ME,29.12,29.36,4.76,,a71d0b2a-620c-4c04-b7bb-45843461db9f,Not Rated,4.76
ddbc149a-db56-41de-bd2c-3624149f6e7e,15.87,1.1.7,16.28,Bronze,MesobanK,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,b03835b7-7408-49a0-a9aa-ea405f9855c9,Silver,60.32
ddd49721-ff49-4f68-b3f5-e95a417fb0ac,15.87,1.1.7,16.28,Bronze,NIMRAD-TRANS,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,039b55f7-d416-49ab-9bdb-4ff7dbc733df,Silver,60.32
ddf35f0d-ca89-4f74-bbdd-65d1a84b38ca,46.03,1.1.7,46.51,Not Rated,VIKING GENES,29.12,29.36,4.76,,43636f80-27fd-43d0-8556-d0a2de0cd819,Not Rated,4.76
de4b46f5-1591-442d-a896-6e0d91657c01,14.29,1.1.7,13.95,Bronze,Children's Health in London and Luton (CHILL),79.93,75.4,73.81,HUB > BREATHE,722be723-04bd-48b4-923b-e7d393f0c22b,Silver,65.08
de8d0b95-b968-45f2-8cd4-2c87d72ff729,55.56,1.1.7,53.49,Not Rated,UK Renal Registry - COVID-19 dataset,32.78,38.88,19.05,,2a3dba77-34ff-4781-b273-1b3d54d11f32,Not Rated,33.33
df23aabd-3e5f-4fc2-aad6-af990cff6f19,26.98,1.1.7,23.26,Gold,Children’s Kidney Cancers - Great Ormond Street Hospital,85.99,86.51,95.24,HUB > DATA-CAN,3f71bef5-c5a2-400c-a482-2ad30b29a240,Silver,100.0
df3cc57d-08ae-4e81-ae79-283d71cf8d95,28.57,1.1.7,23.26,Silver,IBD NIHR BioResource: SNP chip data,83.61,83.34,90.48,HUB > GUT REACTION,3c749cfc-4008-4916-b64f-969d6a754c0f,Silver,95.24
df55c56f-b081-45f4-b265-ed1b2c6d94cd,55.56,1.1.7,53.49,Not Rated,Welsh Health Survey Dataset (WHSD),32.78,38.88,19.05,,e4d8edb3-6e8e-435d-9732-60c83027d8f9,Not Rated,33.33
dfba178f-ce67-4c2d-8693-b23110aeecae,23.81,1.1.7,25.58,Bronze,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),68.16,66.66,61.9,ALLIANCE > HQIP,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,Bronze,57.14
dfc16033-7620-4002-aa3b-e5bbc400bbfd,55.56,1.1.7,53.49,Not Rated,MATCH,32.78,38.88,19.05,,5429fc2a-3d72-414d-9393-4079c4c6c0fa,Not Rated,33.33
dfc3205c-3079-4e95-93e2-8a3a3beeea5a,15.87,1.1.7,16.28,Bronze,Generation Scotland,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,019fad36-65ea-4d47-8d6d-a47240eeb801,Silver,60.32
dfd65358-d5a4-40f1-873a-c8c304799cbf,55.56,1.1.7,53.49,Not Rated,NIHR BioResource: Demographic,32.78,38.88,19.05,,d2c486bb-b95b-4093-bb58-b196cfc08c7b,Not Rated,33.33
dfedefac-c389-4d07-a8a3-eb2e4ff34587,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),46.84,44.45,28.57,ALLIANCE > HQIP,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,Not Rated,23.81
e00284e3-439b-4a6d-9781-679c539404f8,46.03,1.1.7,46.51,Not Rated,COVID Tests,29.12,29.36,4.76,,607b17d6-74de-466a-a377-238444707abb,Not Rated,4.76
e031cb49-e8ef-4fc8-91bb-d8bacb6afe7a,46.03,1.1.7,46.51,Not Rated,TwinsUK,29.12,29.36,4.76,,19b4cd38-3828-4bb1-a980-4f7420658965,Not Rated,4.76
e05de62a-91be-46b8-8c1d-c9ed89d8c740,55.56,1.1.7,53.49,Not Rated,Laboratory turnaround times processing electronic blood test orders in the NHS,32.78,38.88,19.05,,971e2827-3aa4-4af3-bdce-3c8419897654,Not Rated,33.33
e096053e-b028-4487-a6d0-6958cbb5f388,55.56,1.1.7,53.49,Not Rated,UK Renal Registry - Your Health Survey dataset,32.78,38.88,19.05,,14ed4ab3-470b-45c8-b48f-27fd382a912e,Not Rated,33.33
e149e0c4-7edd-4e9c-af9d-2b3b2baef9bd,28.57,1.1.7,30.23,Silver,Rural-Urban classification for CPRD Aurum,72.98,78.57,76.19,ALLIANCE > CPRD,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,Bronze,85.71
e172870f-37c4-4103-afae-8a60cae43ccb,11.11,1.1.7,9.3,Silver,SpiroMeta Consortium Dataset,84.63,79.37,78.57,HUB > BREATHE,fb6d98c5-e41d-4804-bb28-839556e0f657,Silver,69.84
e22f93fb-bc08-44eb-b292-dc2baf0ad343,25.4,1.1.7,25.58,Silver,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,76.5,80.16,78.57,HUB > PIONEER,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,Silver,85.71
e3373d01-48c6-49bc-8c9b-827831e525b3,17.46,1.1.7,18.6,Bronze,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",75.22,71.43,69.05,ALLIANCE > TISSUE DIRECTORY,f94168a1-cab8-4211-90e0-38a241609697,Bronze,60.32
e38ceae6-1ef7-4a26-90c9-9b0c920b3df7,50.79,1.1.7,51.16,Not Rated,The impact of multimorbidity on care pathways during COPD hospitalisations,33.95,41.27,19.05,,76167567-9221-4024-bccf-dfdfb9e4bb07,Not Rated,33.33
e443bc67-bc8a-430b-88a9-d3380cd2ae38,15.87,1.1.7,16.28,Bronze,eLIXIR - Early Life Data Cross-Linkage in Research,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,c8cd0645-b728-4c62-84b8-036c1d8763be,Silver,63.49
e4a1be81-8f3c-4731-ae8a-7cbd594c78f5,46.03,1.1.7,46.51,Not Rated,IBD Registry,29.12,29.36,4.76,,a406d06b-350e-4392-ab4e-b1012e422a34,Not Rated,4.76
e4a745d6-f44c-481a-b337-aae4cfe72594,50.79,1.1.7,51.16,Not Rated,Care Home Dataset (CARE),33.95,41.27,19.05,,aae02f9e-1bad-415d-9730-c46a07a990aa,Not Rated,33.33
e5a0c70c-7429-487d-8dc7-04cf073191cc,65.08,1.1.7,58.14,Not Rated,NHS Scotland General Practice (GP) Contact Data - Subset,30.45,34.12,19.05,,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,Not Rated,33.33
e6433c92-8439-4e2e-a3e7-016e7812dcfb,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,46.84,44.45,28.57,ALLIANCE > HQIP,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,Not Rated,23.81
e6d31775-961b-457f-886c-1c0672308a55,60.32,1.1.7,55.81,Not Rated,HDR UK Papers & Preprints,31.62,36.5,19.05,,fd8d0743-344a-4758-bb97-f8ad84a37357,Not Rated,33.33
e70f4e13-440b-4dec-a13c-c17d9d9da553,46.03,1.1.7,46.51,Not Rated,National Emergency Laparotomy Audit - Patient Audit Dataset,29.12,29.36,4.76,,25b93812-191f-49bb-bbd0-782fb85b2bd2,Not Rated,4.76
e7979d81-708d-4657-857c-4ca95d05cda2,15.87,1.1.7,16.28,Bronze,IDRIS Trial,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,8437b207-c925-4dd1-9478-5af329cd736e,Silver,63.49
e79c5f26-deb0-4531-834d-58912c9fe663,30.16,1.1.7,25.58,Bronze,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),68.16,69.84,61.9,ALLIANCE > GREAT ORMOND STREET HOSPITAL,435bfcda-f378-44f6-9387-042d959eb945,Bronze,69.84
e7b615a0-2867-47ff-bb40-0d459b41226c,60.32,1.1.7,55.81,Not Rated,BathTAP Headache Cohort 2,31.62,36.5,19.05,,2d79feab-3046-4735-a4ec-a4c11c9c1aa8,Not Rated,33.33
e8932b23-ed21-40f4-8fb1-00ef186e6ee1,55.56,1.1.7,53.49,Not Rated,Air Pollution Exposure Estimates,32.78,38.88,19.05,,584cbecc-43ef-4015-adf7-ff70178d7abe,Not Rated,33.33
e8c3b66d-f06b-4e3f-944d-f65235133f00,20.63,1.1.7,20.93,Bronze,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,70.48,66.67,61.9,HUB > BREATHE,e8afaf39-86fa-4085-a075-6118cc25fae0,Bronze,53.97
e956a7a4-896b-47dc-8d98-f48385d110f7,50.79,1.1.7,51.16,Not Rated,Brecon Dataset (BREC),33.95,41.27,19.05,,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,Not Rated,33.33
e9820518-54e3-46d1-a63f-c5da867dcd82,55.56,1.1.7,53.49,Not Rated,IBD NIHR BioResource: Health and Lifestyle Questionnaire,32.78,38.88,19.05,,18bfe765-5733-41f3-8114-0a1ec2524b5b,Not Rated,33.33
e9902b10-84ca-495f-a4d9-a9948d0d64ca,55.56,1.1.7,53.49,Not Rated,National Asthma and COPD Audit Programme - Pulmonary rehab organisational audit,32.78,38.88,19.05,,4b33fc6d-3cac-4404-adac-d693328456fa,Not Rated,33.33
e9cdc12c-6938-4c18-b45c-e0a77df6de56,50.79,1.1.7,51.16,Not Rated,Hospitalised Community Acquired Pneumonia before & during the COVID-19 pandemic,33.95,41.27,19.05,,1861b3dd-4969-490e-9faf-c57809f56bc1,Not Rated,33.33
ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,20.63,1.1.7,16.28,Gold,Children Receiving Care and Support Census,89.48,89.69,95.24,ALLIANCE > SAIL,fb3fac03-a428-4b3f-8058-5622e1fd57d8,Gold,100.0
eaca9ed1-30b6-4157-8894-8e53efc84849,36.51,1.1.7,37.21,Not Rated,Sunquest,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,a80b2567-4755-46f1-bd2a-f3817ce4f10c,Not Rated,14.29
eaec06fa-a27e-46d1-9be9-6e1f9a16fb5d,55.56,1.1.7,53.49,Not Rated,Scottish Birth Record (SBR),32.78,38.88,19.05,,81c53293-ef64-4507-8fcf-2a254dc19936,Not Rated,33.33
eb030592-7f5d-4969-abde-c4a962251406,46.03,1.1.7,46.51,Not Rated,English Longitudinal Study of Ageing (ELSA),29.12,29.36,4.76,,f12cb023-1402-49d1-aa27-e0fe4ed19fd7,Not Rated,4.76
eb376dc5-1abb-4d06-a39a-e479078bcf9d,46.03,1.1.7,46.51,Not Rated,ICT-based intervention for adult asthma with limited health literacy,29.12,29.36,4.76,,1d6b02f1-47b8-42ad-919d-f738b545cff7,Not Rated,4.76
eba50bb1-e971-4062-8ece-81be39ceca5b,20.63,1.1.7,16.28,Gold,Annual District Death Extract,89.48,89.69,95.24,ALLIANCE > SAIL,15cf4241-abad-4dcc-95b0-8cd7c02be999,Gold,100.0
ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,55.56,1.1.7,53.49,Not Rated,Community Services Data Set,32.78,38.88,19.05,,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,Not Rated,33.33
ece82228-9af1-4699-a763-b4608908b645,15.87,1.1.7,16.28,Bronze,NHS Grampian Biorepository,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,10d0def8-dc03-473f-b60b-4c0dc3642a25,Silver,63.49
ee099373-8a72-4ec7-818f-3cbb9c8a793d,34.92,1.1.7,34.88,Not Rated,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,46.84,44.45,28.57,ALLIANCE > HQIP,025c9e8a-938b-4886-9e03-fcad90fe7157,Not Rated,23.81
ee2350f2-c619-446e-9785-fce8e0ac9f44,55.56,1.1.7,53.49,Not Rated,Hospital Episode Statistics Accident and Emergency,32.78,38.88,19.05,,3ddfccc3-ba32-4653-a999-966b8d6c412f,Not Rated,33.33
ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,19.05,1.1.7,18.6,Bronze,The PEACE Study,75.22,70.64,69.05,ALLIANCE > TISSUE DIRECTORY,33b1a989-5f61-412e-bdae-b551c92d1ed6,Bronze,60.32
eee15509-f23a-441e-b5be-ee76bd2ba649,55.56,1.1.7,53.49,Not Rated,Scottish Covid-19 Vaccination Data,32.78,38.88,19.05,,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,Not Rated,33.33
ef478925-7612-4cd6-a10e-5e64ee8a0f4d,46.03,1.1.7,46.51,Not Rated,Understanding Society,29.12,29.36,4.76,,932cecdf-65fb-4e3d-9454-7a2d0585e970,Not Rated,4.76
ef727724-6c38-483b-b28d-8e94b5a9d7ac,38.1,1.1.7,39.53,Not Rated,Freetext Dataset,39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,0f07f939-1265-4e8b-aaa6-d897d254c2f3,Not Rated,15.87
f0109da2-6452-45a9-928e-5376dcb78609,60.32,1.1.7,55.81,Not Rated,Coronavirus and the Social Impacts on Great Britain,31.62,36.5,19.05,,e253257c-48c2-491b-b3b9-205161a16a7e,Not Rated,33.33
f08bfb75-f2b8-4afb-9c3d-59cdd2b6b3ce,50.79,1.1.7,51.16,Not Rated,GP Out of Hours,33.95,41.27,19.05,,731dc868-3e79-4722-9b79-6bb8dec9435b,Not Rated,33.33
f0fc13b4-f801-4647-82f3-07ed07f26ea0,28.57,1.1.7,25.58,Silver,Welsh Health Survey Dataset,78.88,80.96,83.33,ALLIANCE > SAIL,e4d8edb3-6e8e-435d-9732-60c83027d8f9,Silver,90.48
f16f0b1b-650d-486b-bc89-946b1623103e,50.79,1.1.7,51.16,Not Rated,Child Health Systems Programme - 13-15 Month Review,33.95,41.27,19.05,,e77af7a3-32fa-4a08-8455-4fb489e5b64a,Not Rated,33.33
f2268d4e-0149-4913-9832-0399960eecd4,31.75,1.1.7,25.58,Silver,North West London Acute Patient level Data (NWL Acute PLD),77.69,77.78,80.95,HUB > DISCOVER NOW,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,Silver,87.3
f2b4211b-1af7-46ff-82a3-35b29d1d478e,38.1,1.1.7,39.53,Not Rated,"Problems, Diagnosis and Procedures",39.76,38.88,19.05,ALLIANCE > BARTS HEALTH,51b41359-1558-48df-9950-88f75ca6ac4c,Not Rated,15.87
f2c2ea2f-f5e8-4297-8510-c2d430ff0946,55.56,1.1.7,53.49,Not Rated,Emergency Department Dataset (EDDS),32.78,38.88,19.05,,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,Not Rated,33.33
f3957e36-25eb-4e0a-a69a-a1c0ce85cb4f,50.79,1.1.7,51.16,Not Rated,Identification of Medical Admissions suitable for Same Day Emergency Care (SDEC),33.95,41.27,19.05,,7af96f17-5ab6-4275-b8ef-61a3e053d342,Not Rated,33.33
f3f24eff-a21b-45e4-92a2-71c162426f53,50.79,1.1.7,51.16,Not Rated,Capture-24: Activity tracker dataset for human activity recognition,33.95,41.27,19.05,,5713fd1a-4358-4485-bed5-83fb25ec2fce,Not Rated,33.33
f58a3c47-44aa-4815-aeab-e19a4a330926,55.56,1.1.7,53.49,Not Rated,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,32.78,38.88,19.05,,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1,Not Rated,33.33
f5d0e254-1005-43a9-88d3-5180c015b7f0,50.79,1.1.7,51.16,Not Rated,CAFCASS Wales (CAFW),33.95,41.27,19.05,,29a714e1-5289-4362-be24-2848c954344e,Not Rated,33.33
f635894a-61b8-40ad-bfa2-4c31ef23ad34,55.56,1.1.7,53.49,Not Rated,Epilepsy 12 - National organisational audit and Trust profile,32.78,38.88,19.05,,2c737d63-69f4-4a02-8df9-54c1e65e845f,Not Rated,33.33
f636abcd-91b1-4408-b44b-5f6274bc98d6,46.03,1.1.7,46.51,Not Rated,National Cardiac Audit Programme - Myocardial Ischaemia National Audit (MINAP),29.12,29.36,4.76,,3558f8a1-6d52-4b59-b513-51c068095bc2,Not Rated,4.76
f6aa8836-b437-40b6-bd1e-ae20010048dd,20.63,1.1.7,16.28,Gold,Substance Misuse Dataset,89.48,89.69,95.24,ALLIANCE > SAIL,291c0dd4-0988-42d2-8e0b-878a892add57,Gold,100.0
f6e25ba4-4f7a-436e-a5f9-f0257d45a612,23.81,1.1.7,20.93,Gold,North West London Integrated Care Record (NWL ICR),85.97,86.51,92.86,HUB > DISCOVER NOW,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,Silver,96.83
f71e0f89-edf6-4070-9045-6024b00f79ca,15.87,1.1.7,16.28,Bronze,PHOTO Translational bladder cancer biorepository,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,07d1b768-78f6-41e8-995a-66afd2549b34,Silver,63.49
f76d0428-f93c-41ba-9ebb-08e4211bf17a,60.32,1.1.7,55.81,Not Rated,Suspected Cancer Pathway Monthly (SCPM),31.62,36.5,19.05,,fcf5a844-f48d-428e-aa06-abe64e66185e,Not Rated,33.33
f80940e8-0ee1-46be-876b-46fb4bbbc4d2,25.4,1.1.7,25.58,Silver,Medicines dispensed in Primary Care (NHSBSA data),75.31,78.57,76.19,ALLIANCE > NHS DIGITAL,f201b68f-d995-4a70-a9ee-aa3510232777,Bronze,82.54
f8a268c1-831c-4c80-b62c-e254a572b9a0,25.4,1.1.7,25.58,Silver,Ventilation strategies for patients on intensive care,75.31,79.36,76.19,HUB > PIONEER,1a66dbc1-4f06-455c-85fc-68b372575cad,Bronze,84.13
f93aea28-7592-42c0-a5e7-5802f0d6051f,34.92,1.1.7,34.88,Not Rated,UK Longitudinal Linkage Collaboration (UK LLC),42.09,41.27,19.05,OTHER > UK Longitudinal Linkage Collaboration (UK LLC),d858cd90-9a2f-4330-9bbe-46e047a5d0a2,Not Rated,17.46
f969e45f-3a71-4dc0-b5ef-476963fe86d5,50.79,1.1.7,51.16,Not Rated,Daily Situation Report Data (DSRD),33.95,41.27,19.05,,c74a9b9e-1fea-4aac-99fd-54e30668e085,Not Rated,33.33
f98d83ec-ad27-46d7-9786-7a0f2749aa11,50.79,1.1.7,51.16,Not Rated,2019 UK Parkinson's Audit - Speech and language therapy,33.95,41.27,19.05,,c7f7541b-5030-40b9-962a-4aba44af7e1a,Not Rated,33.33
f98f9578-a4a3-4d93-b32e-f30ff75888b7,50.79,1.1.7,51.16,Not Rated,Bowel Screening Wales (SBSW),33.95,41.27,19.05,,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,Not Rated,33.33
f9959c00-c063-4fbf-933d-755e3b6ecedc,22.22,1.1.7,23.26,Not Rated,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,58.61,57.14,40.48,ALLIANCE > IMPERIAL COLLEGE LONDON,70656016-c1c9-4bc2-93d1-c66341fcdf36,Not Rated,36.51
f99d82da-13eb-42db-ad0d-348be2173535,15.87,1.1.7,16.28,Bronze,Tommy's National Reproductive Health Biobank,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,20639743-9a28-43dd-a8af-7571ece2a7f8,Silver,63.49
f9c40294-92d8-45cd-b11a-70eb0fc09004,17.46,1.1.7,18.6,Bronze,PHOENIX DDR-Anti-PD-L1 Trial,76.42,73.02,71.43,ALLIANCE > TISSUE DIRECTORY,df94730b-374b-4d91-8116-1c10a7c77c4e,Silver,63.49
fa07a8df-4584-4dc1-87f9-f03ff8d31861,55.56,1.1.7,53.49,Not Rated,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,32.78,38.88,19.05,,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,Not Rated,33.33
fa179e24-2068-4c34-b73c-230003010e9f,34.92,1.1.7,34.88,Not Rated,Genvasc Primary Care Data,48.04,45.24,30.95,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,f397acff-a7af-4062-8e8b-c85889cc41df,Not Rated,25.4
fa45c071-1852-4c02-bddc-fda4517bffa8,50.79,1.1.7,51.16,Not Rated,Scottish Cancer Registry (SMR06),33.95,41.27,19.05,,ad36dc03-1856-44de-99b0-1af6f312d86b,Not Rated,33.33
fb2a851b-3f1c-4665-bbdb-5461f1f36bca,25.4,1.1.7,27.91,Not Rated,Hospital Inpatient data,57.48,56.35,42.86,UK Biobank,97c68424-dc80-4faa-b777-67c42f92a9b6,Not Rated,38.1
fb4a069b-fd74-47b2-bbb1-9cde6b590d66,15.87,1.1.7,13.95,Gold,Breast Test Wales,90.64,92.06,95.24,ALLIANCE > SAIL,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,Gold,100.0
fb50af29-4aa6-4071-9300-bd2d57c850b0,11.11,1.1.7,9.3,Silver,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,85.83,80.16,80.95,HUB > BREATHE,b850e56c-5c5b-413e-b829-743772053978,Silver,71.43
fb65ff7c-fc02-402e-ab55-59765d7b0d43,55.56,1.1.7,53.49,Not Rated,NHS Tayside and Fife Immunology,32.78,38.88,19.05,,39055449-c074-4b58-adb2-b1c0d2441c4d,Not Rated,33.33
fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,46.03,1.1.7,46.51,Not Rated,Asymptomatic COVID-19 in Education (ACE) Cohort,29.12,29.36,4.76,,48adf432-9b66-4d03-a25e-008fbbb24f56,Not Rated,4.76
fbb5d74c-802a-4888-9452-3e0faf257f82,34.92,1.1.7,34.88,Not Rated,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),46.84,44.45,28.57,ALLIANCE > HQIP,33b36393-3760-40d8-bb98-61806fea5398,Not Rated,23.81
fc08ad6a-3e94-44db-a122-945c4c875616,33.33,1.1.7,32.56,Not Rated,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,48.0,45.24,28.57,ALLIANCE > HQIP,f857055b-c29e-4c7f-99ce-65f4ed59648e,Not Rated,23.81
fc704af0-368b-4dd0-866f-753b6d1dccf8,25.4,1.1.7,18.6,Silver,North West London High Cost Drugs Data (NWL HCD),87.13,85.72,92.86,HUB > DISCOVER NOW,75638d2c-556a-46b6-afcc-7ab425b34679,Gold,96.83
fc7b44f0-eb69-4257-8c07-7516c1210c46,36.51,1.1.7,37.21,Not Rated,CellPath,39.73,38.89,16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,c4538af4-505f-45df-aeae-788ddfd7cb54,Not Rated,14.29
fc7ea07b-d60f-4be9-a840-89b17d4c2414,46.03,1.1.7,46.51,Not Rated,National Bowel Cancer Audit - clinical dataset,29.12,29.36,4.76,,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,Not Rated,4.76
fd2317ea-c729-433b-b578-309118118b78,15.87,1.1.7,16.28,Bronze,Infectious Diseases BioBank at King's College London,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,47b544f4-301c-43e0-b347-fc623ea1a8b3,Silver,60.32
fd296ed6-6e12-49ab-9e5f-f40428a47b02,28.57,1.1.7,27.91,Silver,MSDS (Maternity Services Data Set),76.52,79.37,80.95,ALLIANCE > NHS DIGITAL,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,Silver,87.3
fdb053d7-375a-4422-aa16-c899661d72b1,26.98,1.1.7,25.58,Not Rated,"Projections of global, regional and national prevalence of asthma from 2018-2040",59.83,54.77,45.24,HUB > BREATHE,0911f991-6c0f-4412-b805-1ee0ded93a12,Not Rated,36.51
fe168c6f-7533-413e-94fd-066fd845d7c0,55.56,1.1.7,53.49,Not Rated,National Joint Registry - Revision Knee Replacement dataset,32.78,38.88,19.05,,6664317b-39b9-4133-b6c7-ec4bddf78c76,Not Rated,33.33
fe3f2246-aec4-4be4-8f51-3e5bde80931d,15.87,1.1.7,16.28,Bronze,Bristol Biobank,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,Silver,60.32
fe8852b2-9d0b-4145-8f5c-531378731d39,50.79,1.1.7,51.16,Not Rated,Healthcare Workers Risk Assessment (HWRA),33.95,41.27,19.05,,ed131fee-0635-4613-a453-a383d5dd7cec,Not Rated,33.33
feb9a877-2e22-4a5b-a260-5c5186224028,50.79,1.1.7,51.16,Not Rated,Emergency hospital admissions in patients from care home settings,33.95,41.27,19.05,,6009f720-3cd5-449d-b36b-e2ccf3fbc73a,Not Rated,33.33
fed22efe-8a84-4b1e-a642-2412a1420ce8,34.92,1.1.7,34.88,Not Rated,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,46.84,44.45,28.57,ALLIANCE > HQIP,e06b951b-e9d8-4a2c-a51f-1d819f669205,Not Rated,23.81
fede80e2-aea9-4229-8024-39b09110be7b,15.87,1.1.7,16.28,Bronze,REQUITE,76.38,72.22,69.05,ALLIANCE > TISSUE DIRECTORY,b5217dcb-582f-4914-ae45-9eb3899add30,Silver,60.32
fee7f039-99d6-4eab-951d-b35e0ae71a75,60.32,1.1.7,55.81,Not Rated,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,31.62,36.5,19.05,,69a356d6-599e-4d02-8241-066ce3c297bd,Not Rated,33.33
ff0750c4-2765-4bf6-a294-33215f1ced77,50.79,1.1.7,51.16,Not Rated,The impact of COVID on hospitalised patients with COPD and hospital services,33.95,41.27,19.05,,a1c4dda9-d34b-443f-aaaf-231f2e0c31fa,Not Rated,33.33
ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,46.03,1.1.7,46.51,Not Rated,Enhancing access to pulmonary rehabilitation through implementation research,29.12,29.36,4.76,,6265a41f-9444-457b-b401-1d0978f5c58a,Not Rated,4.76
ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,50.79,1.1.7,51.16,Not Rated,Mortality (Death registration),33.95,41.27,19.05,,59fb436a-f8c3-4d4a-bc76-d4a02904b078,Not Rated,33.33
ff2c6982-00f3-4483-9fc2-19b3a7211d8d,49.21,1.1.7,44.19,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,60.05,64.28,64.29,ALLIANCE > NHS DIGITAL,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,Not Rated,77.78
ff727b8e-4805-424a-ba34-acc9b90225fe,46.03,1.1.7,46.51,Not Rated,Oxford Carpal Tunnel Syndrome (CTS) Cohort,29.12,29.36,4.76,,cd3555b0-514a-4693-8f68-c8267a8e9939,Not Rated,4.76
ff8231e5-3ede-4844-a21b-b1d05120e07e,15.87,1.1.7,16.28,Bronze,IMPORT HIGH trial blood samples,77.58,73.81,71.43,ALLIANCE > TISSUE DIRECTORY,edafebac-9479-4d2c-b44e-349091d5b35b,Silver,63.49
